| ENSG00000160336.10 |
Afatinib |
Breast invasive carcinoma |
0.014682463 |
Resistant |
| ENSG00000183535.5 |
Afatinib |
Breast invasive carcinoma |
0.039120042 |
Resistant |
| ENSG00000196960.3 |
Afatinib |
Breast invasive carcinoma |
0.011580851 |
Resistant |
| ENSG00000205662.2 |
Afatinib |
Breast invasive carcinoma |
0.041469016 |
Resistant |
| ENSG00000212163.2 |
Afatinib |
Breast invasive carcinoma |
0.019015746 |
Resistant |
| ENSG00000223960.2 |
Afatinib |
Breast invasive carcinoma |
0.027009721 |
Resistant |
| ENSG00000224020.1 |
Afatinib |
Breast invasive carcinoma |
0.020187535 |
Resistant |
| ENSG00000224468.3 |
Afatinib |
Breast invasive carcinoma |
0.029258742 |
Resistant |
| ENSG00000226380.3 |
Afatinib |
Breast invasive carcinoma |
0.033537455 |
Resistant |
| ENSG00000226673.1 |
Afatinib |
Breast invasive carcinoma |
0.04064972 |
Resistant |
| ENSG00000226800.5 |
Afatinib |
Breast invasive carcinoma |
0.048176493 |
Resistant |
| ENSG00000227215.1 |
Afatinib |
Breast invasive carcinoma |
0.022100615 |
Resistant |
| ENSG00000227542.1 |
Afatinib |
Breast invasive carcinoma |
0.024143661 |
Resistant |
| ENSG00000229190.1 |
Afatinib |
Breast invasive carcinoma |
0.039006544 |
Resistant |
| ENSG00000229852.2 |
Afatinib |
Breast invasive carcinoma |
0.010932014 |
Resistant |
| ENSG00000230499.1 |
Afatinib |
Breast invasive carcinoma |
0.028211414 |
Resistant |
| ENSG00000230836.1 |
Afatinib |
Breast invasive carcinoma |
0.020638414 |
Resistant |
| ENSG00000231789.2 |
Afatinib |
Breast invasive carcinoma |
0.044660615 |
Resistant |
| ENSG00000232487.1 |
Afatinib |
Breast invasive carcinoma |
0.017710393 |
Resistant |
| ENSG00000232527.3 |
Afatinib |
Breast invasive carcinoma |
0.039437219 |
Resistant |
| ENSG00000233033.1 |
Afatinib |
Breast invasive carcinoma |
0.037292034 |
Resistant |
| ENSG00000233509.2 |
Afatinib |
Breast invasive carcinoma |
0.001522631 |
Resistant |
| ENSG00000234292.3 |
Afatinib |
Breast invasive carcinoma |
0.014482246 |
Resistant |
| ENSG00000236711.2 |
Afatinib |
Breast invasive carcinoma |
0.043545683 |
Resistant |
| ENSG00000237036.4 |
Afatinib |
Breast invasive carcinoma |
0.020533373 |
Resistant |
| ENSG00000238280.1 |
Afatinib |
Breast invasive carcinoma |
0.046275361 |
Resistant |
| ENSG00000240288.3 |
Afatinib |
Breast invasive carcinoma |
0.007457903 |
Resistant |
| ENSG00000240401.4 |
Afatinib |
Breast invasive carcinoma |
0.042544228 |
Resistant |
| ENSG00000241014.1 |
Afatinib |
Breast invasive carcinoma |
0.006291264 |
Resistant |
| ENSG00000241316.2 |
Afatinib |
Breast invasive carcinoma |
0.044389631 |
Resistant |
| ENSG00000242516.1 |
Afatinib |
Breast invasive carcinoma |
0.018284979 |
Resistant |
| ENSG00000243701.1 |
Afatinib |
Breast invasive carcinoma |
0.014177492 |
Resistant |
| ENSG00000246090.2 |
Afatinib |
Breast invasive carcinoma |
0.046476773 |
Resistant |
| ENSG00000246695.3 |
Afatinib |
Breast invasive carcinoma |
0.046085711 |
Resistant |
| ENSG00000248092.3 |
Afatinib |
Breast invasive carcinoma |
0.04174048 |
Resistant |
| ENSG00000248275.1 |
Afatinib |
Breast invasive carcinoma |
0.012423498 |
Resistant |
| ENSG00000248668.1 |
Afatinib |
Breast invasive carcinoma |
0.035703565 |
Resistant |
| ENSG00000249207.1 |
Afatinib |
Breast invasive carcinoma |
0.008356553 |
Resistant |
| ENSG00000249740.1 |
Afatinib |
Breast invasive carcinoma |
0.032731378 |
Resistant |
| ENSG00000250634.1 |
Afatinib |
Breast invasive carcinoma |
0.027160819 |
Resistant |
| ENSG00000253553.1 |
Afatinib |
Breast invasive carcinoma |
0.029677724 |
Resistant |
| ENSG00000254710.1 |
Afatinib |
Breast invasive carcinoma |
0.020462879 |
Resistant |
| ENSG00000255008.2 |
Afatinib |
Breast invasive carcinoma |
0.04378584 |
Resistant |
| ENSG00000255090.1 |
Afatinib |
Breast invasive carcinoma |
0.04530183 |
Resistant |
| ENSG00000255520.1 |
Afatinib |
Breast invasive carcinoma |
0.031175741 |
Resistant |
| ENSG00000255565.1 |
Afatinib |
Breast invasive carcinoma |
0.026407985 |
Resistant |
| ENSG00000257221.1 |
Afatinib |
Breast invasive carcinoma |
0.010469168 |
Resistant |
| ENSG00000257354.1 |
Afatinib |
Breast invasive carcinoma |
0.031377503 |
Resistant |
| ENSG00000257527.1 |
Afatinib |
Breast invasive carcinoma |
0.035167842 |
Resistant |
| ENSG00000257698.1 |
Afatinib |
Breast invasive carcinoma |
0.002479268 |
Resistant |
| ENSG00000258789.1 |
Afatinib |
Breast invasive carcinoma |
0.04890319 |
Resistant |
| ENSG00000259327.1 |
Afatinib |
Breast invasive carcinoma |
0.019071581 |
Resistant |
| ENSG00000259426.1 |
Afatinib |
Breast invasive carcinoma |
0.043417627 |
Resistant |
| ENSG00000259645.1 |
Afatinib |
Breast invasive carcinoma |
0.016394447 |
Resistant |
| ENSG00000259705.1 |
Afatinib |
Breast invasive carcinoma |
0.043047581 |
Resistant |
| ENSG00000259744.1 |
Afatinib |
Breast invasive carcinoma |
0.015460637 |
Resistant |
| ENSG00000260475.1 |
Afatinib |
Breast invasive carcinoma |
0.023459577 |
Resistant |
| ENSG00000260661.1 |
Afatinib |
Breast invasive carcinoma |
0.029801368 |
Resistant |
| ENSG00000261341.1 |
Afatinib |
Breast invasive carcinoma |
0.043168572 |
Resistant |
| ENSG00000261438.1 |
Afatinib |
Breast invasive carcinoma |
0.002423959 |
Resistant |
| ENSG00000261801.1 |
Afatinib |
Breast invasive carcinoma |
0.034284739 |
Resistant |
| ENSG00000262319.1 |
Afatinib |
Breast invasive carcinoma |
0.021420677 |
Resistant |
| ENSG00000262888.1 |
Afatinib |
Breast invasive carcinoma |
0.032204997 |
Resistant |
| ENSG00000263388.1 |
Afatinib |
Breast invasive carcinoma |
0.009716486 |
Resistant |
| ENSG00000264007.1 |
Afatinib |
Breast invasive carcinoma |
0.021659257 |
Resistant |
| ENSG00000264448.2 |
Afatinib |
Breast invasive carcinoma |
0.023110605 |
Resistant |
| ENSG00000264940.2 |
Afatinib |
Breast invasive carcinoma |
0.034644447 |
Resistant |
| ENSG00000266824.1 |
Afatinib |
Breast invasive carcinoma |
0.012653349 |
Resistant |
| ENSG00000266965.1 |
Afatinib |
Breast invasive carcinoma |
0.004654746 |
Resistant |
| ENSG00000267040.2 |
Afatinib |
Breast invasive carcinoma |
0.017942856 |
Resistant |
| ENSG00000267042.1 |
Afatinib |
Breast invasive carcinoma |
0.047605686 |
Resistant |
| ENSG00000267505.1 |
Afatinib |
Breast invasive carcinoma |
0.025614754 |
Resistant |
| ENSG00000267783.1 |
Afatinib |
Breast invasive carcinoma |
0.046478489 |
Resistant |
| ENSG00000267787.1 |
Afatinib |
Breast invasive carcinoma |
0.020089042 |
Resistant |
| ENSG00000269293.2 |
Afatinib |
Breast invasive carcinoma |
0.014695508 |
Resistant |
| ENSG00000269486.1 |
Afatinib |
Breast invasive carcinoma |
0.042257274 |
Resistant |
| ENSG00000269951.1 |
Afatinib |
Breast invasive carcinoma |
0.037321573 |
Resistant |
| ENSG00000270108.1 |
Afatinib |
Breast invasive carcinoma |
0.011687148 |
Resistant |
| ENSG00000270828.1 |
Afatinib |
Breast invasive carcinoma |
0.040717462 |
Resistant |
| ENSG00000271948.1 |
Afatinib |
Breast invasive carcinoma |
0.016390364 |
Resistant |
| ENSG00000272130.1 |
Afatinib |
Breast invasive carcinoma |
0.046414903 |
Resistant |
| ENSG00000272243.1 |
Afatinib |
Breast invasive carcinoma |
0.007495078 |
Resistant |
| ENSG00000272263.1 |
Afatinib |
Breast invasive carcinoma |
0.032236163 |
Resistant |
| ENSG00000272691.1 |
Afatinib |
Breast invasive carcinoma |
0.002540689 |
Resistant |
| ENSG00000272695.1 |
Afatinib |
Breast invasive carcinoma |
0.021936323 |
Resistant |
| ENSG00000272977.1 |
Afatinib |
Breast invasive carcinoma |
0.011073756 |
Resistant |
| ENSG00000273007.1 |
Afatinib |
Breast invasive carcinoma |
0.036649247 |
Resistant |
| ENSG00000273209.1 |
Afatinib |
Breast invasive carcinoma |
0.033610226 |
Resistant |
| ENSG00000273264.1 |
Afatinib |
Breast invasive carcinoma |
0.041819417 |
Resistant |
| ENSG00000226792.2 |
Afatinib |
Colon adenocarcinoma |
0.043851051 |
Resistant |
| ENSG00000230499.1 |
Afatinib |
Colon adenocarcinoma |
0.035673767 |
Resistant |
| ENSG00000236641.1 |
Afatinib |
Colon adenocarcinoma |
0.025073807 |
Resistant |
| ENSG00000249593.2 |
Afatinib |
Colon adenocarcinoma |
0.031531586 |
Resistant |
| ENSG00000259457.1 |
Afatinib |
Colon adenocarcinoma |
0.022108571 |
Resistant |
| ENSG00000259469.1 |
Afatinib |
Colon adenocarcinoma |
0.045016423 |
Resistant |
| ENSG00000262294.1 |
Afatinib |
Colon adenocarcinoma |
0.004768614 |
Resistant |
| ENSG00000264026.1 |
Afatinib |
Colon adenocarcinoma |
0.007736517 |
Resistant |
| ENSG00000271824.1 |
Afatinib |
Colon adenocarcinoma |
0.017805818 |
Resistant |
| ENSG00000272123.1 |
Afatinib |
Colon adenocarcinoma |
0.006199968 |
Resistant |
| ENSG00000224805.2 |
Afatinib |
Esophageal cancer |
0.013489033 |
Resistant |
| ENSG00000227431.1 |
Afatinib |
Esophageal cancer |
0.049262669 |
Resistant |
| ENSG00000229702.1 |
Afatinib |
Esophageal cancer |
0.001806446 |
Resistant |
| ENSG00000234235.1 |
Afatinib |
Esophageal cancer |
0.003831573 |
Resistant |
| ENSG00000235910.1 |
Afatinib |
Esophageal cancer |
0.010549367 |
Resistant |
| ENSG00000236651.1 |
Afatinib |
Esophageal cancer |
0.034999113 |
Resistant |
| ENSG00000241764.3 |
Afatinib |
Esophageal cancer |
0.02503565 |
Resistant |
| ENSG00000249550.2 |
Afatinib |
Esophageal cancer |
0.029691404 |
Resistant |
| ENSG00000253708.1 |
Afatinib |
Esophageal cancer |
0.001045331 |
Resistant |
| ENSG00000256690.1 |
Afatinib |
Esophageal cancer |
0.02144241 |
Resistant |
| ENSG00000258658.1 |
Afatinib |
Esophageal cancer |
0.034063213 |
Resistant |
| ENSG00000260583.1 |
Afatinib |
Esophageal cancer |
0.022414191 |
Resistant |
| ENSG00000264365.1 |
Afatinib |
Esophageal cancer |
0.020113017 |
Resistant |
| ENSG00000265218.1 |
Afatinib |
Esophageal cancer |
0.038522027 |
Resistant |
| ENSG00000265912.1 |
Afatinib |
Esophageal cancer |
0.032424305 |
Resistant |
| ENSG00000266120.1 |
Afatinib |
Esophageal cancer |
0.030564428 |
Resistant |
| ENSG00000267919.1 |
Afatinib |
Esophageal cancer |
0.00073032 |
Resistant |
| ENSG00000271788.1 |
Afatinib |
Esophageal cancer |
0.016077316 |
Resistant |
| ENSG00000272370.1 |
Afatinib |
Esophageal cancer |
0.024297742 |
Resistant |
| ENSG00000197989.9 |
Afatinib |
Head and neck squamous cell carcinoma |
0.036562994 |
Resistant |
| ENSG00000224460.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.034514577 |
Resistant |
| ENSG00000224930.2 |
Afatinib |
Head and neck squamous cell carcinoma |
0.003459499 |
Resistant |
| ENSG00000226328.2 |
Afatinib |
Head and neck squamous cell carcinoma |
0.047123927 |
Resistant |
| ENSG00000227456.3 |
Afatinib |
Head and neck squamous cell carcinoma |
0.023327511 |
Resistant |
| ENSG00000228113.3 |
Afatinib |
Head and neck squamous cell carcinoma |
0.012367175 |
Resistant |
| ENSG00000228437.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.007175228 |
Resistant |
| ENSG00000228763.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.037476082 |
Resistant |
| ENSG00000229153.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.00548748 |
Resistant |
| ENSG00000229656.2 |
Afatinib |
Head and neck squamous cell carcinoma |
0.014591218 |
Resistant |
| ENSG00000230439.2 |
Afatinib |
Head and neck squamous cell carcinoma |
0.048422049 |
Resistant |
| ENSG00000230499.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.032889927 |
Resistant |
| ENSG00000231760.2 |
Afatinib |
Head and neck squamous cell carcinoma |
0.03517618 |
Resistant |
| ENSG00000232336.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.004351798 |
Resistant |
| ENSG00000233117.2 |
Afatinib |
Head and neck squamous cell carcinoma |
0.036139843 |
Resistant |
| ENSG00000233184.2 |
Afatinib |
Head and neck squamous cell carcinoma |
0.029718409 |
Resistant |
| ENSG00000233536.2 |
Afatinib |
Head and neck squamous cell carcinoma |
0.003491529 |
Resistant |
| ENSG00000235077.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.007827529 |
Resistant |
| ENSG00000236021.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.023393961 |
Resistant |
| ENSG00000236095.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.025234439 |
Resistant |
| ENSG00000236591.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.044341532 |
Resistant |
| ENSG00000237596.2 |
Afatinib |
Head and neck squamous cell carcinoma |
0.003756266 |
Resistant |
| ENSG00000240291.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.002303346 |
Resistant |
| ENSG00000245466.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.035890048 |
Resistant |
| ENSG00000246560.2 |
Afatinib |
Head and neck squamous cell carcinoma |
0.008344141 |
Resistant |
| ENSG00000249307.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.006611232 |
Resistant |
| ENSG00000250608.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.031933948 |
Resistant |
| ENSG00000253174.2 |
Afatinib |
Head and neck squamous cell carcinoma |
0.001452051 |
Resistant |
| ENSG00000253476.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.036734634 |
Resistant |
| ENSG00000255400.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.021691424 |
Resistant |
| ENSG00000257681.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.028333153 |
Resistant |
| ENSG00000258777.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.006570346 |
Resistant |
| ENSG00000258791.3 |
Afatinib |
Head and neck squamous cell carcinoma |
0.008713865 |
Resistant |
| ENSG00000259959.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.041498157 |
Resistant |
| ENSG00000260448.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.012574686 |
Resistant |
| ENSG00000260464.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.038536158 |
Resistant |
| ENSG00000260708.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.027231271 |
Resistant |
| ENSG00000260823.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.047071706 |
Resistant |
| ENSG00000261291.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.031223846 |
Resistant |
| ENSG00000261560.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.002164487 |
Resistant |
| ENSG00000261864.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.049349802 |
Resistant |
| ENSG00000264868.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.018332381 |
Resistant |
| ENSG00000266278.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.011263146 |
Resistant |
| ENSG00000266926.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.011169229 |
Resistant |
| ENSG00000267183.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.020814932 |
Resistant |
| ENSG00000267213.3 |
Afatinib |
Head and neck squamous cell carcinoma |
0.03994528 |
Resistant |
| ENSG00000267505.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.035962051 |
Resistant |
| ENSG00000269652.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.007469532 |
Resistant |
| ENSG00000269924.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.007734159 |
Resistant |
| ENSG00000271538.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.02152626 |
Resistant |
| ENSG00000272362.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.034669381 |
Resistant |
| ENSG00000272556.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.041504716 |
Resistant |
| ENSG00000272695.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.013574428 |
Resistant |
| ENSG00000272825.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.035040116 |
Resistant |
| ENSG00000177410.8 |
Afatinib |
Kidney renal clear cell carcinoma |
0.034530029 |
Resistant |
| ENSG00000177757.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.025868188 |
Resistant |
| ENSG00000179523.4 |
Afatinib |
Kidney renal clear cell carcinoma |
0.017593091 |
Resistant |
| ENSG00000182109.3 |
Afatinib |
Kidney renal clear cell carcinoma |
0.002320405 |
Resistant |
| ENSG00000189238.4 |
Afatinib |
Kidney renal clear cell carcinoma |
0.004811969 |
Resistant |
| ENSG00000196566.2 |
Afatinib |
Kidney renal clear cell carcinoma |
0.036302861 |
Resistant |
| ENSG00000203325.3 |
Afatinib |
Kidney renal clear cell carcinoma |
0.028538347 |
Resistant |
| ENSG00000203875.6 |
Afatinib |
Kidney renal clear cell carcinoma |
0.010143793 |
Resistant |
| ENSG00000215244.2 |
Afatinib |
Kidney renal clear cell carcinoma |
0.045493965 |
Resistant |
| ENSG00000215458.4 |
Afatinib |
Kidney renal clear cell carcinoma |
0.003483629 |
Resistant |
| ENSG00000222044.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.030644566 |
Resistant |
| ENSG00000223462.2 |
Afatinib |
Kidney renal clear cell carcinoma |
0.027415665 |
Resistant |
| ENSG00000223485.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.011811208 |
Resistant |
| ENSG00000223685.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.011683649 |
Resistant |
| ENSG00000224081.3 |
Afatinib |
Kidney renal clear cell carcinoma |
0.039964165 |
Resistant |
| ENSG00000224621.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.045461348 |
Resistant |
| ENSG00000224764.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.042545064 |
Resistant |
| ENSG00000224888.3 |
Afatinib |
Kidney renal clear cell carcinoma |
0.039155453 |
Resistant |
| ENSG00000224961.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.009060736 |
Resistant |
| ENSG00000224975.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.01231585 |
Resistant |
| ENSG00000225076.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.024532318 |
Resistant |
| ENSG00000225205.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.006056954 |
Resistant |
| ENSG00000225442.2 |
Afatinib |
Kidney renal clear cell carcinoma |
0.025671865 |
Resistant |
| ENSG00000226155.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.038825775 |
Resistant |
| ENSG00000226287.3 |
Afatinib |
Kidney renal clear cell carcinoma |
0.006312059 |
Resistant |
| ENSG00000226349.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.028477036 |
Resistant |
| ENSG00000226696.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.045306135 |
Resistant |
| ENSG00000226741.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.009408204 |
Resistant |
| ENSG00000226758.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.001254409 |
Resistant |
| ENSG00000226803.3 |
Afatinib |
Kidney renal clear cell carcinoma |
0.013087914 |
Resistant |
| ENSG00000227070.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.023371454 |
Resistant |
| ENSG00000227388.2 |
Afatinib |
Kidney renal clear cell carcinoma |
0.01520217 |
Resistant |
| ENSG00000227484.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.047662739 |
Resistant |
| ENSG00000228737.2 |
Afatinib |
Kidney renal clear cell carcinoma |
0.035379447 |
Resistant |
| ENSG00000228748.2 |
Afatinib |
Kidney renal clear cell carcinoma |
0.004525943 |
Resistant |
| ENSG00000229512.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.009816899 |
Resistant |
| ENSG00000229739.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.048911055 |
Resistant |
| ENSG00000229841.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.04570733 |
Resistant |
| ENSG00000230590.3 |
Afatinib |
Kidney renal clear cell carcinoma |
0.019716188 |
Resistant |
| ENSG00000231551.2 |
Afatinib |
Kidney renal clear cell carcinoma |
0.008923658 |
Resistant |
| ENSG00000232117.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.015442899 |
Resistant |
| ENSG00000232336.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.033201631 |
Resistant |
| ENSG00000232623.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.02349935 |
Resistant |
| ENSG00000232642.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.024386192 |
Resistant |
| ENSG00000232655.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.002501057 |
Resistant |
| ENSG00000232855.2 |
Afatinib |
Kidney renal clear cell carcinoma |
0.049334183 |
Resistant |
| ENSG00000232912.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.018058519 |
Resistant |
| ENSG00000233033.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.046903697 |
Resistant |
| ENSG00000233483.2 |
Afatinib |
Kidney renal clear cell carcinoma |
0.033210247 |
Resistant |
| ENSG00000233521.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.009702117 |
Resistant |
| ENSG00000233527.4 |
Afatinib |
Kidney renal clear cell carcinoma |
0.039949293 |
Resistant |
| ENSG00000233695.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.011543043 |
Resistant |
| ENSG00000234019.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.042199956 |
Resistant |
| ENSG00000234062.3 |
Afatinib |
Kidney renal clear cell carcinoma |
0.037686435 |
Resistant |
| ENSG00000234222.2 |
Afatinib |
Kidney renal clear cell carcinoma |
0.038519851 |
Resistant |
| ENSG00000234235.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.017897837 |
Resistant |
| ENSG00000234509.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.021910765 |
Resistant |
| ENSG00000234722.3 |
Afatinib |
Kidney renal clear cell carcinoma |
0.042168532 |
Resistant |
| ENSG00000235192.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.028918251 |
Resistant |
| ENSG00000235204.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.027872376 |
Resistant |
| ENSG00000235565.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.000869318 |
Resistant |
| ENSG00000235760.3 |
Afatinib |
Kidney renal clear cell carcinoma |
0.015133985 |
Resistant |
| ENSG00000236064.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.024077676 |
Resistant |
| ENSG00000236467.3 |
Afatinib |
Kidney renal clear cell carcinoma |
0.001667775 |
Resistant |
| ENSG00000236711.2 |
Afatinib |
Kidney renal clear cell carcinoma |
0.020486082 |
Resistant |
| ENSG00000236751.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.006736349 |
Resistant |
| ENSG00000236780.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.018034719 |
Resistant |
| ENSG00000237327.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.019959722 |
Resistant |
| ENSG00000237491.4 |
Afatinib |
Kidney renal clear cell carcinoma |
0.016595079 |
Resistant |
| ENSG00000237529.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.01750843 |
Resistant |
| ENSG00000238210.2 |
Afatinib |
Kidney renal clear cell carcinoma |
0.019654275 |
Resistant |
| ENSG00000239377.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.006672388 |
Resistant |
| ENSG00000239653.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.010945378 |
Resistant |
| ENSG00000239920.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.032295514 |
Resistant |
| ENSG00000240032.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.001694794 |
Resistant |
| ENSG00000240254.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.041762326 |
Resistant |
| ENSG00000240453.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.006991342 |
Resistant |
| ENSG00000241684.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.001286316 |
Resistant |
| ENSG00000242094.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.018784846 |
Resistant |
| ENSG00000242375.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.012708576 |
Resistant |
| ENSG00000244161.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.043682092 |
Resistant |
| ENSG00000244265.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.026847752 |
Resistant |
| ENSG00000245067.2 |
Afatinib |
Kidney renal clear cell carcinoma |
0.021423721 |
Resistant |
| ENSG00000245148.2 |
Afatinib |
Kidney renal clear cell carcinoma |
0.007840154 |
Resistant |
| ENSG00000245532.4 |
Afatinib |
Kidney renal clear cell carcinoma |
0.046633025 |
Resistant |
| ENSG00000245571.2 |
Afatinib |
Kidney renal clear cell carcinoma |
0.00374836 |
Resistant |
| ENSG00000246067.3 |
Afatinib |
Kidney renal clear cell carcinoma |
0.004041284 |
Resistant |
| ENSG00000247679.2 |
Afatinib |
Kidney renal clear cell carcinoma |
0.001554993 |
Resistant |
| ENSG00000248445.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.024803174 |
Resistant |
| ENSG00000248693.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.017317355 |
Resistant |
| ENSG00000248936.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.020174712 |
Resistant |
| ENSG00000248954.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.026022491 |
Resistant |
| ENSG00000249412.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.007123898 |
Resistant |
| ENSG00000249417.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.033947144 |
Resistant |
| ENSG00000250260.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.031514019 |
Resistant |
| ENSG00000250950.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.024583379 |
Resistant |
| ENSG00000251323.2 |
Afatinib |
Kidney renal clear cell carcinoma |
0.034784488 |
Resistant |
| ENSG00000251432.2 |
Afatinib |
Kidney renal clear cell carcinoma |
0.006931141 |
Resistant |
| ENSG00000251687.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.00071341 |
Resistant |
| ENSG00000253121.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.03332775 |
Resistant |
| ENSG00000253929.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.017067113 |
Resistant |
| ENSG00000254099.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.02904326 |
Resistant |
| ENSG00000254317.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.044399899 |
Resistant |
| ENSG00000254414.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.020805157 |
Resistant |
| ENSG00000254418.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.00887548 |
Resistant |
| ENSG00000254699.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.009379427 |
Resistant |
| ENSG00000254812.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.010598367 |
Resistant |
| ENSG00000254929.2 |
Afatinib |
Kidney renal clear cell carcinoma |
0.017835444 |
Resistant |
| ENSG00000254936.3 |
Afatinib |
Kidney renal clear cell carcinoma |
0.026344829 |
Resistant |
| ENSG00000255318.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.0000682 |
Resistant |
| ENSG00000255503.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.008963124 |
Resistant |
| ENSG00000255886.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.031163559 |
Resistant |
| ENSG00000255970.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.002872322 |
Resistant |
| ENSG00000256789.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.04675365 |
Resistant |
| ENSG00000256862.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.032611401 |
Resistant |
| ENSG00000257202.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.019032683 |
Resistant |
| ENSG00000257452.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.007462902 |
Resistant |
| ENSG00000257913.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.028020134 |
Resistant |
| ENSG00000258044.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.03186332 |
Resistant |
| ENSG00000258551.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.0211266 |
Resistant |
| ENSG00000258725.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.000170937 |
Resistant |
| ENSG00000259125.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.014873903 |
Resistant |
| ENSG00000259138.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.019719508 |
Resistant |
| ENSG00000259201.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.023255084 |
Resistant |
| ENSG00000259212.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.002092035 |
Resistant |
| ENSG00000259322.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.023856435 |
Resistant |
| ENSG00000259456.2 |
Afatinib |
Kidney renal clear cell carcinoma |
0.024996528 |
Resistant |
| ENSG00000259474.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.011127241 |
Resistant |
| ENSG00000259617.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.01020248 |
Resistant |
| ENSG00000259644.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.010073961 |
Resistant |
| ENSG00000259656.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.011039284 |
Resistant |
| ENSG00000259659.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.047864198 |
Resistant |
| ENSG00000259732.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.003836106 |
Resistant |
| ENSG00000259772.2 |
Afatinib |
Kidney renal clear cell carcinoma |
0.026479712 |
Resistant |
| ENSG00000260179.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.022045611 |
Resistant |
| ENSG00000260591.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.037047365 |
Resistant |
| ENSG00000260932.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.020796873 |
Resistant |
| ENSG00000261399.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.006814641 |
Resistant |
| ENSG00000261584.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.00586668 |
Resistant |
| ENSG00000261618.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.039415481 |
Resistant |
| ENSG00000261798.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.036910941 |
Resistant |
| ENSG00000262873.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.011591601 |
Resistant |
| ENSG00000263874.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.001726153 |
Resistant |
| ENSG00000263923.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.031844027 |
Resistant |
| ENSG00000264083.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.046594369 |
Resistant |
| ENSG00000264107.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.018621159 |
Resistant |
| ENSG00000264290.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.048183219 |
Resistant |
| ENSG00000266677.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.000941995 |
Resistant |
| ENSG00000266912.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.042083653 |
Resistant |
| ENSG00000267065.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.042366554 |
Resistant |
| ENSG00000267096.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.048947099 |
Resistant |
| ENSG00000267149.2 |
Afatinib |
Kidney renal clear cell carcinoma |
0.043869965 |
Resistant |
| ENSG00000267163.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.030785246 |
Resistant |
| ENSG00000267191.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.005816159 |
Resistant |
| ENSG00000267481.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.040678739 |
Resistant |
| ENSG00000267605.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.020661726 |
Resistant |
| ENSG00000267662.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.025150489 |
Resistant |
| ENSG00000267682.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.003142148 |
Resistant |
| ENSG00000268189.2 |
Afatinib |
Kidney renal clear cell carcinoma |
0.012145133 |
Resistant |
| ENSG00000268499.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.029247853 |
Resistant |
| ENSG00000268564.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.026174002 |
Resistant |
| ENSG00000268583.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.022978874 |
Resistant |
| ENSG00000268764.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.003342218 |
Resistant |
| ENSG00000268938.2 |
Afatinib |
Kidney renal clear cell carcinoma |
0.011403801 |
Resistant |
| ENSG00000268970.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.028835514 |
Resistant |
| ENSG00000269148.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.005946871 |
Resistant |
| ENSG00000269202.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.029055053 |
Resistant |
| ENSG00000269399.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.036065853 |
Resistant |
| ENSG00000269867.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.001884693 |
Resistant |
| ENSG00000269923.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.006439747 |
Resistant |
| ENSG00000269997.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.045126913 |
Resistant |
| ENSG00000270031.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.008574202 |
Resistant |
| ENSG00000270061.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.032074975 |
Resistant |
| ENSG00000270123.2 |
Afatinib |
Kidney renal clear cell carcinoma |
0.019564939 |
Resistant |
| ENSG00000271579.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.021707062 |
Resistant |
| ENSG00000272109.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.005235094 |
Resistant |
| ENSG00000272203.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.041962449 |
Resistant |
| ENSG00000272255.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.016372016 |
Resistant |
| ENSG00000272374.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.032347799 |
Resistant |
| ENSG00000272630.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.047239618 |
Resistant |
| ENSG00000272689.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.014679401 |
Resistant |
| ENSG00000272692.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.025475031 |
Resistant |
| ENSG00000272834.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.045733434 |
Resistant |
| ENSG00000272983.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.048373687 |
Resistant |
| ENSG00000273009.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.01745818 |
Resistant |
| ENSG00000273096.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.007149652 |
Resistant |
| ENSG00000273116.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.002133754 |
Resistant |
| ENSG00000273350.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.013241996 |
Resistant |
| ENSG00000160336.10 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.009783631 |
Resistant |
| ENSG00000197332.7 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.026236367 |
Resistant |
| ENSG00000204044.5 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.040689292 |
Resistant |
| ENSG00000220161.4 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.046482607 |
Resistant |
| ENSG00000223525.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.022505792 |
Resistant |
| ENSG00000223842.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.011086633 |
Resistant |
| ENSG00000223855.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.022210752 |
Resistant |
| ENSG00000223882.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.00310338 |
Resistant |
| ENSG00000224020.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.048763824 |
Resistant |
| ENSG00000225057.2 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.008040973 |
Resistant |
| ENSG00000225075.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.031375056 |
Resistant |
| ENSG00000225235.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.018186952 |
Resistant |
| ENSG00000226598.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.047655644 |
Resistant |
| ENSG00000226890.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.026964644 |
Resistant |
| ENSG00000227237.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.048024713 |
Resistant |
| ENSG00000227598.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.015910625 |
Resistant |
| ENSG00000228140.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.027295531 |
Resistant |
| ENSG00000228288.2 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.045166784 |
Resistant |
| ENSG00000228393.3 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.027946974 |
Resistant |
| ENSG00000228404.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.044069683 |
Resistant |
| ENSG00000228719.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.029393662 |
Resistant |
| ENSG00000229582.2 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.048074323 |
Resistant |
| ENSG00000230489.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.036451302 |
Resistant |
| ENSG00000230536.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.034075858 |
Resistant |
| ENSG00000230658.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.046308945 |
Resistant |
| ENSG00000230899.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.030888992 |
Resistant |
| ENSG00000231057.3 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.043690129 |
Resistant |
| ENSG00000231113.2 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.013132171 |
Resistant |
| ENSG00000231327.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.047118504 |
Resistant |
| ENSG00000231530.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.001095646 |
Resistant |
| ENSG00000231607.4 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.025746807 |
Resistant |
| ENSG00000232613.2 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.016919328 |
Resistant |
| ENSG00000232892.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.026900784 |
Resistant |
| ENSG00000233654.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.000911313 |
Resistant |
| ENSG00000233775.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.04285949 |
Resistant |
| ENSG00000233806.3 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.039673774 |
Resistant |
| ENSG00000234181.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.002901654 |
Resistant |
| ENSG00000234650.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.041746393 |
Resistant |
| ENSG00000234694.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.018346414 |
Resistant |
| ENSG00000234915.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.003335042 |
Resistant |
| ENSG00000235262.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.044171319 |
Resistant |
| ENSG00000235423.4 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.017910531 |
Resistant |
| ENSG00000235880.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.030875502 |
Resistant |
| ENSG00000236703.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.034280136 |
Resistant |
| ENSG00000236889.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.016653347 |
Resistant |
| ENSG00000237373.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.039957494 |
Resistant |
| ENSG00000237605.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.040706612 |
Resistant |
| ENSG00000237756.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.027009842 |
Resistant |
| ENSG00000237940.3 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.043863584 |
Resistant |
| ENSG00000238123.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.021503549 |
Resistant |
| ENSG00000238141.2 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.048376247 |
Resistant |
| ENSG00000239664.2 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.040916146 |
Resistant |
| ENSG00000240211.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.043800228 |
Resistant |
| ENSG00000245534.2 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.003933425 |
Resistant |
| ENSG00000245598.2 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.026316334 |
Resistant |
| ENSG00000245928.2 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.04279073 |
Resistant |
| ENSG00000247151.2 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.018765053 |
Resistant |
| ENSG00000247679.2 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.014268226 |
Resistant |
| ENSG00000249234.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.026455772 |
Resistant |
| ENSG00000249786.3 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.025046286 |
Resistant |
| ENSG00000250132.2 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.010511124 |
Resistant |
| ENSG00000251307.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.021298327 |
Resistant |
| ENSG00000253174.2 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.016893205 |
Resistant |
| ENSG00000253878.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.035978194 |
Resistant |
| ENSG00000253965.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.048175739 |
Resistant |
| ENSG00000254223.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.043846701 |
Resistant |
| ENSG00000255142.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.000713117 |
Resistant |
| ENSG00000255158.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.020668907 |
Resistant |
| ENSG00000255160.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.027348024 |
Resistant |
| ENSG00000255893.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.010082541 |
Resistant |
| ENSG00000255966.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.020938532 |
Resistant |
| ENSG00000255989.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.048648749 |
Resistant |
| ENSG00000256739.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.010116496 |
Resistant |
| ENSG00000256789.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.005490483 |
Resistant |
| ENSG00000257167.2 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.020056958 |
Resistant |
| ENSG00000258101.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.008638737 |
Resistant |
| ENSG00000259365.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.03034626 |
Resistant |
| ENSG00000260052.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.047890617 |
Resistant |
| ENSG00000260167.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.012936356 |
Resistant |
| ENSG00000260213.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.036595937 |
Resistant |
| ENSG00000260252.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.015230476 |
Resistant |
| ENSG00000260285.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.010262311 |
Resistant |
| ENSG00000260329.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.043455699 |
Resistant |
| ENSG00000260394.2 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.008336492 |
Resistant |
| ENSG00000260447.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.033174848 |
Resistant |
| ENSG00000260464.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.040046907 |
Resistant |
| ENSG00000260495.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.033820576 |
Resistant |
| ENSG00000260646.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.046015388 |
Resistant |
| ENSG00000260664.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.017841019 |
Resistant |
| ENSG00000260912.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.002799722 |
Resistant |
| ENSG00000261008.2 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.013306187 |
Resistant |
| ENSG00000261200.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.026252858 |
Resistant |
| ENSG00000261266.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.006614024 |
Resistant |
| ENSG00000261267.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.03571563 |
Resistant |
| ENSG00000261280.2 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.042488724 |
Resistant |
| ENSG00000261329.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.021136578 |
Resistant |
| ENSG00000261404.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.040243071 |
Resistant |
| ENSG00000261654.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.013291825 |
Resistant |
| ENSG00000261823.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.036678225 |
Resistant |
| ENSG00000261838.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.020625734 |
Resistant |
| ENSG00000261839.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.03600872 |
Resistant |
| ENSG00000262678.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.049201262 |
Resistant |
| ENSG00000266456.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.042265953 |
Resistant |
| ENSG00000266644.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.023240466 |
Resistant |
| ENSG00000266783.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.023228712 |
Resistant |
| ENSG00000266994.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.033608214 |
Resistant |
| ENSG00000267212.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.002379544 |
Resistant |
| ENSG00000267348.2 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.018168023 |
Resistant |
| ENSG00000267414.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.049737584 |
Resistant |
| ENSG00000267804.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.039939323 |
Resistant |
| ENSG00000267927.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.026505591 |
Resistant |
| ENSG00000267939.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.011125215 |
Resistant |
| ENSG00000268355.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.046099405 |
Resistant |
| ENSG00000268613.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.039470828 |
Resistant |
| ENSG00000269102.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.002667605 |
Resistant |
| ENSG00000269444.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.004330778 |
Resistant |
| ENSG00000269656.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.036583861 |
Resistant |
| ENSG00000269934.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.043676078 |
Resistant |
| ENSG00000270006.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.041732509 |
Resistant |
| ENSG00000271218.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.042753581 |
Resistant |
| ENSG00000271732.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.009037871 |
Resistant |
| ENSG00000271734.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.022920217 |
Resistant |
| ENSG00000271757.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.028341347 |
Resistant |
| ENSG00000272070.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.031242761 |
Resistant |
| ENSG00000272092.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.021669145 |
Resistant |
| ENSG00000272524.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.016800782 |
Resistant |
| ENSG00000272562.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.007142877 |
Resistant |
| ENSG00000272682.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.016579875 |
Resistant |
| ENSG00000272696.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.023574721 |
Resistant |
| ENSG00000273056.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.01375458 |
Resistant |
| ENSG00000273076.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.017027477 |
Resistant |
| ENSG00000273253.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.027956356 |
Resistant |
| ENSG00000187156.4 |
Afatinib |
Brain lower grade glioma |
0.039805673 |
Resistant |
| ENSG00000224707.1 |
Afatinib |
Brain lower grade glioma |
0.018904801 |
Resistant |
| ENSG00000224812.2 |
Afatinib |
Brain lower grade glioma |
0.046620438 |
Resistant |
| ENSG00000225096.1 |
Afatinib |
Brain lower grade glioma |
0.045508974 |
Resistant |
| ENSG00000225572.1 |
Afatinib |
Brain lower grade glioma |
0.012210041 |
Resistant |
| ENSG00000226367.1 |
Afatinib |
Brain lower grade glioma |
0.009210341 |
Resistant |
| ENSG00000228293.1 |
Afatinib |
Brain lower grade glioma |
0.021228067 |
Resistant |
| ENSG00000231865.1 |
Afatinib |
Brain lower grade glioma |
0.046852674 |
Resistant |
| ENSG00000232019.1 |
Afatinib |
Brain lower grade glioma |
0.048869868 |
Resistant |
| ENSG00000232224.1 |
Afatinib |
Brain lower grade glioma |
0.012133771 |
Resistant |
| ENSG00000232386.5 |
Afatinib |
Brain lower grade glioma |
0.013806893 |
Resistant |
| ENSG00000232677.2 |
Afatinib |
Brain lower grade glioma |
0.022015325 |
Resistant |
| ENSG00000248576.1 |
Afatinib |
Brain lower grade glioma |
0.033312437 |
Resistant |
| ENSG00000250451.1 |
Afatinib |
Brain lower grade glioma |
0.045130831 |
Resistant |
| ENSG00000253706.1 |
Afatinib |
Brain lower grade glioma |
0.037693586 |
Resistant |
| ENSG00000253773.1 |
Afatinib |
Brain lower grade glioma |
0.020629346 |
Resistant |
| ENSG00000254563.1 |
Afatinib |
Brain lower grade glioma |
0.044103538 |
Resistant |
| ENSG00000254854.1 |
Afatinib |
Brain lower grade glioma |
0.024740927 |
Resistant |
| ENSG00000256092.2 |
Afatinib |
Brain lower grade glioma |
0.048629553 |
Resistant |
| ENSG00000257551.1 |
Afatinib |
Brain lower grade glioma |
0.038017005 |
Resistant |
| ENSG00000258442.1 |
Afatinib |
Brain lower grade glioma |
0.040014184 |
Resistant |
| ENSG00000259280.1 |
Afatinib |
Brain lower grade glioma |
0.049844789 |
Resistant |
| ENSG00000259604.1 |
Afatinib |
Brain lower grade glioma |
0.029545277 |
Resistant |
| ENSG00000261168.1 |
Afatinib |
Brain lower grade glioma |
0.044553721 |
Resistant |
| ENSG00000261685.2 |
Afatinib |
Brain lower grade glioma |
0.026616502 |
Resistant |
| ENSG00000263096.1 |
Afatinib |
Brain lower grade glioma |
0.028118202 |
Resistant |
| ENSG00000264853.1 |
Afatinib |
Brain lower grade glioma |
0.049344861 |
Resistant |
| ENSG00000266913.1 |
Afatinib |
Brain lower grade glioma |
0.02921462 |
Resistant |
| ENSG00000269392.1 |
Afatinib |
Brain lower grade glioma |
0.049246329 |
Resistant |
| ENSG00000269887.1 |
Afatinib |
Brain lower grade glioma |
0.019848927 |
Resistant |
| ENSG00000269994.1 |
Afatinib |
Brain lower grade glioma |
0.002523637 |
Resistant |
| ENSG00000270173.1 |
Afatinib |
Brain lower grade glioma |
0.03507607 |
Resistant |
| ENSG00000271185.1 |
Afatinib |
Brain lower grade glioma |
0.036462528 |
Resistant |
| ENSG00000272489.1 |
Afatinib |
Brain lower grade glioma |
0.045684753 |
Resistant |
| ENSG00000272508.1 |
Afatinib |
Brain lower grade glioma |
0.017076447 |
Resistant |
| ENSG00000272639.1 |
Afatinib |
Brain lower grade glioma |
0.033986715 |
Resistant |
| ENSG00000272808.1 |
Afatinib |
Brain lower grade glioma |
0.017566744 |
Resistant |
| ENSG00000273007.1 |
Afatinib |
Brain lower grade glioma |
0.045485127 |
Resistant |
| ENSG00000273188.1 |
Afatinib |
Brain lower grade glioma |
0.046370627 |
Resistant |
| ENSG00000163364.5 |
Afatinib |
Lung squamous cell carcinoma |
0.025231562 |
Resistant |
| ENSG00000185904.7 |
Afatinib |
Lung squamous cell carcinoma |
0.047892571 |
Resistant |
| ENSG00000186019.10 |
Afatinib |
Lung squamous cell carcinoma |
0.025235641 |
Resistant |
| ENSG00000188424.5 |
Afatinib |
Lung squamous cell carcinoma |
0.024636376 |
Resistant |
| ENSG00000196960.3 |
Afatinib |
Lung squamous cell carcinoma |
0.015666411 |
Resistant |
| ENSG00000203808.6 |
Afatinib |
Lung squamous cell carcinoma |
0.028945984 |
Resistant |
| ENSG00000204832.5 |
Afatinib |
Lung squamous cell carcinoma |
0.015647985 |
Resistant |
| ENSG00000206417.4 |
Afatinib |
Lung squamous cell carcinoma |
0.008702788 |
Resistant |
| ENSG00000214773.1 |
Afatinib |
Lung squamous cell carcinoma |
0.009404872 |
Resistant |
| ENSG00000223379.1 |
Afatinib |
Lung squamous cell carcinoma |
0.045543946 |
Resistant |
| ENSG00000223791.1 |
Afatinib |
Lung squamous cell carcinoma |
0.020614029 |
Resistant |
| ENSG00000223884.1 |
Afatinib |
Lung squamous cell carcinoma |
0.030881167 |
Resistant |
| ENSG00000224189.2 |
Afatinib |
Lung squamous cell carcinoma |
0.011266044 |
Resistant |
| ENSG00000224384.1 |
Afatinib |
Lung squamous cell carcinoma |
0.043136396 |
Resistant |
| ENSG00000224577.1 |
Afatinib |
Lung squamous cell carcinoma |
0.014424411 |
Resistant |
| ENSG00000224713.3 |
Afatinib |
Lung squamous cell carcinoma |
0.004651492 |
Resistant |
| ENSG00000224875.2 |
Afatinib |
Lung squamous cell carcinoma |
0.023046101 |
Resistant |
| ENSG00000224883.1 |
Afatinib |
Lung squamous cell carcinoma |
0.033532212 |
Resistant |
| ENSG00000225152.1 |
Afatinib |
Lung squamous cell carcinoma |
0.027103369 |
Resistant |
| ENSG00000225439.2 |
Afatinib |
Lung squamous cell carcinoma |
0.029200004 |
Resistant |
| ENSG00000225465.6 |
Afatinib |
Lung squamous cell carcinoma |
0.041624134 |
Resistant |
| ENSG00000225602.1 |
Afatinib |
Lung squamous cell carcinoma |
0.012178694 |
Resistant |
| ENSG00000225767.1 |
Afatinib |
Lung squamous cell carcinoma |
0.003171757 |
Resistant |
| ENSG00000225850.2 |
Afatinib |
Lung squamous cell carcinoma |
0.027622291 |
Resistant |
| ENSG00000226363.3 |
Afatinib |
Lung squamous cell carcinoma |
0.034176008 |
Resistant |
| ENSG00000226791.3 |
Afatinib |
Lung squamous cell carcinoma |
0.048658514 |
Resistant |
| ENSG00000226935.2 |
Afatinib |
Lung squamous cell carcinoma |
0.023522305 |
Resistant |
| ENSG00000227189.2 |
Afatinib |
Lung squamous cell carcinoma |
0.007114074 |
Resistant |
| ENSG00000227487.3 |
Afatinib |
Lung squamous cell carcinoma |
0.035885852 |
Resistant |
| ENSG00000227748.1 |
Afatinib |
Lung squamous cell carcinoma |
0.049472756 |
Resistant |
| ENSG00000227906.3 |
Afatinib |
Lung squamous cell carcinoma |
0.012676924 |
Resistant |
| ENSG00000228203.2 |
Afatinib |
Lung squamous cell carcinoma |
0.034964711 |
Resistant |
| ENSG00000228290.2 |
Afatinib |
Lung squamous cell carcinoma |
0.044955358 |
Resistant |
| ENSG00000228544.1 |
Afatinib |
Lung squamous cell carcinoma |
0.024586637 |
Resistant |
| ENSG00000228643.1 |
Afatinib |
Lung squamous cell carcinoma |
0.036760051 |
Resistant |
| ENSG00000228939.1 |
Afatinib |
Lung squamous cell carcinoma |
0.016830007 |
Resistant |
| ENSG00000229154.1 |
Afatinib |
Lung squamous cell carcinoma |
0.004591745 |
Resistant |
| ENSG00000229196.3 |
Afatinib |
Lung squamous cell carcinoma |
0.044049275 |
Resistant |
| ENSG00000229294.1 |
Afatinib |
Lung squamous cell carcinoma |
0.031012699 |
Resistant |
| ENSG00000229311.1 |
Afatinib |
Lung squamous cell carcinoma |
0.04389528 |
Resistant |
| ENSG00000229531.1 |
Afatinib |
Lung squamous cell carcinoma |
0.035990324 |
Resistant |
| ENSG00000229582.2 |
Afatinib |
Lung squamous cell carcinoma |
0.007043005 |
Resistant |
| ENSG00000229766.2 |
Afatinib |
Lung squamous cell carcinoma |
0.023610034 |
Resistant |
| ENSG00000229821.1 |
Afatinib |
Lung squamous cell carcinoma |
0.047446588 |
Resistant |
| ENSG00000230184.1 |
Afatinib |
Lung squamous cell carcinoma |
0.047638312 |
Resistant |
| ENSG00000230319.1 |
Afatinib |
Lung squamous cell carcinoma |
0.036475218 |
Resistant |
| ENSG00000230506.1 |
Afatinib |
Lung squamous cell carcinoma |
0.031285915 |
Resistant |
| ENSG00000230699.2 |
Afatinib |
Lung squamous cell carcinoma |
0.037843028 |
Resistant |
| ENSG00000230725.1 |
Afatinib |
Lung squamous cell carcinoma |
0.035039281 |
Resistant |
| ENSG00000231367.1 |
Afatinib |
Lung squamous cell carcinoma |
0.043071624 |
Resistant |
| ENSG00000231871.1 |
Afatinib |
Lung squamous cell carcinoma |
0.018286899 |
Resistant |
| ENSG00000231976.3 |
Afatinib |
Lung squamous cell carcinoma |
0.020137807 |
Resistant |
| ENSG00000232118.1 |
Afatinib |
Lung squamous cell carcinoma |
0.012734777 |
Resistant |
| ENSG00000232131.1 |
Afatinib |
Lung squamous cell carcinoma |
0.008467114 |
Resistant |
| ENSG00000232184.1 |
Afatinib |
Lung squamous cell carcinoma |
0.046826262 |
Resistant |
| ENSG00000232696.1 |
Afatinib |
Lung squamous cell carcinoma |
0.038956133 |
Resistant |
| ENSG00000233058.1 |
Afatinib |
Lung squamous cell carcinoma |
0.031098355 |
Resistant |
| ENSG00000233261.1 |
Afatinib |
Lung squamous cell carcinoma |
0.031322919 |
Resistant |
| ENSG00000233303.1 |
Afatinib |
Lung squamous cell carcinoma |
0.028835731 |
Resistant |
| ENSG00000233451.1 |
Afatinib |
Lung squamous cell carcinoma |
0.03607147 |
Resistant |
| ENSG00000233848.1 |
Afatinib |
Lung squamous cell carcinoma |
0.037310555 |
Resistant |
| ENSG00000234206.1 |
Afatinib |
Lung squamous cell carcinoma |
0.004973498 |
Resistant |
| ENSG00000234215.2 |
Afatinib |
Lung squamous cell carcinoma |
0.0252033 |
Resistant |
| ENSG00000234428.2 |
Afatinib |
Lung squamous cell carcinoma |
0.030220778 |
Resistant |
| ENSG00000234456.3 |
Afatinib |
Lung squamous cell carcinoma |
0.014054505 |
Resistant |
| ENSG00000234917.1 |
Afatinib |
Lung squamous cell carcinoma |
0.00503092 |
Resistant |
| ENSG00000235117.2 |
Afatinib |
Lung squamous cell carcinoma |
0.043540138 |
Resistant |
| ENSG00000236194.2 |
Afatinib |
Lung squamous cell carcinoma |
0.030863363 |
Resistant |
| ENSG00000236394.1 |
Afatinib |
Lung squamous cell carcinoma |
0.047634427 |
Resistant |
| ENSG00000236536.1 |
Afatinib |
Lung squamous cell carcinoma |
0.01729791 |
Resistant |
| ENSG00000236703.1 |
Afatinib |
Lung squamous cell carcinoma |
0.047242454 |
Resistant |
| ENSG00000237336.1 |
Afatinib |
Lung squamous cell carcinoma |
0.02148937 |
Resistant |
| ENSG00000237485.1 |
Afatinib |
Lung squamous cell carcinoma |
0.015651099 |
Resistant |
| ENSG00000237707.1 |
Afatinib |
Lung squamous cell carcinoma |
0.043512456 |
Resistant |
| ENSG00000240553.1 |
Afatinib |
Lung squamous cell carcinoma |
0.011146197 |
Resistant |
| ENSG00000241180.1 |
Afatinib |
Lung squamous cell carcinoma |
0.032656744 |
Resistant |
| ENSG00000241570.4 |
Afatinib |
Lung squamous cell carcinoma |
0.047745487 |
Resistant |
| ENSG00000242540.2 |
Afatinib |
Lung squamous cell carcinoma |
0.012087498 |
Resistant |
| ENSG00000244302.1 |
Afatinib |
Lung squamous cell carcinoma |
0.045181497 |
Resistant |
| ENSG00000246528.3 |
Afatinib |
Lung squamous cell carcinoma |
0.047087789 |
Resistant |
| ENSG00000247416.2 |
Afatinib |
Lung squamous cell carcinoma |
0.041203054 |
Resistant |
| ENSG00000248138.1 |
Afatinib |
Lung squamous cell carcinoma |
0.044624775 |
Resistant |
| ENSG00000248152.1 |
Afatinib |
Lung squamous cell carcinoma |
0.019680159 |
Resistant |
| ENSG00000248371.1 |
Afatinib |
Lung squamous cell carcinoma |
0.041808975 |
Resistant |
| ENSG00000248714.2 |
Afatinib |
Lung squamous cell carcinoma |
0.012928752 |
Resistant |
| ENSG00000248774.1 |
Afatinib |
Lung squamous cell carcinoma |
0.007705852 |
Resistant |
| ENSG00000250046.3 |
Afatinib |
Lung squamous cell carcinoma |
0.035830694 |
Resistant |
| ENSG00000250320.1 |
Afatinib |
Lung squamous cell carcinoma |
0.043567066 |
Resistant |
| ENSG00000250592.1 |
Afatinib |
Lung squamous cell carcinoma |
0.001285735 |
Resistant |
| ENSG00000250698.1 |
Afatinib |
Lung squamous cell carcinoma |
0.049530649 |
Resistant |
| ENSG00000250948.1 |
Afatinib |
Lung squamous cell carcinoma |
0.040183544 |
Resistant |
| ENSG00000251221.1 |
Afatinib |
Lung squamous cell carcinoma |
0.004239261 |
Resistant |
| ENSG00000253390.1 |
Afatinib |
Lung squamous cell carcinoma |
0.044858716 |
Resistant |
| ENSG00000253837.1 |
Afatinib |
Lung squamous cell carcinoma |
0.045047317 |
Resistant |
| ENSG00000253875.1 |
Afatinib |
Lung squamous cell carcinoma |
0.025501536 |
Resistant |
| ENSG00000254226.1 |
Afatinib |
Lung squamous cell carcinoma |
0.029823857 |
Resistant |
| ENSG00000254266.1 |
Afatinib |
Lung squamous cell carcinoma |
0.035402176 |
Resistant |
| ENSG00000254319.1 |
Afatinib |
Lung squamous cell carcinoma |
0.038344233 |
Resistant |
| ENSG00000254528.3 |
Afatinib |
Lung squamous cell carcinoma |
0.038435351 |
Resistant |
| ENSG00000254533.1 |
Afatinib |
Lung squamous cell carcinoma |
0.043526136 |
Resistant |
| ENSG00000254539.1 |
Afatinib |
Lung squamous cell carcinoma |
0.027221488 |
Resistant |
| ENSG00000254710.1 |
Afatinib |
Lung squamous cell carcinoma |
0.027298344 |
Resistant |
| ENSG00000254777.1 |
Afatinib |
Lung squamous cell carcinoma |
0.045730571 |
Resistant |
| ENSG00000254898.1 |
Afatinib |
Lung squamous cell carcinoma |
0.015094868 |
Resistant |
| ENSG00000254990.1 |
Afatinib |
Lung squamous cell carcinoma |
0.015244728 |
Resistant |
| ENSG00000255124.1 |
Afatinib |
Lung squamous cell carcinoma |
0.046945564 |
Resistant |
| ENSG00000255321.1 |
Afatinib |
Lung squamous cell carcinoma |
0.044478134 |
Resistant |
| ENSG00000255334.1 |
Afatinib |
Lung squamous cell carcinoma |
0.025772245 |
Resistant |
| ENSG00000256084.1 |
Afatinib |
Lung squamous cell carcinoma |
0.020252996 |
Resistant |
| ENSG00000257264.2 |
Afatinib |
Lung squamous cell carcinoma |
0.017717243 |
Resistant |
| ENSG00000257527.1 |
Afatinib |
Lung squamous cell carcinoma |
0.042134952 |
Resistant |
| ENSG00000258303.1 |
Afatinib |
Lung squamous cell carcinoma |
0.035700057 |
Resistant |
| ENSG00000258824.2 |
Afatinib |
Lung squamous cell carcinoma |
0.001826454 |
Resistant |
| ENSG00000259081.1 |
Afatinib |
Lung squamous cell carcinoma |
0.046860145 |
Resistant |
| ENSG00000259163.1 |
Afatinib |
Lung squamous cell carcinoma |
0.028142387 |
Resistant |
| ENSG00000259296.1 |
Afatinib |
Lung squamous cell carcinoma |
0.048182615 |
Resistant |
| ENSG00000259462.1 |
Afatinib |
Lung squamous cell carcinoma |
0.031367409 |
Resistant |
| ENSG00000259814.1 |
Afatinib |
Lung squamous cell carcinoma |
0.036627646 |
Resistant |
| ENSG00000259969.1 |
Afatinib |
Lung squamous cell carcinoma |
0.048903084 |
Resistant |
| ENSG00000260196.1 |
Afatinib |
Lung squamous cell carcinoma |
0.033281719 |
Resistant |
| ENSG00000260329.1 |
Afatinib |
Lung squamous cell carcinoma |
0.015312887 |
Resistant |
| ENSG00000260398.1 |
Afatinib |
Lung squamous cell carcinoma |
0.025290225 |
Resistant |
| ENSG00000260614.1 |
Afatinib |
Lung squamous cell carcinoma |
0.031590925 |
Resistant |
| ENSG00000260655.1 |
Afatinib |
Lung squamous cell carcinoma |
0.024869999 |
Resistant |
| ENSG00000260831.1 |
Afatinib |
Lung squamous cell carcinoma |
0.012814411 |
Resistant |
| ENSG00000260931.1 |
Afatinib |
Lung squamous cell carcinoma |
0.040378433 |
Resistant |
| ENSG00000261024.2 |
Afatinib |
Lung squamous cell carcinoma |
0.046976622 |
Resistant |
| ENSG00000261168.1 |
Afatinib |
Lung squamous cell carcinoma |
0.024339835 |
Resistant |
| ENSG00000261416.1 |
Afatinib |
Lung squamous cell carcinoma |
0.017425505 |
Resistant |
| ENSG00000262119.1 |
Afatinib |
Lung squamous cell carcinoma |
0.000372519 |
Resistant |
| ENSG00000262265.1 |
Afatinib |
Lung squamous cell carcinoma |
0.043410618 |
Resistant |
| ENSG00000264895.1 |
Afatinib |
Lung squamous cell carcinoma |
0.006133684 |
Resistant |
| ENSG00000265113.1 |
Afatinib |
Lung squamous cell carcinoma |
0.007956843 |
Resistant |
| ENSG00000266111.1 |
Afatinib |
Lung squamous cell carcinoma |
0.015580264 |
Resistant |
| ENSG00000266256.1 |
Afatinib |
Lung squamous cell carcinoma |
0.035694174 |
Resistant |
| ENSG00000267093.1 |
Afatinib |
Lung squamous cell carcinoma |
0.047498089 |
Resistant |
| ENSG00000267289.1 |
Afatinib |
Lung squamous cell carcinoma |
0.016390996 |
Resistant |
| ENSG00000267672.1 |
Afatinib |
Lung squamous cell carcinoma |
0.020122019 |
Resistant |
| ENSG00000267758.1 |
Afatinib |
Lung squamous cell carcinoma |
0.016370851 |
Resistant |
| ENSG00000269806.1 |
Afatinib |
Lung squamous cell carcinoma |
0.041727638 |
Resistant |
| ENSG00000269908.1 |
Afatinib |
Lung squamous cell carcinoma |
0.042260566 |
Resistant |
| ENSG00000270072.1 |
Afatinib |
Lung squamous cell carcinoma |
0.012752011 |
Resistant |
| ENSG00000270174.1 |
Afatinib |
Lung squamous cell carcinoma |
0.048870229 |
Resistant |
| ENSG00000270457.1 |
Afatinib |
Lung squamous cell carcinoma |
0.032801319 |
Resistant |
| ENSG00000270704.2 |
Afatinib |
Lung squamous cell carcinoma |
0.042057944 |
Resistant |
| ENSG00000271314.1 |
Afatinib |
Lung squamous cell carcinoma |
0.018750459 |
Resistant |
| ENSG00000271347.1 |
Afatinib |
Lung squamous cell carcinoma |
0.033315122 |
Resistant |
| ENSG00000271367.1 |
Afatinib |
Lung squamous cell carcinoma |
0.009276444 |
Resistant |
| ENSG00000271716.1 |
Afatinib |
Lung squamous cell carcinoma |
0.0005341 |
Resistant |
| ENSG00000271914.1 |
Afatinib |
Lung squamous cell carcinoma |
0.034032089 |
Resistant |
| ENSG00000271948.1 |
Afatinib |
Lung squamous cell carcinoma |
0.014496115 |
Resistant |
| ENSG00000272002.1 |
Afatinib |
Lung squamous cell carcinoma |
0.049992621 |
Resistant |
| ENSG00000272033.1 |
Afatinib |
Lung squamous cell carcinoma |
0.015975618 |
Resistant |
| ENSG00000272334.1 |
Afatinib |
Lung squamous cell carcinoma |
0.020052055 |
Resistant |
| ENSG00000272452.1 |
Afatinib |
Lung squamous cell carcinoma |
0.040588908 |
Resistant |
| ENSG00000272983.1 |
Afatinib |
Lung squamous cell carcinoma |
0.030732377 |
Resistant |
| ENSG00000273077.1 |
Afatinib |
Lung squamous cell carcinoma |
0.047432823 |
Resistant |
| ENSG00000273175.1 |
Afatinib |
Lung squamous cell carcinoma |
0.042473509 |
Resistant |
| ENSG00000273483.1 |
Afatinib |
Lung squamous cell carcinoma |
0.026606557 |
Resistant |
| ENSG00000273493.1 |
Afatinib |
Lung squamous cell carcinoma |
0.038798591 |
Resistant |
| ENSG00000170590.4 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.038894807 |
Resistant |
| ENSG00000179406.6 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.021040214 |
Resistant |
| ENSG00000182648.7 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.00537069 |
Resistant |
| ENSG00000203288.3 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.032656618 |
Resistant |
| ENSG00000205885.3 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.040057005 |
Resistant |
| ENSG00000206028.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.028951417 |
Resistant |
| ENSG00000213468.3 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.008689091 |
Resistant |
| ENSG00000214293.4 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.014091379 |
Resistant |
| ENSG00000215241.3 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.000326498 |
Resistant |
| ENSG00000223396.2 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.007591994 |
Resistant |
| ENSG00000224281.4 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.033282784 |
Resistant |
| ENSG00000224969.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.024772367 |
Resistant |
| ENSG00000225578.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.016082002 |
Resistant |
| ENSG00000225891.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.024851937 |
Resistant |
| ENSG00000228192.3 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.037787949 |
Resistant |
| ENSG00000228237.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.037142461 |
Resistant |
| ENSG00000231721.2 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.046827801 |
Resistant |
| ENSG00000231966.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.001849409 |
Resistant |
| ENSG00000232611.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.030993561 |
Resistant |
| ENSG00000233242.2 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.046845097 |
Resistant |
| ENSG00000234062.3 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.049568151 |
Resistant |
| ENSG00000234185.2 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.007121008 |
Resistant |
| ENSG00000235530.2 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.025202637 |
Resistant |
| ENSG00000235837.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.048574923 |
Resistant |
| ENSG00000235903.3 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.030819123 |
Resistant |
| ENSG00000236088.5 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.012478202 |
Resistant |
| ENSG00000239213.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.039471766 |
Resistant |
| ENSG00000239523.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.009837868 |
Resistant |
| ENSG00000240211.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.04000155 |
Resistant |
| ENSG00000240875.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.007542301 |
Resistant |
| ENSG00000241933.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.048150689 |
Resistant |
| ENSG00000242474.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.023251841 |
Resistant |
| ENSG00000246263.2 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.023998369 |
Resistant |
| ENSG00000246334.2 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.016824418 |
Resistant |
| ENSG00000246465.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.025349338 |
Resistant |
| ENSG00000246523.3 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.049057541 |
Resistant |
| ENSG00000248079.2 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.01975385 |
Resistant |
| ENSG00000248664.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.034273702 |
Resistant |
| ENSG00000250234.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.046591276 |
Resistant |
| ENSG00000250326.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.00193898 |
Resistant |
| ENSG00000251666.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.048551809 |
Resistant |
| ENSG00000254362.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.044222758 |
Resistant |
| ENSG00000255139.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.024899788 |
Resistant |
| ENSG00000255968.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.037307812 |
Resistant |
| ENSG00000259899.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.02970789 |
Resistant |
| ENSG00000260022.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.029967091 |
Resistant |
| ENSG00000260336.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.019791396 |
Resistant |
| ENSG00000260655.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.024304083 |
Resistant |
| ENSG00000263280.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.04895365 |
Resistant |
| ENSG00000264575.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.024391376 |
Resistant |
| ENSG00000265091.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.015695671 |
Resistant |
| ENSG00000269290.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.006409328 |
Resistant |
| ENSG00000269956.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.037895265 |
Resistant |
| ENSG00000270720.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.022267534 |
Resistant |
| ENSG00000271270.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.042962741 |
Resistant |
| ENSG00000272426.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.037954528 |
Resistant |
| ENSG00000272760.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.049582151 |
Resistant |
| ENSG00000272983.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.035468779 |
Resistant |
| ENSG00000273174.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.047302097 |
Resistant |
| ENSG00000273344.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.003445734 |
Resistant |
| ENSG00000273374.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.007625541 |
Resistant |
| ENSG00000179406.6 |
Afatinib |
Pancreatic adenocarcinoma |
0.007269173 |
Resistant |
| ENSG00000225555.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.048360133 |
Resistant |
| ENSG00000233038.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.002271852 |
Resistant |
| ENSG00000237945.3 |
Afatinib |
Pancreatic adenocarcinoma |
0.019953656 |
Resistant |
| ENSG00000246363.2 |
Afatinib |
Pancreatic adenocarcinoma |
0.033915649 |
Resistant |
| ENSG00000250934.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.000061 |
Resistant |
| ENSG00000253875.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.029762564 |
Resistant |
| ENSG00000254409.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.044785485 |
Resistant |
| ENSG00000260536.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.00191984 |
Resistant |
| ENSG00000260896.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.005631498 |
Resistant |
| ENSG00000264043.2 |
Afatinib |
Pancreatic adenocarcinoma |
0.037598018 |
Resistant |
| ENSG00000265728.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.022157483 |
Resistant |
| ENSG00000267296.2 |
Afatinib |
Pancreatic adenocarcinoma |
0.030322302 |
Resistant |
| ENSG00000267939.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.020830384 |
Resistant |
| ENSG00000269386.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.031086609 |
Resistant |
| ENSG00000272102.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.040155206 |
Resistant |
| ENSG00000272375.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.049476285 |
Resistant |
| ENSG00000272520.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.011739312 |
Resistant |
| ENSG00000272604.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.000705045 |
Resistant |
| ENSG00000182404.6 |
Afatinib |
Sarcoma |
0.047679107 |
Resistant |
| ENSG00000187621.10 |
Afatinib |
Sarcoma |
0.004325682 |
Resistant |
| ENSG00000213468.3 |
Afatinib |
Sarcoma |
0.044993367 |
Resistant |
| ENSG00000214401.4 |
Afatinib |
Sarcoma |
0.006737809 |
Resistant |
| ENSG00000223711.1 |
Afatinib |
Sarcoma |
0.017972673 |
Resistant |
| ENSG00000227165.3 |
Afatinib |
Sarcoma |
0.005768136 |
Resistant |
| ENSG00000228201.1 |
Afatinib |
Sarcoma |
0.013714362 |
Resistant |
| ENSG00000230679.1 |
Afatinib |
Sarcoma |
0.014526652 |
Resistant |
| ENSG00000232131.1 |
Afatinib |
Sarcoma |
0.037599387 |
Resistant |
| ENSG00000232160.2 |
Afatinib |
Sarcoma |
0.009906959 |
Resistant |
| ENSG00000232415.1 |
Afatinib |
Sarcoma |
0.003241072 |
Resistant |
| ENSG00000232645.1 |
Afatinib |
Sarcoma |
0.025969231 |
Resistant |
| ENSG00000233246.1 |
Afatinib |
Sarcoma |
0.016673584 |
Resistant |
| ENSG00000233775.1 |
Afatinib |
Sarcoma |
0.033050393 |
Resistant |
| ENSG00000233776.1 |
Afatinib |
Sarcoma |
0.000117023 |
Resistant |
| ENSG00000234208.1 |
Afatinib |
Sarcoma |
0.015561208 |
Resistant |
| ENSG00000234610.1 |
Afatinib |
Sarcoma |
0.040062267 |
Resistant |
| ENSG00000234998.1 |
Afatinib |
Sarcoma |
0.002999541 |
Resistant |
| ENSG00000238221.1 |
Afatinib |
Sarcoma |
0.00666271 |
Resistant |
| ENSG00000242190.1 |
Afatinib |
Sarcoma |
0.027818219 |
Resistant |
| ENSG00000243055.1 |
Afatinib |
Sarcoma |
0.01401589 |
Resistant |
| ENSG00000244286.1 |
Afatinib |
Sarcoma |
0.012311021 |
Resistant |
| ENSG00000248027.1 |
Afatinib |
Sarcoma |
0.012539542 |
Resistant |
| ENSG00000249655.1 |
Afatinib |
Sarcoma |
0.030239936 |
Resistant |
| ENSG00000250015.1 |
Afatinib |
Sarcoma |
0.028344426 |
Resistant |
| ENSG00000250541.1 |
Afatinib |
Sarcoma |
0.044199041 |
Resistant |
| ENSG00000250614.1 |
Afatinib |
Sarcoma |
0.042562471 |
Resistant |
| ENSG00000251072.2 |
Afatinib |
Sarcoma |
0.00880075 |
Resistant |
| ENSG00000251175.1 |
Afatinib |
Sarcoma |
0.002925562 |
Resistant |
| ENSG00000253392.2 |
Afatinib |
Sarcoma |
0.000141429 |
Resistant |
| ENSG00000253925.1 |
Afatinib |
Sarcoma |
0.000899654 |
Resistant |
| ENSG00000258803.1 |
Afatinib |
Sarcoma |
0.003875816 |
Resistant |
| ENSG00000259172.1 |
Afatinib |
Sarcoma |
0.006954649 |
Resistant |
| ENSG00000261777.1 |
Afatinib |
Sarcoma |
0.049076608 |
Resistant |
| ENSG00000264575.1 |
Afatinib |
Sarcoma |
0.033847773 |
Resistant |
| ENSG00000265943.1 |
Afatinib |
Sarcoma |
0.024316119 |
Resistant |
| ENSG00000267922.1 |
Afatinib |
Sarcoma |
0.0000149 |
Resistant |
| ENSG00000271646.1 |
Afatinib |
Sarcoma |
0.022716095 |
Resistant |
| ENSG00000272483.1 |
Afatinib |
Sarcoma |
0.003646237 |
Resistant |
| ENSG00000272796.1 |
Afatinib |
Sarcoma |
0.020291148 |
Resistant |
| ENSG00000273056.1 |
Afatinib |
Sarcoma |
0.003501381 |
Resistant |
| ENSG00000214353.3 |
Afatinib |
Skin cutaneous melanoma |
0.029429048 |
Resistant |
| ENSG00000223442.1 |
Afatinib |
Skin cutaneous melanoma |
0.037662505 |
Resistant |
| ENSG00000223482.3 |
Afatinib |
Skin cutaneous melanoma |
0.040261329 |
Resistant |
| ENSG00000225335.2 |
Afatinib |
Skin cutaneous melanoma |
0.033112586 |
Resistant |
| ENSG00000226091.3 |
Afatinib |
Skin cutaneous melanoma |
0.008855186 |
Resistant |
| ENSG00000226276.1 |
Afatinib |
Skin cutaneous melanoma |
0.030499144 |
Resistant |
| ENSG00000226287.3 |
Afatinib |
Skin cutaneous melanoma |
0.041924967 |
Resistant |
| ENSG00000226950.2 |
Afatinib |
Skin cutaneous melanoma |
0.017995406 |
Resistant |
| ENSG00000227071.1 |
Afatinib |
Skin cutaneous melanoma |
0.0234629 |
Resistant |
| ENSG00000228124.1 |
Afatinib |
Skin cutaneous melanoma |
0.028007083 |
Resistant |
| ENSG00000228478.1 |
Afatinib |
Skin cutaneous melanoma |
0.048109173 |
Resistant |
| ENSG00000228544.1 |
Afatinib |
Skin cutaneous melanoma |
0.038480749 |
Resistant |
| ENSG00000229178.1 |
Afatinib |
Skin cutaneous melanoma |
0.039781482 |
Resistant |
| ENSG00000229618.1 |
Afatinib |
Skin cutaneous melanoma |
0.03369643 |
Resistant |
| ENSG00000231806.2 |
Afatinib |
Skin cutaneous melanoma |
0.047877797 |
Resistant |
| ENSG00000233016.2 |
Afatinib |
Skin cutaneous melanoma |
0.008758357 |
Resistant |
| ENSG00000233695.1 |
Afatinib |
Skin cutaneous melanoma |
0.01811504 |
Resistant |
| ENSG00000234678.1 |
Afatinib |
Skin cutaneous melanoma |
0.002942851 |
Resistant |
| ENSG00000234912.5 |
Afatinib |
Skin cutaneous melanoma |
0.012516711 |
Resistant |
| ENSG00000236003.1 |
Afatinib |
Skin cutaneous melanoma |
0.048027913 |
Resistant |
| ENSG00000237222.3 |
Afatinib |
Skin cutaneous melanoma |
0.022975351 |
Resistant |
| ENSG00000237438.2 |
Afatinib |
Skin cutaneous melanoma |
0.014654028 |
Resistant |
| ENSG00000239335.4 |
Afatinib |
Skin cutaneous melanoma |
0.031996111 |
Resistant |
| ENSG00000242370.1 |
Afatinib |
Skin cutaneous melanoma |
0.015486207 |
Resistant |
| ENSG00000244268.1 |
Afatinib |
Skin cutaneous melanoma |
0.033446672 |
Resistant |
| ENSG00000244733.4 |
Afatinib |
Skin cutaneous melanoma |
0.007974924 |
Resistant |
| ENSG00000247572.3 |
Afatinib |
Skin cutaneous melanoma |
0.03337026 |
Resistant |
| ENSG00000247775.2 |
Afatinib |
Skin cutaneous melanoma |
0.017536313 |
Resistant |
| ENSG00000248416.1 |
Afatinib |
Skin cutaneous melanoma |
0.0000679 |
Resistant |
| ENSG00000249753.2 |
Afatinib |
Skin cutaneous melanoma |
0.008777437 |
Resistant |
| ENSG00000250734.2 |
Afatinib |
Skin cutaneous melanoma |
0.030211389 |
Resistant |
| ENSG00000251018.2 |
Afatinib |
Skin cutaneous melanoma |
0.033466381 |
Resistant |
| ENSG00000251666.1 |
Afatinib |
Skin cutaneous melanoma |
0.034565179 |
Resistant |
| ENSG00000253878.1 |
Afatinib |
Skin cutaneous melanoma |
0.024531828 |
Resistant |
| ENSG00000254205.1 |
Afatinib |
Skin cutaneous melanoma |
0.039532874 |
Resistant |
| ENSG00000254791.1 |
Afatinib |
Skin cutaneous melanoma |
0.041376107 |
Resistant |
| ENSG00000255367.1 |
Afatinib |
Skin cutaneous melanoma |
0.026834421 |
Resistant |
| ENSG00000255474.1 |
Afatinib |
Skin cutaneous melanoma |
0.009364259 |
Resistant |
| ENSG00000255717.2 |
Afatinib |
Skin cutaneous melanoma |
0.046508209 |
Resistant |
| ENSG00000257568.1 |
Afatinib |
Skin cutaneous melanoma |
0.011881285 |
Resistant |
| ENSG00000258556.1 |
Afatinib |
Skin cutaneous melanoma |
0.042241129 |
Resistant |
| ENSG00000259172.1 |
Afatinib |
Skin cutaneous melanoma |
0.020069225 |
Resistant |
| ENSG00000259469.1 |
Afatinib |
Skin cutaneous melanoma |
0.029554183 |
Resistant |
| ENSG00000259935.1 |
Afatinib |
Skin cutaneous melanoma |
0.020711894 |
Resistant |
| ENSG00000260411.2 |
Afatinib |
Skin cutaneous melanoma |
0.047276091 |
Resistant |
| ENSG00000260558.1 |
Afatinib |
Skin cutaneous melanoma |
0.016221862 |
Resistant |
| ENSG00000260778.2 |
Afatinib |
Skin cutaneous melanoma |
0.04942043 |
Resistant |
| ENSG00000261399.1 |
Afatinib |
Skin cutaneous melanoma |
0.038703537 |
Resistant |
| ENSG00000261886.1 |
Afatinib |
Skin cutaneous melanoma |
0.024419543 |
Resistant |
| ENSG00000262152.2 |
Afatinib |
Skin cutaneous melanoma |
0.029637733 |
Resistant |
| ENSG00000263013.1 |
Afatinib |
Skin cutaneous melanoma |
0.025269405 |
Resistant |
| ENSG00000265912.1 |
Afatinib |
Skin cutaneous melanoma |
0.00900084 |
Resistant |
| ENSG00000266111.1 |
Afatinib |
Skin cutaneous melanoma |
0.028723675 |
Resistant |
| ENSG00000266402.2 |
Afatinib |
Skin cutaneous melanoma |
0.005682333 |
Resistant |
| ENSG00000266801.1 |
Afatinib |
Skin cutaneous melanoma |
0.02164888 |
Resistant |
| ENSG00000267149.2 |
Afatinib |
Skin cutaneous melanoma |
0.036205831 |
Resistant |
| ENSG00000267255.1 |
Afatinib |
Skin cutaneous melanoma |
0.041159804 |
Resistant |
| ENSG00000267306.1 |
Afatinib |
Skin cutaneous melanoma |
0.000960205 |
Resistant |
| ENSG00000267321.1 |
Afatinib |
Skin cutaneous melanoma |
0.017367885 |
Resistant |
| ENSG00000267778.1 |
Afatinib |
Skin cutaneous melanoma |
0.023268268 |
Resistant |
| ENSG00000268573.1 |
Afatinib |
Skin cutaneous melanoma |
0.039544133 |
Resistant |
| ENSG00000269321.1 |
Afatinib |
Skin cutaneous melanoma |
0.044144157 |
Resistant |
| ENSG00000269814.1 |
Afatinib |
Skin cutaneous melanoma |
0.034919292 |
Resistant |
| ENSG00000269924.1 |
Afatinib |
Skin cutaneous melanoma |
0.035276647 |
Resistant |
| ENSG00000270190.1 |
Afatinib |
Skin cutaneous melanoma |
0.003418985 |
Resistant |
| ENSG00000271200.1 |
Afatinib |
Skin cutaneous melanoma |
0.021064767 |
Resistant |
| ENSG00000271782.1 |
Afatinib |
Skin cutaneous melanoma |
0.036080019 |
Resistant |
| ENSG00000272023.1 |
Afatinib |
Skin cutaneous melanoma |
0.005925943 |
Resistant |
| ENSG00000272373.1 |
Afatinib |
Skin cutaneous melanoma |
0.000963305 |
Resistant |
| ENSG00000272449.1 |
Afatinib |
Skin cutaneous melanoma |
0.040838831 |
Resistant |
| ENSG00000272525.1 |
Afatinib |
Skin cutaneous melanoma |
0.041938623 |
Resistant |
| ENSG00000272529.1 |
Afatinib |
Skin cutaneous melanoma |
0.011116924 |
Resistant |
| ENSG00000272862.1 |
Afatinib |
Skin cutaneous melanoma |
0.04617378 |
Resistant |
| ENSG00000272931.1 |
Afatinib |
Skin cutaneous melanoma |
0.041614767 |
Resistant |
| ENSG00000273188.1 |
Afatinib |
Skin cutaneous melanoma |
0.00333823 |
Resistant |
| ENSG00000273248.1 |
Afatinib |
Skin cutaneous melanoma |
0.0448762 |
Resistant |
| ENSG00000273443.1 |
Afatinib |
Skin cutaneous melanoma |
0.048229654 |
Resistant |
| ENSG00000232336.1 |
Afatinib |
Stomach adenocarcinoma |
0.00988445 |
Resistant |
| ENSG00000251002.3 |
Afatinib |
Stomach adenocarcinoma |
0.038295853 |
Resistant |
| ENSG00000251138.2 |
Afatinib |
Stomach adenocarcinoma |
0.026892998 |
Resistant |
| ENSG00000256894.1 |
Afatinib |
Stomach adenocarcinoma |
0.029350458 |
Resistant |
| ENSG00000272942.1 |
Afatinib |
Stomach adenocarcinoma |
0.030770578 |
Resistant |
| ENSG00000171671.6 |
Afatinib |
Breast invasive carcinoma |
0.026543799 |
Sensitive |
| ENSG00000175147.7 |
Afatinib |
Breast invasive carcinoma |
0.040361467 |
Sensitive |
| ENSG00000177788.5 |
Afatinib |
Breast invasive carcinoma |
0.002648293 |
Sensitive |
| ENSG00000197558.7 |
Afatinib |
Breast invasive carcinoma |
0.012522333 |
Sensitive |
| ENSG00000203280.3 |
Afatinib |
Breast invasive carcinoma |
0.025790986 |
Sensitive |
| ENSG00000203499.6 |
Afatinib |
Breast invasive carcinoma |
0.01542615 |
Sensitive |
| ENSG00000203635.2 |
Afatinib |
Breast invasive carcinoma |
0.02174647 |
Sensitive |
| ENSG00000204832.5 |
Afatinib |
Breast invasive carcinoma |
0.011674729 |
Sensitive |
| ENSG00000205037.2 |
Afatinib |
Breast invasive carcinoma |
0.048567944 |
Sensitive |
| ENSG00000205444.2 |
Afatinib |
Breast invasive carcinoma |
0.039451989 |
Sensitive |
| ENSG00000205890.3 |
Afatinib |
Breast invasive carcinoma |
0.019975779 |
Sensitive |
| ENSG00000205959.3 |
Afatinib |
Breast invasive carcinoma |
0.024005211 |
Sensitive |
| ENSG00000213863.2 |
Afatinib |
Breast invasive carcinoma |
0.025534587 |
Sensitive |
| ENSG00000214546.3 |
Afatinib |
Breast invasive carcinoma |
0.018014891 |
Sensitive |
| ENSG00000214851.4 |
Afatinib |
Breast invasive carcinoma |
0.011712337 |
Sensitive |
| ENSG00000215841.3 |
Afatinib |
Breast invasive carcinoma |
0.009095402 |
Sensitive |
| ENSG00000223813.2 |
Afatinib |
Breast invasive carcinoma |
0.008041795 |
Sensitive |
| ENSG00000223842.1 |
Afatinib |
Breast invasive carcinoma |
0.030595284 |
Sensitive |
| ENSG00000224079.1 |
Afatinib |
Breast invasive carcinoma |
0.015066764 |
Sensitive |
| ENSG00000224387.1 |
Afatinib |
Breast invasive carcinoma |
0.031549074 |
Sensitive |
| ENSG00000224481.1 |
Afatinib |
Breast invasive carcinoma |
0.016079659 |
Sensitive |
| ENSG00000224652.1 |
Afatinib |
Breast invasive carcinoma |
0.047564023 |
Sensitive |
| ENSG00000224805.2 |
Afatinib |
Breast invasive carcinoma |
0.026715798 |
Sensitive |
| ENSG00000224822.1 |
Afatinib |
Breast invasive carcinoma |
0.046134606 |
Sensitive |
| ENSG00000225030.1 |
Afatinib |
Breast invasive carcinoma |
0.034212135 |
Sensitive |
| ENSG00000225083.1 |
Afatinib |
Breast invasive carcinoma |
0.047141141 |
Sensitive |
| ENSG00000225408.1 |
Afatinib |
Breast invasive carcinoma |
0.023327348 |
Sensitive |
| ENSG00000225532.1 |
Afatinib |
Breast invasive carcinoma |
0.006473725 |
Sensitive |
| ENSG00000226051.2 |
Afatinib |
Breast invasive carcinoma |
0.039567574 |
Sensitive |
| ENSG00000226155.1 |
Afatinib |
Breast invasive carcinoma |
0.023795537 |
Sensitive |
| ENSG00000226287.3 |
Afatinib |
Breast invasive carcinoma |
0.004447616 |
Sensitive |
| ENSG00000226310.1 |
Afatinib |
Breast invasive carcinoma |
0.008612016 |
Sensitive |
| ENSG00000226330.1 |
Afatinib |
Breast invasive carcinoma |
0.033604712 |
Sensitive |
| ENSG00000227050.1 |
Afatinib |
Breast invasive carcinoma |
0.049517131 |
Sensitive |
| ENSG00000227117.2 |
Afatinib |
Breast invasive carcinoma |
0.035498635 |
Sensitive |
| ENSG00000227359.1 |
Afatinib |
Breast invasive carcinoma |
0.021197399 |
Sensitive |
| ENSG00000227617.4 |
Afatinib |
Breast invasive carcinoma |
0.034137321 |
Sensitive |
| ENSG00000227719.1 |
Afatinib |
Breast invasive carcinoma |
0.025487786 |
Sensitive |
| ENSG00000227885.1 |
Afatinib |
Breast invasive carcinoma |
0.013693162 |
Sensitive |
| ENSG00000228043.1 |
Afatinib |
Breast invasive carcinoma |
0.045610863 |
Sensitive |
| ENSG00000228126.1 |
Afatinib |
Breast invasive carcinoma |
0.00185968 |
Sensitive |
| ENSG00000228204.2 |
Afatinib |
Breast invasive carcinoma |
0.022648156 |
Sensitive |
| ENSG00000228288.2 |
Afatinib |
Breast invasive carcinoma |
0.016380592 |
Sensitive |
| ENSG00000228487.1 |
Afatinib |
Breast invasive carcinoma |
0.024535608 |
Sensitive |
| ENSG00000228613.1 |
Afatinib |
Breast invasive carcinoma |
0.025577107 |
Sensitive |
| ENSG00000228917.1 |
Afatinib |
Breast invasive carcinoma |
0.000203737 |
Sensitive |
| ENSG00000228918.3 |
Afatinib |
Breast invasive carcinoma |
0.017300206 |
Sensitive |
| ENSG00000229272.1 |
Afatinib |
Breast invasive carcinoma |
0.014786488 |
Sensitive |
| ENSG00000229380.1 |
Afatinib |
Breast invasive carcinoma |
0.039526138 |
Sensitive |
| ENSG00000229782.1 |
Afatinib |
Breast invasive carcinoma |
0.043013875 |
Sensitive |
| ENSG00000229952.1 |
Afatinib |
Breast invasive carcinoma |
0.018052921 |
Sensitive |
| ENSG00000229980.4 |
Afatinib |
Breast invasive carcinoma |
0.001962464 |
Sensitive |
| ENSG00000229990.2 |
Afatinib |
Breast invasive carcinoma |
0.025042037 |
Sensitive |
| ENSG00000230005.2 |
Afatinib |
Breast invasive carcinoma |
0.024699488 |
Sensitive |
| ENSG00000230091.2 |
Afatinib |
Breast invasive carcinoma |
0.042718264 |
Sensitive |
| ENSG00000230423.1 |
Afatinib |
Breast invasive carcinoma |
0.000575223 |
Sensitive |
| ENSG00000230470.1 |
Afatinib |
Breast invasive carcinoma |
0.048061356 |
Sensitive |
| ENSG00000230633.1 |
Afatinib |
Breast invasive carcinoma |
0.043062441 |
Sensitive |
| ENSG00000231107.1 |
Afatinib |
Breast invasive carcinoma |
0.00343486 |
Sensitive |
| ENSG00000231226.1 |
Afatinib |
Breast invasive carcinoma |
0.036637728 |
Sensitive |
| ENSG00000231310.2 |
Afatinib |
Breast invasive carcinoma |
0.037868638 |
Sensitive |
| ENSG00000231651.1 |
Afatinib |
Breast invasive carcinoma |
0.016803187 |
Sensitive |
| ENSG00000231654.1 |
Afatinib |
Breast invasive carcinoma |
0.031474302 |
Sensitive |
| ENSG00000231691.1 |
Afatinib |
Breast invasive carcinoma |
0.021595467 |
Sensitive |
| ENSG00000231709.1 |
Afatinib |
Breast invasive carcinoma |
0.001749868 |
Sensitive |
| ENSG00000231868.1 |
Afatinib |
Breast invasive carcinoma |
0.030437784 |
Sensitive |
| ENSG00000231920.1 |
Afatinib |
Breast invasive carcinoma |
0.014217228 |
Sensitive |
| ENSG00000231944.1 |
Afatinib |
Breast invasive carcinoma |
0.045752852 |
Sensitive |
| ENSG00000232093.1 |
Afatinib |
Breast invasive carcinoma |
0.027006994 |
Sensitive |
| ENSG00000232124.1 |
Afatinib |
Breast invasive carcinoma |
0.005896327 |
Sensitive |
| ENSG00000232354.3 |
Afatinib |
Breast invasive carcinoma |
0.046981328 |
Sensitive |
| ENSG00000232586.1 |
Afatinib |
Breast invasive carcinoma |
0.045932875 |
Sensitive |
| ENSG00000233006.2 |
Afatinib |
Breast invasive carcinoma |
0.043384367 |
Sensitive |
| ENSG00000233108.1 |
Afatinib |
Breast invasive carcinoma |
0.030206147 |
Sensitive |
| ENSG00000233154.1 |
Afatinib |
Breast invasive carcinoma |
0.014747626 |
Sensitive |
| ENSG00000233517.1 |
Afatinib |
Breast invasive carcinoma |
0.048142009 |
Sensitive |
| ENSG00000233693.1 |
Afatinib |
Breast invasive carcinoma |
0.012908951 |
Sensitive |
| ENSG00000233834.2 |
Afatinib |
Breast invasive carcinoma |
0.019189507 |
Sensitive |
| ENSG00000233862.1 |
Afatinib |
Breast invasive carcinoma |
0.036036031 |
Sensitive |
| ENSG00000233930.3 |
Afatinib |
Breast invasive carcinoma |
0.014356718 |
Sensitive |
| ENSG00000234174.1 |
Afatinib |
Breast invasive carcinoma |
0.015217282 |
Sensitive |
| ENSG00000234245.2 |
Afatinib |
Breast invasive carcinoma |
0.005429267 |
Sensitive |
| ENSG00000234261.1 |
Afatinib |
Breast invasive carcinoma |
0.045856284 |
Sensitive |
| ENSG00000234614.1 |
Afatinib |
Breast invasive carcinoma |
0.046920399 |
Sensitive |
| ENSG00000234678.1 |
Afatinib |
Breast invasive carcinoma |
0.001726384 |
Sensitive |
| ENSG00000235146.2 |
Afatinib |
Breast invasive carcinoma |
0.041961534 |
Sensitive |
| ENSG00000235772.1 |
Afatinib |
Breast invasive carcinoma |
0.026503262 |
Sensitive |
| ENSG00000235823.1 |
Afatinib |
Breast invasive carcinoma |
0.011333528 |
Sensitive |
| ENSG00000235837.1 |
Afatinib |
Breast invasive carcinoma |
0.028601677 |
Sensitive |
| ENSG00000235939.1 |
Afatinib |
Breast invasive carcinoma |
0.025604316 |
Sensitive |
| ENSG00000236008.1 |
Afatinib |
Breast invasive carcinoma |
0.035908557 |
Sensitive |
| ENSG00000236230.1 |
Afatinib |
Breast invasive carcinoma |
0.04851266 |
Sensitive |
| ENSG00000236262.1 |
Afatinib |
Breast invasive carcinoma |
0.010512921 |
Sensitive |
| ENSG00000236394.1 |
Afatinib |
Breast invasive carcinoma |
0.020252591 |
Sensitive |
| ENSG00000236601.1 |
Afatinib |
Breast invasive carcinoma |
0.003676869 |
Sensitive |
| ENSG00000236743.1 |
Afatinib |
Breast invasive carcinoma |
0.006922392 |
Sensitive |
| ENSG00000236830.2 |
Afatinib |
Breast invasive carcinoma |
0.014640735 |
Sensitive |
| ENSG00000236833.1 |
Afatinib |
Breast invasive carcinoma |
0.031875061 |
Sensitive |
| ENSG00000237188.3 |
Afatinib |
Breast invasive carcinoma |
0.011771805 |
Sensitive |
| ENSG00000237520.1 |
Afatinib |
Breast invasive carcinoma |
0.009076481 |
Sensitive |
| ENSG00000237588.2 |
Afatinib |
Breast invasive carcinoma |
0.014042692 |
Sensitive |
| ENSG00000237772.1 |
Afatinib |
Breast invasive carcinoma |
0.038704013 |
Sensitive |
| ENSG00000238005.2 |
Afatinib |
Breast invasive carcinoma |
0.002709312 |
Sensitive |
| ENSG00000239508.1 |
Afatinib |
Breast invasive carcinoma |
0.037978508 |
Sensitive |
| ENSG00000239664.2 |
Afatinib |
Breast invasive carcinoma |
0.027619409 |
Sensitive |
| ENSG00000240499.3 |
Afatinib |
Breast invasive carcinoma |
0.044653898 |
Sensitive |
| ENSG00000240541.2 |
Afatinib |
Breast invasive carcinoma |
0.00334844 |
Sensitive |
| ENSG00000240758.2 |
Afatinib |
Breast invasive carcinoma |
0.021053565 |
Sensitive |
| ENSG00000242136.1 |
Afatinib |
Breast invasive carcinoma |
0.031892343 |
Sensitive |
| ENSG00000242861.1 |
Afatinib |
Breast invasive carcinoma |
0.0141837 |
Sensitive |
| ENSG00000243069.3 |
Afatinib |
Breast invasive carcinoma |
0.032017331 |
Sensitive |
| ENSG00000243368.2 |
Afatinib |
Breast invasive carcinoma |
0.024303539 |
Sensitive |
| ENSG00000243885.1 |
Afatinib |
Breast invasive carcinoma |
0.013629822 |
Sensitive |
| ENSG00000245080.4 |
Afatinib |
Breast invasive carcinoma |
0.020434757 |
Sensitive |
| ENSG00000245105.1 |
Afatinib |
Breast invasive carcinoma |
0.006739379 |
Sensitive |
| ENSG00000245281.2 |
Afatinib |
Breast invasive carcinoma |
0.005202924 |
Sensitive |
| ENSG00000246263.2 |
Afatinib |
Breast invasive carcinoma |
0.019119818 |
Sensitive |
| ENSG00000246526.2 |
Afatinib |
Breast invasive carcinoma |
0.010716195 |
Sensitive |
| ENSG00000246582.2 |
Afatinib |
Breast invasive carcinoma |
0.001288297 |
Sensitive |
| ENSG00000246790.2 |
Afatinib |
Breast invasive carcinoma |
0.030265626 |
Sensitive |
| ENSG00000247287.2 |
Afatinib |
Breast invasive carcinoma |
0.015188347 |
Sensitive |
| ENSG00000248494.1 |
Afatinib |
Breast invasive carcinoma |
0.033289907 |
Sensitive |
| ENSG00000248968.1 |
Afatinib |
Breast invasive carcinoma |
0.029188876 |
Sensitive |
| ENSG00000249042.1 |
Afatinib |
Breast invasive carcinoma |
0.014971395 |
Sensitive |
| ENSG00000249173.1 |
Afatinib |
Breast invasive carcinoma |
0.033617635 |
Sensitive |
| ENSG00000249641.2 |
Afatinib |
Breast invasive carcinoma |
0.041780978 |
Sensitive |
| ENSG00000249807.1 |
Afatinib |
Breast invasive carcinoma |
0.035633556 |
Sensitive |
| ENSG00000249825.1 |
Afatinib |
Breast invasive carcinoma |
0.027331388 |
Sensitive |
| ENSG00000249885.1 |
Afatinib |
Breast invasive carcinoma |
0.039816288 |
Sensitive |
| ENSG00000249955.1 |
Afatinib |
Breast invasive carcinoma |
0.025411739 |
Sensitive |
| ENSG00000250131.1 |
Afatinib |
Breast invasive carcinoma |
0.020652285 |
Sensitive |
| ENSG00000250295.2 |
Afatinib |
Breast invasive carcinoma |
0.041915279 |
Sensitive |
| ENSG00000250522.1 |
Afatinib |
Breast invasive carcinoma |
0.039905423 |
Sensitive |
| ENSG00000250714.3 |
Afatinib |
Breast invasive carcinoma |
0.004108967 |
Sensitive |
| ENSG00000250891.1 |
Afatinib |
Breast invasive carcinoma |
0.035472826 |
Sensitive |
| ENSG00000251432.2 |
Afatinib |
Breast invasive carcinoma |
0.016031585 |
Sensitive |
| ENSG00000251455.1 |
Afatinib |
Breast invasive carcinoma |
0.015763529 |
Sensitive |
| ENSG00000251665.1 |
Afatinib |
Breast invasive carcinoma |
0.049261666 |
Sensitive |
| ENSG00000251675.1 |
Afatinib |
Breast invasive carcinoma |
0.0000598 |
Sensitive |
| ENSG00000253182.1 |
Afatinib |
Breast invasive carcinoma |
0.022931489 |
Sensitive |
| ENSG00000253302.1 |
Afatinib |
Breast invasive carcinoma |
0.025058783 |
Sensitive |
| ENSG00000253824.1 |
Afatinib |
Breast invasive carcinoma |
0.031567006 |
Sensitive |
| ENSG00000253930.1 |
Afatinib |
Breast invasive carcinoma |
0.024785098 |
Sensitive |
| ENSG00000253972.1 |
Afatinib |
Breast invasive carcinoma |
0.014687281 |
Sensitive |
| ENSG00000254024.1 |
Afatinib |
Breast invasive carcinoma |
0.03892273 |
Sensitive |
| ENSG00000254039.1 |
Afatinib |
Breast invasive carcinoma |
0.01305273 |
Sensitive |
| ENSG00000254153.1 |
Afatinib |
Breast invasive carcinoma |
0.049192455 |
Sensitive |
| ENSG00000254248.1 |
Afatinib |
Breast invasive carcinoma |
0.002411469 |
Sensitive |
| ENSG00000254286.1 |
Afatinib |
Breast invasive carcinoma |
0.019773994 |
Sensitive |
| ENSG00000254632.1 |
Afatinib |
Breast invasive carcinoma |
0.043700113 |
Sensitive |
| ENSG00000254693.1 |
Afatinib |
Breast invasive carcinoma |
0.006523335 |
Sensitive |
| ENSG00000254854.1 |
Afatinib |
Breast invasive carcinoma |
0.019673747 |
Sensitive |
| ENSG00000254973.1 |
Afatinib |
Breast invasive carcinoma |
0.016853625 |
Sensitive |
| ENSG00000255092.1 |
Afatinib |
Breast invasive carcinoma |
0.018948793 |
Sensitive |
| ENSG00000255145.1 |
Afatinib |
Breast invasive carcinoma |
0.007755247 |
Sensitive |
| ENSG00000255247.1 |
Afatinib |
Breast invasive carcinoma |
0.001863451 |
Sensitive |
| ENSG00000255367.1 |
Afatinib |
Breast invasive carcinoma |
0.026368596 |
Sensitive |
| ENSG00000255693.1 |
Afatinib |
Breast invasive carcinoma |
0.040837421 |
Sensitive |
| ENSG00000255774.1 |
Afatinib |
Breast invasive carcinoma |
0.040013689 |
Sensitive |
| ENSG00000256248.1 |
Afatinib |
Breast invasive carcinoma |
0.044555084 |
Sensitive |
| ENSG00000256443.1 |
Afatinib |
Breast invasive carcinoma |
0.026965292 |
Sensitive |
| ENSG00000256582.1 |
Afatinib |
Breast invasive carcinoma |
0.010871344 |
Sensitive |
| ENSG00000257084.1 |
Afatinib |
Breast invasive carcinoma |
0.000185602 |
Sensitive |
| ENSG00000257588.1 |
Afatinib |
Breast invasive carcinoma |
0.03677796 |
Sensitive |
| ENSG00000257671.1 |
Afatinib |
Breast invasive carcinoma |
0.033570916 |
Sensitive |
| ENSG00000257830.1 |
Afatinib |
Breast invasive carcinoma |
0.041458433 |
Sensitive |
| ENSG00000258455.1 |
Afatinib |
Breast invasive carcinoma |
0.023723121 |
Sensitive |
| ENSG00000258593.2 |
Afatinib |
Breast invasive carcinoma |
0.004931866 |
Sensitive |
| ENSG00000258630.1 |
Afatinib |
Breast invasive carcinoma |
0.023480382 |
Sensitive |
| ENSG00000258647.1 |
Afatinib |
Breast invasive carcinoma |
0.024736326 |
Sensitive |
| ENSG00000259087.1 |
Afatinib |
Breast invasive carcinoma |
0.035234022 |
Sensitive |
| ENSG00000259222.1 |
Afatinib |
Breast invasive carcinoma |
0.046661366 |
Sensitive |
| ENSG00000259420.1 |
Afatinib |
Breast invasive carcinoma |
0.01963091 |
Sensitive |
| ENSG00000259563.1 |
Afatinib |
Breast invasive carcinoma |
0.004899124 |
Sensitive |
| ENSG00000259678.1 |
Afatinib |
Breast invasive carcinoma |
0.03747824 |
Sensitive |
| ENSG00000260166.1 |
Afatinib |
Breast invasive carcinoma |
0.030019883 |
Sensitive |
| ENSG00000260249.2 |
Afatinib |
Breast invasive carcinoma |
0.036183576 |
Sensitive |
| ENSG00000260418.1 |
Afatinib |
Breast invasive carcinoma |
0.010066671 |
Sensitive |
| ENSG00000260592.1 |
Afatinib |
Breast invasive carcinoma |
0.042424709 |
Sensitive |
| ENSG00000260711.1 |
Afatinib |
Breast invasive carcinoma |
0.011514085 |
Sensitive |
| ENSG00000260979.1 |
Afatinib |
Breast invasive carcinoma |
0.017158441 |
Sensitive |
| ENSG00000261087.1 |
Afatinib |
Breast invasive carcinoma |
0.037761505 |
Sensitive |
| ENSG00000261104.1 |
Afatinib |
Breast invasive carcinoma |
0.035874572 |
Sensitive |
| ENSG00000261183.1 |
Afatinib |
Breast invasive carcinoma |
0.006935658 |
Sensitive |
| ENSG00000261572.1 |
Afatinib |
Breast invasive carcinoma |
0.031665502 |
Sensitive |
| ENSG00000261632.1 |
Afatinib |
Breast invasive carcinoma |
0.045150576 |
Sensitive |
| ENSG00000261633.1 |
Afatinib |
Breast invasive carcinoma |
0.033805012 |
Sensitive |
| ENSG00000261693.1 |
Afatinib |
Breast invasive carcinoma |
0.025955231 |
Sensitive |
| ENSG00000262094.1 |
Afatinib |
Breast invasive carcinoma |
0.003241966 |
Sensitive |
| ENSG00000262362.1 |
Afatinib |
Breast invasive carcinoma |
0.034041931 |
Sensitive |
| ENSG00000262823.1 |
Afatinib |
Breast invasive carcinoma |
0.015588433 |
Sensitive |
| ENSG00000262952.1 |
Afatinib |
Breast invasive carcinoma |
0.011250714 |
Sensitive |
| ENSG00000265130.1 |
Afatinib |
Breast invasive carcinoma |
0.04697375 |
Sensitive |
| ENSG00000265490.1 |
Afatinib |
Breast invasive carcinoma |
0.011961075 |
Sensitive |
| ENSG00000266877.1 |
Afatinib |
Breast invasive carcinoma |
0.024082298 |
Sensitive |
| ENSG00000267174.1 |
Afatinib |
Breast invasive carcinoma |
0.03080845 |
Sensitive |
| ENSG00000268355.1 |
Afatinib |
Breast invasive carcinoma |
0.036873034 |
Sensitive |
| ENSG00000269321.1 |
Afatinib |
Breast invasive carcinoma |
0.045067478 |
Sensitive |
| ENSG00000269887.1 |
Afatinib |
Breast invasive carcinoma |
0.048768857 |
Sensitive |
| ENSG00000270124.1 |
Afatinib |
Breast invasive carcinoma |
0.010118165 |
Sensitive |
| ENSG00000270720.1 |
Afatinib |
Breast invasive carcinoma |
0.032096876 |
Sensitive |
| ENSG00000270742.1 |
Afatinib |
Breast invasive carcinoma |
0.028275302 |
Sensitive |
| ENSG00000270933.1 |
Afatinib |
Breast invasive carcinoma |
0.048656132 |
Sensitive |
| ENSG00000271366.1 |
Afatinib |
Breast invasive carcinoma |
0.001375394 |
Sensitive |
| ENSG00000271430.1 |
Afatinib |
Breast invasive carcinoma |
0.034994461 |
Sensitive |
| ENSG00000271916.1 |
Afatinib |
Breast invasive carcinoma |
0.049524539 |
Sensitive |
| ENSG00000271917.1 |
Afatinib |
Breast invasive carcinoma |
0.000849302 |
Sensitive |
| ENSG00000271975.1 |
Afatinib |
Breast invasive carcinoma |
0.018237796 |
Sensitive |
| ENSG00000271983.1 |
Afatinib |
Breast invasive carcinoma |
0.009274764 |
Sensitive |
| ENSG00000272079.1 |
Afatinib |
Breast invasive carcinoma |
0.007946554 |
Sensitive |
| ENSG00000272384.1 |
Afatinib |
Breast invasive carcinoma |
0.011519484 |
Sensitive |
| ENSG00000272411.1 |
Afatinib |
Breast invasive carcinoma |
0.006580665 |
Sensitive |
| ENSG00000272588.1 |
Afatinib |
Breast invasive carcinoma |
0.010706683 |
Sensitive |
| ENSG00000272717.1 |
Afatinib |
Breast invasive carcinoma |
0.041432746 |
Sensitive |
| ENSG00000272732.1 |
Afatinib |
Breast invasive carcinoma |
0.007849762 |
Sensitive |
| ENSG00000272824.1 |
Afatinib |
Breast invasive carcinoma |
0.047800984 |
Sensitive |
| ENSG00000272894.1 |
Afatinib |
Breast invasive carcinoma |
0.001561032 |
Sensitive |
| ENSG00000272917.1 |
Afatinib |
Breast invasive carcinoma |
0.047931429 |
Sensitive |
| ENSG00000273009.1 |
Afatinib |
Breast invasive carcinoma |
0.028961423 |
Sensitive |
| ENSG00000273058.1 |
Afatinib |
Breast invasive carcinoma |
0.039808105 |
Sensitive |
| ENSG00000273059.1 |
Afatinib |
Breast invasive carcinoma |
0.032262777 |
Sensitive |
| ENSG00000273381.1 |
Afatinib |
Breast invasive carcinoma |
0.042760696 |
Sensitive |
| ENSG00000135253.9 |
Afatinib |
Colon adenocarcinoma |
0.009379365 |
Sensitive |
| ENSG00000226889.3 |
Afatinib |
Colon adenocarcinoma |
0.01159607 |
Sensitive |
| ENSG00000227733.4 |
Afatinib |
Colon adenocarcinoma |
0.038904764 |
Sensitive |
| ENSG00000234290.2 |
Afatinib |
Colon adenocarcinoma |
0.044280153 |
Sensitive |
| ENSG00000237063.1 |
Afatinib |
Colon adenocarcinoma |
0.012225571 |
Sensitive |
| ENSG00000237357.1 |
Afatinib |
Colon adenocarcinoma |
0.005261175 |
Sensitive |
| ENSG00000250994.1 |
Afatinib |
Colon adenocarcinoma |
0.043422457 |
Sensitive |
| ENSG00000253737.1 |
Afatinib |
Colon adenocarcinoma |
0.046311242 |
Sensitive |
| ENSG00000254731.1 |
Afatinib |
Colon adenocarcinoma |
0.028389632 |
Sensitive |
| ENSG00000258412.1 |
Afatinib |
Colon adenocarcinoma |
0.034831898 |
Sensitive |
| ENSG00000260439.1 |
Afatinib |
Colon adenocarcinoma |
0.029491845 |
Sensitive |
| ENSG00000264527.1 |
Afatinib |
Colon adenocarcinoma |
0.04577402 |
Sensitive |
| ENSG00000267040.2 |
Afatinib |
Colon adenocarcinoma |
0.018675009 |
Sensitive |
| ENSG00000271200.1 |
Afatinib |
Colon adenocarcinoma |
0.037814069 |
Sensitive |
| ENSG00000272057.1 |
Afatinib |
Colon adenocarcinoma |
0.009773661 |
Sensitive |
| ENSG00000272715.1 |
Afatinib |
Colon adenocarcinoma |
0.040911909 |
Sensitive |
| ENSG00000174171.4 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048329292 |
Sensitive |
| ENSG00000177757.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.033042654 |
Sensitive |
| ENSG00000184068.2 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.017242042 |
Sensitive |
| ENSG00000213904.4 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039054429 |
Sensitive |
| ENSG00000223842.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022372204 |
Sensitive |
| ENSG00000224079.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047595909 |
Sensitive |
| ENSG00000224490.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.008120311 |
Sensitive |
| ENSG00000224934.2 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.029017719 |
Sensitive |
| ENSG00000225300.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.012857002 |
Sensitive |
| ENSG00000225578.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03255604 |
Sensitive |
| ENSG00000225721.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034146149 |
Sensitive |
| ENSG00000225762.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.002693449 |
Sensitive |
| ENSG00000226009.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039201733 |
Sensitive |
| ENSG00000226291.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.0236723 |
Sensitive |
| ENSG00000226330.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.000171304 |
Sensitive |
| ENSG00000226352.2 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015567265 |
Sensitive |
| ENSG00000226645.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040599751 |
Sensitive |
| ENSG00000227071.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.045528744 |
Sensitive |
| ENSG00000227218.3 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.010362678 |
Sensitive |
| ENSG00000227403.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034037075 |
Sensitive |
| ENSG00000227527.2 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044755646 |
Sensitive |
| ENSG00000227598.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.005103871 |
Sensitive |
| ENSG00000227885.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.002232502 |
Sensitive |
| ENSG00000228237.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022378062 |
Sensitive |
| ENSG00000228261.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.0329157 |
Sensitive |
| ENSG00000228315.7 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.019328825 |
Sensitive |
| ENSG00000228327.2 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.037441855 |
Sensitive |
| ENSG00000228649.4 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.026087504 |
Sensitive |
| ENSG00000228737.2 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023884476 |
Sensitive |
| ENSG00000229122.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024939879 |
Sensitive |
| ENSG00000229127.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023555054 |
Sensitive |
| ENSG00000229839.2 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.028835578 |
Sensitive |
| ENSG00000229956.5 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.041542563 |
Sensitive |
| ENSG00000229999.2 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.004489252 |
Sensitive |
| ENSG00000230084.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043603499 |
Sensitive |
| ENSG00000230289.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.014146802 |
Sensitive |
| ENSG00000230679.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039629605 |
Sensitive |
| ENSG00000230732.3 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023463088 |
Sensitive |
| ENSG00000231305.3 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.017759608 |
Sensitive |
| ENSG00000231407.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.011822451 |
Sensitive |
| ENSG00000231865.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.033244239 |
Sensitive |
| ENSG00000232118.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.045085068 |
Sensitive |
| ENSG00000232545.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024882482 |
Sensitive |
| ENSG00000233250.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022525997 |
Sensitive |
| ENSG00000233483.2 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048073331 |
Sensitive |
| ENSG00000233602.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.021196862 |
Sensitive |
| ENSG00000233672.2 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042545811 |
Sensitive |
| ENSG00000233806.3 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03656856 |
Sensitive |
| ENSG00000234252.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.032454657 |
Sensitive |
| ENSG00000234676.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024184722 |
Sensitive |
| ENSG00000234772.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.008660332 |
Sensitive |
| ENSG00000234773.2 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.011924693 |
Sensitive |
| ENSG00000235078.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.044583773 |
Sensitive |
| ENSG00000235408.2 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023412353 |
Sensitive |
| ENSG00000235724.4 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.0195665 |
Sensitive |
| ENSG00000236432.3 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.003583965 |
Sensitive |
| ENSG00000236537.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04868618 |
Sensitive |
| ENSG00000236778.3 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.02861348 |
Sensitive |
| ENSG00000236896.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042887065 |
Sensitive |
| ENSG00000237756.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.017550736 |
Sensitive |
| ENSG00000237836.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030058913 |
Sensitive |
| ENSG00000237934.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.004484607 |
Sensitive |
| ENSG00000237938.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.011931603 |
Sensitive |
| ENSG00000239653.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04821392 |
Sensitive |
| ENSG00000240453.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.033425888 |
Sensitive |
| ENSG00000240549.2 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015549163 |
Sensitive |
| ENSG00000240731.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.014130028 |
Sensitive |
| ENSG00000242282.2 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036863063 |
Sensitive |
| ENSG00000242767.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039423786 |
Sensitive |
| ENSG00000245748.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.02812008 |
Sensitive |
| ENSG00000246174.3 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.016253366 |
Sensitive |
| ENSG00000247925.2 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.042499656 |
Sensitive |
| ENSG00000248008.2 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04853508 |
Sensitive |
| ENSG00000248476.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007432187 |
Sensitive |
| ENSG00000248932.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007629733 |
Sensitive |
| ENSG00000249532.2 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023987825 |
Sensitive |
| ENSG00000249700.4 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.033963456 |
Sensitive |
| ENSG00000250765.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04073394 |
Sensitive |
| ENSG00000250903.4 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024107176 |
Sensitive |
| ENSG00000253390.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015121391 |
Sensitive |
| ENSG00000253986.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043010716 |
Sensitive |
| ENSG00000254003.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.021747073 |
Sensitive |
| ENSG00000254180.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.033614114 |
Sensitive |
| ENSG00000254208.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.045006132 |
Sensitive |
| ENSG00000254231.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.018539089 |
Sensitive |
| ENSG00000254433.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.001919315 |
Sensitive |
| ENSG00000254604.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.026288379 |
Sensitive |
| ENSG00000254694.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007659783 |
Sensitive |
| ENSG00000255182.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043633915 |
Sensitive |
| ENSG00000255557.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.035330409 |
Sensitive |
| ENSG00000256196.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036383013 |
Sensitive |
| ENSG00000256381.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.011793784 |
Sensitive |
| ENSG00000256448.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.012945965 |
Sensitive |
| ENSG00000257947.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.017339787 |
Sensitive |
| ENSG00000258515.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.031758794 |
Sensitive |
| ENSG00000258646.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048199244 |
Sensitive |
| ENSG00000259212.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022813217 |
Sensitive |
| ENSG00000259349.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.011703576 |
Sensitive |
| ENSG00000260276.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.022506977 |
Sensitive |
| ENSG00000260277.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04735529 |
Sensitive |
| ENSG00000260296.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030559087 |
Sensitive |
| ENSG00000260396.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.020037187 |
Sensitive |
| ENSG00000260411.2 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039667833 |
Sensitive |
| ENSG00000260425.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.013320411 |
Sensitive |
| ENSG00000260536.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047716839 |
Sensitive |
| ENSG00000260601.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.018812036 |
Sensitive |
| ENSG00000260751.2 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040334324 |
Sensitive |
| ENSG00000261096.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024052205 |
Sensitive |
| ENSG00000261428.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.025351184 |
Sensitive |
| ENSG00000261490.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.019732328 |
Sensitive |
| ENSG00000261534.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.012614923 |
Sensitive |
| ENSG00000261560.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03591996 |
Sensitive |
| ENSG00000261582.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.000616817 |
Sensitive |
| ENSG00000261654.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007398064 |
Sensitive |
| ENSG00000261766.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03549609 |
Sensitive |
| ENSG00000262265.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007332299 |
Sensitive |
| ENSG00000262952.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.012493104 |
Sensitive |
| ENSG00000263327.2 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.045256796 |
Sensitive |
| ENSG00000263624.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.026571931 |
Sensitive |
| ENSG00000264860.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040388257 |
Sensitive |
| ENSG00000265142.2 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.011573442 |
Sensitive |
| ENSG00000266644.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.046596413 |
Sensitive |
| ENSG00000266936.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.025957274 |
Sensitive |
| ENSG00000267018.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049521516 |
Sensitive |
| ENSG00000267067.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043873991 |
Sensitive |
| ENSG00000267100.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.045536144 |
Sensitive |
| ENSG00000267149.2 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.006757779 |
Sensitive |
| ENSG00000267183.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.040371483 |
Sensitive |
| ENSG00000267344.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024686252 |
Sensitive |
| ENSG00000267348.2 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.041708382 |
Sensitive |
| ENSG00000267397.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030440871 |
Sensitive |
| ENSG00000267476.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047664588 |
Sensitive |
| ENSG00000267567.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.039730908 |
Sensitive |
| ENSG00000267649.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036536345 |
Sensitive |
| ENSG00000267904.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.032886414 |
Sensitive |
| ENSG00000268087.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.041275176 |
Sensitive |
| ENSG00000268366.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.017314378 |
Sensitive |
| ENSG00000268401.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024012889 |
Sensitive |
| ENSG00000269235.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.048386156 |
Sensitive |
| ENSG00000269427.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.034370434 |
Sensitive |
| ENSG00000269486.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.004086701 |
Sensitive |
| ENSG00000269843.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.02413496 |
Sensitive |
| ENSG00000269896.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.007388804 |
Sensitive |
| ENSG00000269956.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015753773 |
Sensitive |
| ENSG00000270020.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.015379008 |
Sensitive |
| ENSG00000270031.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.01951167 |
Sensitive |
| ENSG00000270091.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.006573979 |
Sensitive |
| ENSG00000270100.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.03569503 |
Sensitive |
| ENSG00000270951.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.014020684 |
Sensitive |
| ENSG00000271032.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.036927849 |
Sensitive |
| ENSG00000271228.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.00591561 |
Sensitive |
| ENSG00000271265.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.030112656 |
Sensitive |
| ENSG00000271551.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.023028715 |
Sensitive |
| ENSG00000271843.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.0023703 |
Sensitive |
| ENSG00000271889.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.046358916 |
Sensitive |
| ENSG00000271914.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.049070775 |
Sensitive |
| ENSG00000271921.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.035559856 |
Sensitive |
| ENSG00000271967.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.045102001 |
Sensitive |
| ENSG00000272029.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.006251782 |
Sensitive |
| ENSG00000272148.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.01003619 |
Sensitive |
| ENSG00000272240.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.045539577 |
Sensitive |
| ENSG00000272248.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.04442158 |
Sensitive |
| ENSG00000272374.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.033142538 |
Sensitive |
| ENSG00000272449.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.016280934 |
Sensitive |
| ENSG00000272452.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.012232602 |
Sensitive |
| ENSG00000272699.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.016718086 |
Sensitive |
| ENSG00000272754.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.021014832 |
Sensitive |
| ENSG00000272812.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043594397 |
Sensitive |
| ENSG00000273000.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.018361178 |
Sensitive |
| ENSG00000273011.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.014345054 |
Sensitive |
| ENSG00000273056.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.024896297 |
Sensitive |
| ENSG00000273081.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.032952569 |
Sensitive |
| ENSG00000273096.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.045623516 |
Sensitive |
| ENSG00000273216.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.047428568 |
Sensitive |
| ENSG00000273243.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.043153769 |
Sensitive |
| ENSG00000273338.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.037831793 |
Sensitive |
| ENSG00000273369.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.020038077 |
Sensitive |
| ENSG00000273486.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.003490377 |
Sensitive |
| ENSG00000273488.1 |
Afatinib |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.016910769 |
Sensitive |
| ENSG00000153363.8 |
Afatinib |
Esophageal cancer |
0.010735443 |
Sensitive |
| ENSG00000215483.4 |
Afatinib |
Esophageal cancer |
0.029246827 |
Sensitive |
| ENSG00000215841.3 |
Afatinib |
Esophageal cancer |
0.04866467 |
Sensitive |
| ENSG00000222043.2 |
Afatinib |
Esophageal cancer |
0.036014089 |
Sensitive |
| ENSG00000224888.3 |
Afatinib |
Esophageal cancer |
0.031608083 |
Sensitive |
| ENSG00000225767.1 |
Afatinib |
Esophageal cancer |
0.02188599 |
Sensitive |
| ENSG00000226281.2 |
Afatinib |
Esophageal cancer |
0.027623417 |
Sensitive |
| ENSG00000227627.1 |
Afatinib |
Esophageal cancer |
0.029762555 |
Sensitive |
| ENSG00000228886.1 |
Afatinib |
Esophageal cancer |
0.01127484 |
Sensitive |
| ENSG00000230392.1 |
Afatinib |
Esophageal cancer |
0.009765416 |
Sensitive |
| ENSG00000230658.1 |
Afatinib |
Esophageal cancer |
0.03112738 |
Sensitive |
| ENSG00000230817.1 |
Afatinib |
Esophageal cancer |
0.001982359 |
Sensitive |
| ENSG00000231439.3 |
Afatinib |
Esophageal cancer |
0.021555291 |
Sensitive |
| ENSG00000231881.1 |
Afatinib |
Esophageal cancer |
0.046170519 |
Sensitive |
| ENSG00000231920.1 |
Afatinib |
Esophageal cancer |
0.046352288 |
Sensitive |
| ENSG00000232077.1 |
Afatinib |
Esophageal cancer |
0.037623443 |
Sensitive |
| ENSG00000236095.1 |
Afatinib |
Esophageal cancer |
0.011200995 |
Sensitive |
| ENSG00000236137.1 |
Afatinib |
Esophageal cancer |
0.01797186 |
Sensitive |
| ENSG00000236364.2 |
Afatinib |
Esophageal cancer |
0.042528258 |
Sensitive |
| ENSG00000237152.2 |
Afatinib |
Esophageal cancer |
0.016611263 |
Sensitive |
| ENSG00000237404.1 |
Afatinib |
Esophageal cancer |
0.031148901 |
Sensitive |
| ENSG00000246130.1 |
Afatinib |
Esophageal cancer |
0.033663627 |
Sensitive |
| ENSG00000249241.1 |
Afatinib |
Esophageal cancer |
0.017497004 |
Sensitive |
| ENSG00000249395.2 |
Afatinib |
Esophageal cancer |
0.011656821 |
Sensitive |
| ENSG00000254484.1 |
Afatinib |
Esophageal cancer |
0.028126545 |
Sensitive |
| ENSG00000255571.2 |
Afatinib |
Esophageal cancer |
0.042911931 |
Sensitive |
| ENSG00000256001.1 |
Afatinib |
Esophageal cancer |
0.045738876 |
Sensitive |
| ENSG00000256115.1 |
Afatinib |
Esophageal cancer |
0.031360019 |
Sensitive |
| ENSG00000256288.1 |
Afatinib |
Esophageal cancer |
0.011764859 |
Sensitive |
| ENSG00000257176.1 |
Afatinib |
Esophageal cancer |
0.025800639 |
Sensitive |
| ENSG00000257497.1 |
Afatinib |
Esophageal cancer |
0.049819381 |
Sensitive |
| ENSG00000257636.2 |
Afatinib |
Esophageal cancer |
0.047682185 |
Sensitive |
| ENSG00000258593.2 |
Afatinib |
Esophageal cancer |
0.046490689 |
Sensitive |
| ENSG00000258815.1 |
Afatinib |
Esophageal cancer |
0.012282949 |
Sensitive |
| ENSG00000258940.2 |
Afatinib |
Esophageal cancer |
0.025564203 |
Sensitive |
| ENSG00000260468.1 |
Afatinib |
Esophageal cancer |
0.049458766 |
Sensitive |
| ENSG00000260588.1 |
Afatinib |
Esophageal cancer |
0.035556172 |
Sensitive |
| ENSG00000261775.1 |
Afatinib |
Esophageal cancer |
0.025549421 |
Sensitive |
| ENSG00000262296.1 |
Afatinib |
Esophageal cancer |
0.049959497 |
Sensitive |
| ENSG00000265334.1 |
Afatinib |
Esophageal cancer |
0.036687134 |
Sensitive |
| ENSG00000266651.1 |
Afatinib |
Esophageal cancer |
0.003744825 |
Sensitive |
| ENSG00000266969.1 |
Afatinib |
Esophageal cancer |
0.040609727 |
Sensitive |
| ENSG00000266999.1 |
Afatinib |
Esophageal cancer |
0.019151241 |
Sensitive |
| ENSG00000267018.1 |
Afatinib |
Esophageal cancer |
0.034692571 |
Sensitive |
| ENSG00000267505.1 |
Afatinib |
Esophageal cancer |
0.036872768 |
Sensitive |
| ENSG00000267583.1 |
Afatinib |
Esophageal cancer |
0.049781082 |
Sensitive |
| ENSG00000268583.1 |
Afatinib |
Esophageal cancer |
0.039270215 |
Sensitive |
| ENSG00000269614.1 |
Afatinib |
Esophageal cancer |
0.044436558 |
Sensitive |
| ENSG00000270117.1 |
Afatinib |
Esophageal cancer |
0.043523378 |
Sensitive |
| ENSG00000272057.1 |
Afatinib |
Esophageal cancer |
0.043643155 |
Sensitive |
| ENSG00000272254.1 |
Afatinib |
Esophageal cancer |
0.009640105 |
Sensitive |
| ENSG00000273341.1 |
Afatinib |
Esophageal cancer |
0.035804648 |
Sensitive |
| ENSG00000273399.1 |
Afatinib |
Esophageal cancer |
0.047596554 |
Sensitive |
| ENSG00000225057.2 |
Afatinib |
Head and neck squamous cell carcinoma |
0.003929906 |
Sensitive |
| ENSG00000225140.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.038220529 |
Sensitive |
| ENSG00000225311.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.023872554 |
Sensitive |
| ENSG00000225889.3 |
Afatinib |
Head and neck squamous cell carcinoma |
0.017643781 |
Sensitive |
| ENSG00000225982.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.003607685 |
Sensitive |
| ENSG00000228072.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.023400342 |
Sensitive |
| ENSG00000229891.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.039552511 |
Sensitive |
| ENSG00000230061.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.022244584 |
Sensitive |
| ENSG00000230498.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.039080328 |
Sensitive |
| ENSG00000230922.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.040524196 |
Sensitive |
| ENSG00000232900.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.003451191 |
Sensitive |
| ENSG00000234998.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.036151685 |
Sensitive |
| ENSG00000235159.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.021670416 |
Sensitive |
| ENSG00000235529.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.018845339 |
Sensitive |
| ENSG00000235852.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.031086552 |
Sensitive |
| ENSG00000236914.3 |
Afatinib |
Head and neck squamous cell carcinoma |
0.042360886 |
Sensitive |
| ENSG00000237073.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.049726522 |
Sensitive |
| ENSG00000237248.3 |
Afatinib |
Head and neck squamous cell carcinoma |
0.032703267 |
Sensitive |
| ENSG00000243479.3 |
Afatinib |
Head and neck squamous cell carcinoma |
0.046541543 |
Sensitive |
| ENSG00000248456.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.003032961 |
Sensitive |
| ENSG00000249669.3 |
Afatinib |
Head and neck squamous cell carcinoma |
0.005019719 |
Sensitive |
| ENSG00000250509.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.01041515 |
Sensitive |
| ENSG00000253477.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.047940078 |
Sensitive |
| ENSG00000254473.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.009993105 |
Sensitive |
| ENSG00000255966.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.0445348 |
Sensitive |
| ENSG00000258586.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.045553329 |
Sensitive |
| ENSG00000259343.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.008564696 |
Sensitive |
| ENSG00000260065.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.031682364 |
Sensitive |
| ENSG00000261280.2 |
Afatinib |
Head and neck squamous cell carcinoma |
0.009472781 |
Sensitive |
| ENSG00000261729.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.040760774 |
Sensitive |
| ENSG00000264107.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.031697865 |
Sensitive |
| ENSG00000266667.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.013976699 |
Sensitive |
| ENSG00000266925.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.021240087 |
Sensitive |
| ENSG00000269425.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.017727623 |
Sensitive |
| ENSG00000272788.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.021270248 |
Sensitive |
| ENSG00000273125.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.001213958 |
Sensitive |
| ENSG00000273203.1 |
Afatinib |
Head and neck squamous cell carcinoma |
0.011754302 |
Sensitive |
| ENSG00000226363.3 |
Afatinib |
Kidney renal clear cell carcinoma |
0.01948448 |
Sensitive |
| ENSG00000226754.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.012470661 |
Sensitive |
| ENSG00000227482.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.014726731 |
Sensitive |
| ENSG00000228624.3 |
Afatinib |
Kidney renal clear cell carcinoma |
0.025394867 |
Sensitive |
| ENSG00000236537.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.035659323 |
Sensitive |
| ENSG00000236545.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.025102781 |
Sensitive |
| ENSG00000237149.4 |
Afatinib |
Kidney renal clear cell carcinoma |
0.03904741 |
Sensitive |
| ENSG00000246145.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.044608209 |
Sensitive |
| ENSG00000246898.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.032533822 |
Sensitive |
| ENSG00000250548.2 |
Afatinib |
Kidney renal clear cell carcinoma |
0.03910771 |
Sensitive |
| ENSG00000253508.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.01252286 |
Sensitive |
| ENSG00000253917.3 |
Afatinib |
Kidney renal clear cell carcinoma |
0.03869363 |
Sensitive |
| ENSG00000254854.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.027131939 |
Sensitive |
| ENSG00000260018.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.021120754 |
Sensitive |
| ENSG00000260777.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.016878587 |
Sensitive |
| ENSG00000260814.2 |
Afatinib |
Kidney renal clear cell carcinoma |
0.009668322 |
Sensitive |
| ENSG00000261079.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.049634212 |
Sensitive |
| ENSG00000261238.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.039421011 |
Sensitive |
| ENSG00000263105.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.04590386 |
Sensitive |
| ENSG00000263731.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.045021544 |
Sensitive |
| ENSG00000264745.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.023737179 |
Sensitive |
| ENSG00000270137.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.048746006 |
Sensitive |
| ENSG00000272518.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.02766008 |
Sensitive |
| ENSG00000273281.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.017811613 |
Sensitive |
| ENSG00000273399.1 |
Afatinib |
Kidney renal clear cell carcinoma |
0.035661901 |
Sensitive |
| ENSG00000204588.5 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.036472114 |
Sensitive |
| ENSG00000225311.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.036589307 |
Sensitive |
| ENSG00000226194.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.030676978 |
Sensitive |
| ENSG00000226852.2 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.045707051 |
Sensitive |
| ENSG00000230176.2 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.025196331 |
Sensitive |
| ENSG00000233427.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.013867702 |
Sensitive |
| ENSG00000237705.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.044203421 |
Sensitive |
| ENSG00000254610.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.049503517 |
Sensitive |
| ENSG00000255362.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.046279682 |
Sensitive |
| ENSG00000261670.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.004473318 |
Sensitive |
| ENSG00000268683.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.006199208 |
Sensitive |
| ENSG00000272483.1 |
Afatinib |
Chronic Lymphocytic Leukemia |
0.017252624 |
Sensitive |
| ENSG00000185186.4 |
Afatinib |
Brain lower grade glioma |
0.017683477 |
Sensitive |
| ENSG00000214955.5 |
Afatinib |
Brain lower grade glioma |
0.031046396 |
Sensitive |
| ENSG00000223975.1 |
Afatinib |
Brain lower grade glioma |
0.004514064 |
Sensitive |
| ENSG00000224888.3 |
Afatinib |
Brain lower grade glioma |
0.044024472 |
Sensitive |
| ENSG00000224950.1 |
Afatinib |
Brain lower grade glioma |
0.043028502 |
Sensitive |
| ENSG00000225140.1 |
Afatinib |
Brain lower grade glioma |
0.026995153 |
Sensitive |
| ENSG00000225652.1 |
Afatinib |
Brain lower grade glioma |
0.046915487 |
Sensitive |
| ENSG00000225744.1 |
Afatinib |
Brain lower grade glioma |
0.010441597 |
Sensitive |
| ENSG00000226637.1 |
Afatinib |
Brain lower grade glioma |
0.038754714 |
Sensitive |
| ENSG00000226816.2 |
Afatinib |
Brain lower grade glioma |
0.040951018 |
Sensitive |
| ENSG00000227496.1 |
Afatinib |
Brain lower grade glioma |
0.004380459 |
Sensitive |
| ENSG00000228679.1 |
Afatinib |
Brain lower grade glioma |
0.045280587 |
Sensitive |
| ENSG00000229291.1 |
Afatinib |
Brain lower grade glioma |
0.010512204 |
Sensitive |
| ENSG00000229373.4 |
Afatinib |
Brain lower grade glioma |
0.030900155 |
Sensitive |
| ENSG00000229401.1 |
Afatinib |
Brain lower grade glioma |
0.037686167 |
Sensitive |
| ENSG00000229512.1 |
Afatinib |
Brain lower grade glioma |
0.003321784 |
Sensitive |
| ENSG00000230798.1 |
Afatinib |
Brain lower grade glioma |
0.044533332 |
Sensitive |
| ENSG00000232455.2 |
Afatinib |
Brain lower grade glioma |
0.015087544 |
Sensitive |
| ENSG00000233110.1 |
Afatinib |
Brain lower grade glioma |
0.01695467 |
Sensitive |
| ENSG00000237807.3 |
Afatinib |
Brain lower grade glioma |
0.034833311 |
Sensitive |
| ENSG00000239593.1 |
Afatinib |
Brain lower grade glioma |
0.043080961 |
Sensitive |
| ENSG00000241313.2 |
Afatinib |
Brain lower grade glioma |
0.029560068 |
Sensitive |
| ENSG00000244137.1 |
Afatinib |
Brain lower grade glioma |
0.042756207 |
Sensitive |
| ENSG00000245293.2 |
Afatinib |
Brain lower grade glioma |
0.01271861 |
Sensitive |
| ENSG00000245571.2 |
Afatinib |
Brain lower grade glioma |
0.021698306 |
Sensitive |
| ENSG00000248125.1 |
Afatinib |
Brain lower grade glioma |
0.025825206 |
Sensitive |
| ENSG00000248724.2 |
Afatinib |
Brain lower grade glioma |
0.039717485 |
Sensitive |
| ENSG00000249996.1 |
Afatinib |
Brain lower grade glioma |
0.006616947 |
Sensitive |
| ENSG00000250362.1 |
Afatinib |
Brain lower grade glioma |
0.038040961 |
Sensitive |
| ENSG00000250829.2 |
Afatinib |
Brain lower grade glioma |
0.021449164 |
Sensitive |
| ENSG00000250889.2 |
Afatinib |
Brain lower grade glioma |
0.048542066 |
Sensitive |
| ENSG00000251003.3 |
Afatinib |
Brain lower grade glioma |
0.003753888 |
Sensitive |
| ENSG00000251307.1 |
Afatinib |
Brain lower grade glioma |
0.046368773 |
Sensitive |
| ENSG00000254204.1 |
Afatinib |
Brain lower grade glioma |
0.037068924 |
Sensitive |
| ENSG00000254363.2 |
Afatinib |
Brain lower grade glioma |
0.030555099 |
Sensitive |
| ENSG00000254847.1 |
Afatinib |
Brain lower grade glioma |
0.029593508 |
Sensitive |
| ENSG00000258884.1 |
Afatinib |
Brain lower grade glioma |
0.009645749 |
Sensitive |
| ENSG00000259732.1 |
Afatinib |
Brain lower grade glioma |
0.018373186 |
Sensitive |
| ENSG00000260145.1 |
Afatinib |
Brain lower grade glioma |
0.023612904 |
Sensitive |
| ENSG00000260257.1 |
Afatinib |
Brain lower grade glioma |
0.015373216 |
Sensitive |
| ENSG00000260910.1 |
Afatinib |
Brain lower grade glioma |
0.009774217 |
Sensitive |
| ENSG00000265394.1 |
Afatinib |
Brain lower grade glioma |
0.015027001 |
Sensitive |
| ENSG00000266126.1 |
Afatinib |
Brain lower grade glioma |
0.026317644 |
Sensitive |
| ENSG00000267798.1 |
Afatinib |
Brain lower grade glioma |
0.032865132 |
Sensitive |
| ENSG00000268340.1 |
Afatinib |
Brain lower grade glioma |
0.041612937 |
Sensitive |
| ENSG00000269019.1 |
Afatinib |
Brain lower grade glioma |
0.047665833 |
Sensitive |
| ENSG00000270000.1 |
Afatinib |
Brain lower grade glioma |
0.030145698 |
Sensitive |
| ENSG00000270031.1 |
Afatinib |
Brain lower grade glioma |
0.026264895 |
Sensitive |
| ENSG00000270036.1 |
Afatinib |
Brain lower grade glioma |
0.03594377 |
Sensitive |
| ENSG00000270210.1 |
Afatinib |
Brain lower grade glioma |
0.038189816 |
Sensitive |
| ENSG00000271826.1 |
Afatinib |
Brain lower grade glioma |
0.016218169 |
Sensitive |
| ENSG00000271882.1 |
Afatinib |
Brain lower grade glioma |
0.018382836 |
Sensitive |
| ENSG00000271926.1 |
Afatinib |
Brain lower grade glioma |
0.035701863 |
Sensitive |
| ENSG00000271948.1 |
Afatinib |
Brain lower grade glioma |
0.037690144 |
Sensitive |
| ENSG00000272141.1 |
Afatinib |
Brain lower grade glioma |
0.008253101 |
Sensitive |
| ENSG00000272236.1 |
Afatinib |
Brain lower grade glioma |
0.00577918 |
Sensitive |
| ENSG00000272505.1 |
Afatinib |
Brain lower grade glioma |
0.013518918 |
Sensitive |
| ENSG00000273186.1 |
Afatinib |
Brain lower grade glioma |
0.004701916 |
Sensitive |
| ENSG00000273232.1 |
Afatinib |
Brain lower grade glioma |
0.02258204 |
Sensitive |
| ENSG00000273233.1 |
Afatinib |
Brain lower grade glioma |
0.04431516 |
Sensitive |
| ENSG00000135253.9 |
Afatinib |
Lung squamous cell carcinoma |
0.018018457 |
Sensitive |
| ENSG00000175147.7 |
Afatinib |
Lung squamous cell carcinoma |
0.013578373 |
Sensitive |
| ENSG00000180712.3 |
Afatinib |
Lung squamous cell carcinoma |
0.021321864 |
Sensitive |
| ENSG00000185168.5 |
Afatinib |
Lung squamous cell carcinoma |
0.029534759 |
Sensitive |
| ENSG00000203280.3 |
Afatinib |
Lung squamous cell carcinoma |
0.018465449 |
Sensitive |
| ENSG00000203499.6 |
Afatinib |
Lung squamous cell carcinoma |
0.003860576 |
Sensitive |
| ENSG00000205488.4 |
Afatinib |
Lung squamous cell carcinoma |
0.036429309 |
Sensitive |
| ENSG00000205890.3 |
Afatinib |
Lung squamous cell carcinoma |
0.015157918 |
Sensitive |
| ENSG00000214049.6 |
Afatinib |
Lung squamous cell carcinoma |
0.013603337 |
Sensitive |
| ENSG00000214353.3 |
Afatinib |
Lung squamous cell carcinoma |
0.047424481 |
Sensitive |
| ENSG00000214733.4 |
Afatinib |
Lung squamous cell carcinoma |
0.035166341 |
Sensitive |
| ENSG00000214851.4 |
Afatinib |
Lung squamous cell carcinoma |
0.029349879 |
Sensitive |
| ENSG00000215244.2 |
Afatinib |
Lung squamous cell carcinoma |
0.009427422 |
Sensitive |
| ENSG00000215483.4 |
Afatinib |
Lung squamous cell carcinoma |
0.008108551 |
Sensitive |
| ENSG00000215841.3 |
Afatinib |
Lung squamous cell carcinoma |
0.014049874 |
Sensitive |
| ENSG00000224081.3 |
Afatinib |
Lung squamous cell carcinoma |
0.033217964 |
Sensitive |
| ENSG00000224509.1 |
Afatinib |
Lung squamous cell carcinoma |
0.046984308 |
Sensitive |
| ENSG00000224621.1 |
Afatinib |
Lung squamous cell carcinoma |
0.045089049 |
Sensitive |
| ENSG00000224649.1 |
Afatinib |
Lung squamous cell carcinoma |
0.047306486 |
Sensitive |
| ENSG00000224794.1 |
Afatinib |
Lung squamous cell carcinoma |
0.030692832 |
Sensitive |
| ENSG00000224961.1 |
Afatinib |
Lung squamous cell carcinoma |
0.017527807 |
Sensitive |
| ENSG00000224984.1 |
Afatinib |
Lung squamous cell carcinoma |
0.037408821 |
Sensitive |
| ENSG00000224992.1 |
Afatinib |
Lung squamous cell carcinoma |
0.021396753 |
Sensitive |
| ENSG00000225956.1 |
Afatinib |
Lung squamous cell carcinoma |
0.040442633 |
Sensitive |
| ENSG00000226101.1 |
Afatinib |
Lung squamous cell carcinoma |
0.041701609 |
Sensitive |
| ENSG00000226332.2 |
Afatinib |
Lung squamous cell carcinoma |
0.004908769 |
Sensitive |
| ENSG00000226377.1 |
Afatinib |
Lung squamous cell carcinoma |
0.012020849 |
Sensitive |
| ENSG00000227192.1 |
Afatinib |
Lung squamous cell carcinoma |
0.028191391 |
Sensitive |
| ENSG00000227479.1 |
Afatinib |
Lung squamous cell carcinoma |
0.044475977 |
Sensitive |
| ENSG00000227486.1 |
Afatinib |
Lung squamous cell carcinoma |
0.026933299 |
Sensitive |
| ENSG00000227533.1 |
Afatinib |
Lung squamous cell carcinoma |
0.015557241 |
Sensitive |
| ENSG00000227726.1 |
Afatinib |
Lung squamous cell carcinoma |
0.035966962 |
Sensitive |
| ENSG00000227885.1 |
Afatinib |
Lung squamous cell carcinoma |
0.001652566 |
Sensitive |
| ENSG00000228176.1 |
Afatinib |
Lung squamous cell carcinoma |
0.009374486 |
Sensitive |
| ENSG00000228313.3 |
Afatinib |
Lung squamous cell carcinoma |
0.049105478 |
Sensitive |
| ENSG00000228481.1 |
Afatinib |
Lung squamous cell carcinoma |
0.014056155 |
Sensitive |
| ENSG00000228526.2 |
Afatinib |
Lung squamous cell carcinoma |
0.02438702 |
Sensitive |
| ENSG00000228791.3 |
Afatinib |
Lung squamous cell carcinoma |
0.026744812 |
Sensitive |
| ENSG00000228812.3 |
Afatinib |
Lung squamous cell carcinoma |
0.007659287 |
Sensitive |
| ENSG00000228865.1 |
Afatinib |
Lung squamous cell carcinoma |
0.013830439 |
Sensitive |
| ENSG00000228917.1 |
Afatinib |
Lung squamous cell carcinoma |
0.00267494 |
Sensitive |
| ENSG00000228952.1 |
Afatinib |
Lung squamous cell carcinoma |
0.04683272 |
Sensitive |
| ENSG00000229017.2 |
Afatinib |
Lung squamous cell carcinoma |
0.037487852 |
Sensitive |
| ENSG00000229021.2 |
Afatinib |
Lung squamous cell carcinoma |
0.04181868 |
Sensitive |
| ENSG00000229656.2 |
Afatinib |
Lung squamous cell carcinoma |
0.046860326 |
Sensitive |
| ENSG00000229660.1 |
Afatinib |
Lung squamous cell carcinoma |
0.037913803 |
Sensitive |
| ENSG00000229666.1 |
Afatinib |
Lung squamous cell carcinoma |
0.005705977 |
Sensitive |
| ENSG00000230058.1 |
Afatinib |
Lung squamous cell carcinoma |
0.016361755 |
Sensitive |
| ENSG00000230140.1 |
Afatinib |
Lung squamous cell carcinoma |
0.019874446 |
Sensitive |
| ENSG00000230698.1 |
Afatinib |
Lung squamous cell carcinoma |
0.032629206 |
Sensitive |
| ENSG00000230753.1 |
Afatinib |
Lung squamous cell carcinoma |
0.008177321 |
Sensitive |
| ENSG00000231187.2 |
Afatinib |
Lung squamous cell carcinoma |
0.04238432 |
Sensitive |
| ENSG00000231335.1 |
Afatinib |
Lung squamous cell carcinoma |
0.042763757 |
Sensitive |
| ENSG00000231401.1 |
Afatinib |
Lung squamous cell carcinoma |
0.026383517 |
Sensitive |
| ENSG00000231483.1 |
Afatinib |
Lung squamous cell carcinoma |
0.034669746 |
Sensitive |
| ENSG00000232034.1 |
Afatinib |
Lung squamous cell carcinoma |
0.023842298 |
Sensitive |
| ENSG00000232082.1 |
Afatinib |
Lung squamous cell carcinoma |
0.027370288 |
Sensitive |
| ENSG00000232725.1 |
Afatinib |
Lung squamous cell carcinoma |
0.04136245 |
Sensitive |
| ENSG00000233387.1 |
Afatinib |
Lung squamous cell carcinoma |
0.049420986 |
Sensitive |
| ENSG00000233411.1 |
Afatinib |
Lung squamous cell carcinoma |
0.03464923 |
Sensitive |
| ENSG00000233694.1 |
Afatinib |
Lung squamous cell carcinoma |
0.02919175 |
Sensitive |
| ENSG00000233695.1 |
Afatinib |
Lung squamous cell carcinoma |
0.048698775 |
Sensitive |
| ENSG00000233845.1 |
Afatinib |
Lung squamous cell carcinoma |
0.02037656 |
Sensitive |
| ENSG00000233895.1 |
Afatinib |
Lung squamous cell carcinoma |
0.014591026 |
Sensitive |
| ENSG00000233967.2 |
Afatinib |
Lung squamous cell carcinoma |
0.013366739 |
Sensitive |
| ENSG00000234111.2 |
Afatinib |
Lung squamous cell carcinoma |
0.008395002 |
Sensitive |
| ENSG00000234147.1 |
Afatinib |
Lung squamous cell carcinoma |
0.021373155 |
Sensitive |
| ENSG00000234174.1 |
Afatinib |
Lung squamous cell carcinoma |
0.015420015 |
Sensitive |
| ENSG00000234678.1 |
Afatinib |
Lung squamous cell carcinoma |
0.023775053 |
Sensitive |
| ENSG00000234899.5 |
Afatinib |
Lung squamous cell carcinoma |
0.025467041 |
Sensitive |
| ENSG00000234900.1 |
Afatinib |
Lung squamous cell carcinoma |
0.048872146 |
Sensitive |
| ENSG00000235005.1 |
Afatinib |
Lung squamous cell carcinoma |
0.037549712 |
Sensitive |
| ENSG00000235609.4 |
Afatinib |
Lung squamous cell carcinoma |
0.024847108 |
Sensitive |
| ENSG00000235663.1 |
Afatinib |
Lung squamous cell carcinoma |
0.026568345 |
Sensitive |
| ENSG00000235781.1 |
Afatinib |
Lung squamous cell carcinoma |
0.020930693 |
Sensitive |
| ENSG00000236153.1 |
Afatinib |
Lung squamous cell carcinoma |
0.029956632 |
Sensitive |
| ENSG00000236305.1 |
Afatinib |
Lung squamous cell carcinoma |
0.0000298 |
Sensitive |
| ENSG00000236347.1 |
Afatinib |
Lung squamous cell carcinoma |
0.025136228 |
Sensitive |
| ENSG00000236740.2 |
Afatinib |
Lung squamous cell carcinoma |
0.046073315 |
Sensitive |
| ENSG00000236935.1 |
Afatinib |
Lung squamous cell carcinoma |
0.033706864 |
Sensitive |
| ENSG00000237356.1 |
Afatinib |
Lung squamous cell carcinoma |
0.015318749 |
Sensitive |
| ENSG00000237453.1 |
Afatinib |
Lung squamous cell carcinoma |
0.020304209 |
Sensitive |
| ENSG00000237523.1 |
Afatinib |
Lung squamous cell carcinoma |
0.011752794 |
Sensitive |
| ENSG00000237772.1 |
Afatinib |
Lung squamous cell carcinoma |
0.026890121 |
Sensitive |
| ENSG00000237773.1 |
Afatinib |
Lung squamous cell carcinoma |
0.009371452 |
Sensitive |
| ENSG00000238068.1 |
Afatinib |
Lung squamous cell carcinoma |
0.009178126 |
Sensitive |
| ENSG00000239828.2 |
Afatinib |
Lung squamous cell carcinoma |
0.023912554 |
Sensitive |
| ENSG00000240875.1 |
Afatinib |
Lung squamous cell carcinoma |
0.037089649 |
Sensitive |
| ENSG00000241599.1 |
Afatinib |
Lung squamous cell carcinoma |
0.017365309 |
Sensitive |
| ENSG00000241912.1 |
Afatinib |
Lung squamous cell carcinoma |
0.023875811 |
Sensitive |
| ENSG00000242828.1 |
Afatinib |
Lung squamous cell carcinoma |
0.045531041 |
Sensitive |
| ENSG00000242861.1 |
Afatinib |
Lung squamous cell carcinoma |
0.041736862 |
Sensitive |
| ENSG00000243636.1 |
Afatinib |
Lung squamous cell carcinoma |
0.049861119 |
Sensitive |
| ENSG00000245025.2 |
Afatinib |
Lung squamous cell carcinoma |
0.039969956 |
Sensitive |
| ENSG00000245330.4 |
Afatinib |
Lung squamous cell carcinoma |
0.018812536 |
Sensitive |
| ENSG00000245532.4 |
Afatinib |
Lung squamous cell carcinoma |
0.010843727 |
Sensitive |
| ENSG00000246582.2 |
Afatinib |
Lung squamous cell carcinoma |
0.004600632 |
Sensitive |
| ENSG00000246640.1 |
Afatinib |
Lung squamous cell carcinoma |
0.004125598 |
Sensitive |
| ENSG00000246740.2 |
Afatinib |
Lung squamous cell carcinoma |
0.003289865 |
Sensitive |
| ENSG00000246898.1 |
Afatinib |
Lung squamous cell carcinoma |
0.033705416 |
Sensitive |
| ENSG00000247095.2 |
Afatinib |
Lung squamous cell carcinoma |
0.010445798 |
Sensitive |
| ENSG00000248112.1 |
Afatinib |
Lung squamous cell carcinoma |
0.043559186 |
Sensitive |
| ENSG00000248429.1 |
Afatinib |
Lung squamous cell carcinoma |
0.030098954 |
Sensitive |
| ENSG00000248468.1 |
Afatinib |
Lung squamous cell carcinoma |
0.02721511 |
Sensitive |
| ENSG00000248663.2 |
Afatinib |
Lung squamous cell carcinoma |
0.04286131 |
Sensitive |
| ENSG00000248779.1 |
Afatinib |
Lung squamous cell carcinoma |
0.047309257 |
Sensitive |
| ENSG00000248954.1 |
Afatinib |
Lung squamous cell carcinoma |
0.042347885 |
Sensitive |
| ENSG00000249199.1 |
Afatinib |
Lung squamous cell carcinoma |
0.036732678 |
Sensitive |
| ENSG00000249275.1 |
Afatinib |
Lung squamous cell carcinoma |
0.008319711 |
Sensitive |
| ENSG00000249604.1 |
Afatinib |
Lung squamous cell carcinoma |
0.027012212 |
Sensitive |
| ENSG00000249631.1 |
Afatinib |
Lung squamous cell carcinoma |
0.03862797 |
Sensitive |
| ENSG00000249738.2 |
Afatinib |
Lung squamous cell carcinoma |
0.017775459 |
Sensitive |
| ENSG00000250039.3 |
Afatinib |
Lung squamous cell carcinoma |
0.012340202 |
Sensitive |
| ENSG00000250072.1 |
Afatinib |
Lung squamous cell carcinoma |
0.005671886 |
Sensitive |
| ENSG00000250590.1 |
Afatinib |
Lung squamous cell carcinoma |
0.011281092 |
Sensitive |
| ENSG00000250604.1 |
Afatinib |
Lung squamous cell carcinoma |
0.02203439 |
Sensitive |
| ENSG00000250889.2 |
Afatinib |
Lung squamous cell carcinoma |
0.041286421 |
Sensitive |
| ENSG00000251169.2 |
Afatinib |
Lung squamous cell carcinoma |
0.018282977 |
Sensitive |
| ENSG00000251292.1 |
Afatinib |
Lung squamous cell carcinoma |
0.020986637 |
Sensitive |
| ENSG00000251603.1 |
Afatinib |
Lung squamous cell carcinoma |
0.002466093 |
Sensitive |
| ENSG00000251611.1 |
Afatinib |
Lung squamous cell carcinoma |
0.020300976 |
Sensitive |
| ENSG00000251675.1 |
Afatinib |
Lung squamous cell carcinoma |
0.010996451 |
Sensitive |
| ENSG00000253530.1 |
Afatinib |
Lung squamous cell carcinoma |
0.003587577 |
Sensitive |
| ENSG00000253671.1 |
Afatinib |
Lung squamous cell carcinoma |
0.006606004 |
Sensitive |
| ENSG00000253701.1 |
Afatinib |
Lung squamous cell carcinoma |
0.029271051 |
Sensitive |
| ENSG00000253842.1 |
Afatinib |
Lung squamous cell carcinoma |
0.0274912 |
Sensitive |
| ENSG00000253944.1 |
Afatinib |
Lung squamous cell carcinoma |
0.030887639 |
Sensitive |
| ENSG00000254109.1 |
Afatinib |
Lung squamous cell carcinoma |
0.015731825 |
Sensitive |
| ENSG00000254142.2 |
Afatinib |
Lung squamous cell carcinoma |
0.008847346 |
Sensitive |
| ENSG00000254154.4 |
Afatinib |
Lung squamous cell carcinoma |
0.014863939 |
Sensitive |
| ENSG00000254231.1 |
Afatinib |
Lung squamous cell carcinoma |
0.021447806 |
Sensitive |
| ENSG00000254267.1 |
Afatinib |
Lung squamous cell carcinoma |
0.005415681 |
Sensitive |
| ENSG00000254286.1 |
Afatinib |
Lung squamous cell carcinoma |
0.038168083 |
Sensitive |
| ENSG00000254333.1 |
Afatinib |
Lung squamous cell carcinoma |
0.026050804 |
Sensitive |
| ENSG00000254973.1 |
Afatinib |
Lung squamous cell carcinoma |
0.016283306 |
Sensitive |
| ENSG00000255031.1 |
Afatinib |
Lung squamous cell carcinoma |
0.017941071 |
Sensitive |
| ENSG00000255045.1 |
Afatinib |
Lung squamous cell carcinoma |
0.004240329 |
Sensitive |
| ENSG00000255050.1 |
Afatinib |
Lung squamous cell carcinoma |
0.037529902 |
Sensitive |
| ENSG00000255120.1 |
Afatinib |
Lung squamous cell carcinoma |
0.02311481 |
Sensitive |
| ENSG00000255241.1 |
Afatinib |
Lung squamous cell carcinoma |
0.03323755 |
Sensitive |
| ENSG00000255959.1 |
Afatinib |
Lung squamous cell carcinoma |
0.00658261 |
Sensitive |
| ENSG00000256050.2 |
Afatinib |
Lung squamous cell carcinoma |
0.028234718 |
Sensitive |
| ENSG00000256650.1 |
Afatinib |
Lung squamous cell carcinoma |
0.012040733 |
Sensitive |
| ENSG00000257038.1 |
Afatinib |
Lung squamous cell carcinoma |
0.036630315 |
Sensitive |
| ENSG00000257671.1 |
Afatinib |
Lung squamous cell carcinoma |
0.028167284 |
Sensitive |
| ENSG00000258122.1 |
Afatinib |
Lung squamous cell carcinoma |
0.044814555 |
Sensitive |
| ENSG00000258593.2 |
Afatinib |
Lung squamous cell carcinoma |
0.034490588 |
Sensitive |
| ENSG00000258689.1 |
Afatinib |
Lung squamous cell carcinoma |
0.049136319 |
Sensitive |
| ENSG00000258882.1 |
Afatinib |
Lung squamous cell carcinoma |
0.018417506 |
Sensitive |
| ENSG00000258903.1 |
Afatinib |
Lung squamous cell carcinoma |
0.021630881 |
Sensitive |
| ENSG00000258929.2 |
Afatinib |
Lung squamous cell carcinoma |
0.011621202 |
Sensitive |
| ENSG00000259354.1 |
Afatinib |
Lung squamous cell carcinoma |
0.04569614 |
Sensitive |
| ENSG00000259796.1 |
Afatinib |
Lung squamous cell carcinoma |
0.016172258 |
Sensitive |
| ENSG00000259871.1 |
Afatinib |
Lung squamous cell carcinoma |
0.036772101 |
Sensitive |
| ENSG00000259942.1 |
Afatinib |
Lung squamous cell carcinoma |
0.035011755 |
Sensitive |
| ENSG00000260118.1 |
Afatinib |
Lung squamous cell carcinoma |
0.01383609 |
Sensitive |
| ENSG00000260136.1 |
Afatinib |
Lung squamous cell carcinoma |
0.001232374 |
Sensitive |
| ENSG00000260173.1 |
Afatinib |
Lung squamous cell carcinoma |
0.018178695 |
Sensitive |
| ENSG00000260328.1 |
Afatinib |
Lung squamous cell carcinoma |
0.015948606 |
Sensitive |
| ENSG00000260352.1 |
Afatinib |
Lung squamous cell carcinoma |
0.001789012 |
Sensitive |
| ENSG00000260577.1 |
Afatinib |
Lung squamous cell carcinoma |
0.034376145 |
Sensitive |
| ENSG00000260798.1 |
Afatinib |
Lung squamous cell carcinoma |
0.027383741 |
Sensitive |
| ENSG00000261000.1 |
Afatinib |
Lung squamous cell carcinoma |
0.015403142 |
Sensitive |
| ENSG00000261055.1 |
Afatinib |
Lung squamous cell carcinoma |
0.037647734 |
Sensitive |
| ENSG00000261068.1 |
Afatinib |
Lung squamous cell carcinoma |
0.028799404 |
Sensitive |
| ENSG00000261183.1 |
Afatinib |
Lung squamous cell carcinoma |
0.028825594 |
Sensitive |
| ENSG00000261220.2 |
Afatinib |
Lung squamous cell carcinoma |
0.031036858 |
Sensitive |
| ENSG00000261286.1 |
Afatinib |
Lung squamous cell carcinoma |
0.002190249 |
Sensitive |
| ENSG00000261521.1 |
Afatinib |
Lung squamous cell carcinoma |
0.041563896 |
Sensitive |
| ENSG00000261690.1 |
Afatinib |
Lung squamous cell carcinoma |
0.004154169 |
Sensitive |
| ENSG00000261804.1 |
Afatinib |
Lung squamous cell carcinoma |
0.014943673 |
Sensitive |
| ENSG00000261916.1 |
Afatinib |
Lung squamous cell carcinoma |
0.018673455 |
Sensitive |
| ENSG00000262343.1 |
Afatinib |
Lung squamous cell carcinoma |
0.007486703 |
Sensitive |
| ENSG00000262714.1 |
Afatinib |
Lung squamous cell carcinoma |
0.011210084 |
Sensitive |
| ENSG00000262979.1 |
Afatinib |
Lung squamous cell carcinoma |
0.031155771 |
Sensitive |
| ENSG00000263325.1 |
Afatinib |
Lung squamous cell carcinoma |
0.001113112 |
Sensitive |
| ENSG00000263680.2 |
Afatinib |
Lung squamous cell carcinoma |
0.017154035 |
Sensitive |
| ENSG00000264222.1 |
Afatinib |
Lung squamous cell carcinoma |
0.01139464 |
Sensitive |
| ENSG00000264859.1 |
Afatinib |
Lung squamous cell carcinoma |
0.000281276 |
Sensitive |
| ENSG00000265055.1 |
Afatinib |
Lung squamous cell carcinoma |
0.014474535 |
Sensitive |
| ENSG00000265349.1 |
Afatinib |
Lung squamous cell carcinoma |
0.00963948 |
Sensitive |
| ENSG00000265519.1 |
Afatinib |
Lung squamous cell carcinoma |
0.005371374 |
Sensitive |
| ENSG00000265787.1 |
Afatinib |
Lung squamous cell carcinoma |
0.031281318 |
Sensitive |
| ENSG00000266088.1 |
Afatinib |
Lung squamous cell carcinoma |
0.021202473 |
Sensitive |
| ENSG00000266869.1 |
Afatinib |
Lung squamous cell carcinoma |
0.012699239 |
Sensitive |
| ENSG00000266970.1 |
Afatinib |
Lung squamous cell carcinoma |
0.020472999 |
Sensitive |
| ENSG00000267026.1 |
Afatinib |
Lung squamous cell carcinoma |
0.012049037 |
Sensitive |
| ENSG00000267079.1 |
Afatinib |
Lung squamous cell carcinoma |
0.038653942 |
Sensitive |
| ENSG00000267112.1 |
Afatinib |
Lung squamous cell carcinoma |
0.043778883 |
Sensitive |
| ENSG00000267288.1 |
Afatinib |
Lung squamous cell carcinoma |
0.014401621 |
Sensitive |
| ENSG00000267308.1 |
Afatinib |
Lung squamous cell carcinoma |
0.012638257 |
Sensitive |
| ENSG00000267311.1 |
Afatinib |
Lung squamous cell carcinoma |
0.02527981 |
Sensitive |
| ENSG00000267344.1 |
Afatinib |
Lung squamous cell carcinoma |
0.00304387 |
Sensitive |
| ENSG00000267446.1 |
Afatinib |
Lung squamous cell carcinoma |
0.037201069 |
Sensitive |
| ENSG00000267519.2 |
Afatinib |
Lung squamous cell carcinoma |
0.003706973 |
Sensitive |
| ENSG00000268355.1 |
Afatinib |
Lung squamous cell carcinoma |
0.042084265 |
Sensitive |
| ENSG00000268812.2 |
Afatinib |
Lung squamous cell carcinoma |
0.033902031 |
Sensitive |
| ENSG00000268913.1 |
Afatinib |
Lung squamous cell carcinoma |
0.009713718 |
Sensitive |
| ENSG00000268931.1 |
Afatinib |
Lung squamous cell carcinoma |
0.034117789 |
Sensitive |
| ENSG00000269946.1 |
Afatinib |
Lung squamous cell carcinoma |
0.023989541 |
Sensitive |
| ENSG00000269989.1 |
Afatinib |
Lung squamous cell carcinoma |
0.022957968 |
Sensitive |
| ENSG00000270115.1 |
Afatinib |
Lung squamous cell carcinoma |
0.024901365 |
Sensitive |
| ENSG00000270190.1 |
Afatinib |
Lung squamous cell carcinoma |
0.004316101 |
Sensitive |
| ENSG00000270265.1 |
Afatinib |
Lung squamous cell carcinoma |
0.002185133 |
Sensitive |
| ENSG00000270951.1 |
Afatinib |
Lung squamous cell carcinoma |
0.025190424 |
Sensitive |
| ENSG00000271252.1 |
Afatinib |
Lung squamous cell carcinoma |
0.044385358 |
Sensitive |
| ENSG00000271344.1 |
Afatinib |
Lung squamous cell carcinoma |
0.009233866 |
Sensitive |
| ENSG00000271722.1 |
Afatinib |
Lung squamous cell carcinoma |
0.010836476 |
Sensitive |
| ENSG00000272465.1 |
Afatinib |
Lung squamous cell carcinoma |
0.004843466 |
Sensitive |
| ENSG00000272482.1 |
Afatinib |
Lung squamous cell carcinoma |
0.030586575 |
Sensitive |
| ENSG00000272554.1 |
Afatinib |
Lung squamous cell carcinoma |
0.007339991 |
Sensitive |
| ENSG00000272620.1 |
Afatinib |
Lung squamous cell carcinoma |
0.008745575 |
Sensitive |
| ENSG00000273065.1 |
Afatinib |
Lung squamous cell carcinoma |
0.017504369 |
Sensitive |
| ENSG00000273399.1 |
Afatinib |
Lung squamous cell carcinoma |
0.012513055 |
Sensitive |
| ENSG00000273443.1 |
Afatinib |
Lung squamous cell carcinoma |
0.006940739 |
Sensitive |
| ENSG00000214353.3 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.030922472 |
Sensitive |
| ENSG00000214559.3 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.042682958 |
Sensitive |
| ENSG00000223571.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.006802156 |
Sensitive |
| ENSG00000223697.2 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.02967977 |
Sensitive |
| ENSG00000223956.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.030314167 |
Sensitive |
| ENSG00000224081.3 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.017975546 |
Sensitive |
| ENSG00000224687.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.047985157 |
Sensitive |
| ENSG00000225111.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.00442783 |
Sensitive |
| ENSG00000225187.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.005523993 |
Sensitive |
| ENSG00000225511.2 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.009866938 |
Sensitive |
| ENSG00000225760.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.012782169 |
Sensitive |
| ENSG00000226772.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.0373554 |
Sensitive |
| ENSG00000226803.3 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.023057031 |
Sensitive |
| ENSG00000227045.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.042323996 |
Sensitive |
| ENSG00000227681.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.019498856 |
Sensitive |
| ENSG00000227704.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.044546606 |
Sensitive |
| ENSG00000228084.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.027382618 |
Sensitive |
| ENSG00000228865.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.044224285 |
Sensitive |
| ENSG00000232194.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.038145162 |
Sensitive |
| ENSG00000232290.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.02287925 |
Sensitive |
| ENSG00000232490.2 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.020583234 |
Sensitive |
| ENSG00000233237.2 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.029088322 |
Sensitive |
| ENSG00000233871.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.002046583 |
Sensitive |
| ENSG00000235529.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.048626495 |
Sensitive |
| ENSG00000235947.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.046491659 |
Sensitive |
| ENSG00000236617.2 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.043147953 |
Sensitive |
| ENSG00000237689.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.002397559 |
Sensitive |
| ENSG00000240241.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.016450153 |
Sensitive |
| ENSG00000241570.4 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.014938521 |
Sensitive |
| ENSG00000241818.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.045875056 |
Sensitive |
| ENSG00000247498.5 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.000356604 |
Sensitive |
| ENSG00000247774.2 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.016117877 |
Sensitive |
| ENSG00000253708.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.048581377 |
Sensitive |
| ENSG00000253986.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.041409846 |
Sensitive |
| ENSG00000254109.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.033208094 |
Sensitive |
| ENSG00000254495.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.043736981 |
Sensitive |
| ENSG00000255118.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.0000334 |
Sensitive |
| ENSG00000255857.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.035481385 |
Sensitive |
| ENSG00000256006.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.013072412 |
Sensitive |
| ENSG00000256448.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.047504381 |
Sensitive |
| ENSG00000257137.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.002633544 |
Sensitive |
| ENSG00000257391.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.024789781 |
Sensitive |
| ENSG00000257660.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.002660574 |
Sensitive |
| ENSG00000257940.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.007999248 |
Sensitive |
| ENSG00000258099.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.009428206 |
Sensitive |
| ENSG00000258413.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.025711539 |
Sensitive |
| ENSG00000258479.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.015589438 |
Sensitive |
| ENSG00000258891.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.015645047 |
Sensitive |
| ENSG00000259088.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.008614728 |
Sensitive |
| ENSG00000259250.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.040691906 |
Sensitive |
| ENSG00000259792.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.027898467 |
Sensitive |
| ENSG00000260173.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.014909266 |
Sensitive |
| ENSG00000260361.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.016397715 |
Sensitive |
| ENSG00000261003.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.013179176 |
Sensitive |
| ENSG00000261055.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.029390176 |
Sensitive |
| ENSG00000261280.2 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.025099321 |
Sensitive |
| ENSG00000261685.2 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.028132457 |
Sensitive |
| ENSG00000262222.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.0000668 |
Sensitive |
| ENSG00000262810.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.007239786 |
Sensitive |
| ENSG00000263013.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.00018473 |
Sensitive |
| ENSG00000264043.2 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.022585681 |
Sensitive |
| ENSG00000265656.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.002074737 |
Sensitive |
| ENSG00000266149.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.035352814 |
Sensitive |
| ENSG00000266466.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.041626461 |
Sensitive |
| ENSG00000266912.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.045671948 |
Sensitive |
| ENSG00000266922.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.012083018 |
Sensitive |
| ENSG00000267003.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.038898444 |
Sensitive |
| ENSG00000269082.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.002601261 |
Sensitive |
| ENSG00000269487.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.015742153 |
Sensitive |
| ENSG00000269694.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.00555877 |
Sensitive |
| ENSG00000269949.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.029951248 |
Sensitive |
| ENSG00000272191.1 |
Afatinib |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
0.00469964 |
Sensitive |
| ENSG00000175147.7 |
Afatinib |
Pancreatic adenocarcinoma |
0.026340311 |
Sensitive |
| ENSG00000177993.3 |
Afatinib |
Pancreatic adenocarcinoma |
0.034620129 |
Sensitive |
| ENSG00000187904.3 |
Afatinib |
Pancreatic adenocarcinoma |
0.023378658 |
Sensitive |
| ENSG00000198221.7 |
Afatinib |
Pancreatic adenocarcinoma |
0.017166468 |
Sensitive |
| ENSG00000203801.4 |
Afatinib |
Pancreatic adenocarcinoma |
0.021500193 |
Sensitive |
| ENSG00000204625.6 |
Afatinib |
Pancreatic adenocarcinoma |
0.023170772 |
Sensitive |
| ENSG00000205266.5 |
Afatinib |
Pancreatic adenocarcinoma |
0.000378708 |
Sensitive |
| ENSG00000214894.2 |
Afatinib |
Pancreatic adenocarcinoma |
0.033060822 |
Sensitive |
| ENSG00000215863.2 |
Afatinib |
Pancreatic adenocarcinoma |
0.047534743 |
Sensitive |
| ENSG00000223576.2 |
Afatinib |
Pancreatic adenocarcinoma |
0.044032396 |
Sensitive |
| ENSG00000223759.2 |
Afatinib |
Pancreatic adenocarcinoma |
0.032532135 |
Sensitive |
| ENSG00000223784.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.006587448 |
Sensitive |
| ENSG00000223804.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.039496499 |
Sensitive |
| ENSG00000224220.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.012454071 |
Sensitive |
| ENSG00000224356.3 |
Afatinib |
Pancreatic adenocarcinoma |
0.029158786 |
Sensitive |
| ENSG00000224606.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.022648692 |
Sensitive |
| ENSG00000224666.2 |
Afatinib |
Pancreatic adenocarcinoma |
0.008810123 |
Sensitive |
| ENSG00000226067.2 |
Afatinib |
Pancreatic adenocarcinoma |
0.034127922 |
Sensitive |
| ENSG00000226272.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.014338245 |
Sensitive |
| ENSG00000226963.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.021101516 |
Sensitive |
| ENSG00000227006.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.048345617 |
Sensitive |
| ENSG00000227036.2 |
Afatinib |
Pancreatic adenocarcinoma |
0.011263873 |
Sensitive |
| ENSG00000227071.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.030585513 |
Sensitive |
| ENSG00000227885.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.015899365 |
Sensitive |
| ENSG00000228201.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.031769114 |
Sensitive |
| ENSG00000228204.2 |
Afatinib |
Pancreatic adenocarcinoma |
0.049401558 |
Sensitive |
| ENSG00000228598.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.003838081 |
Sensitive |
| ENSG00000229140.4 |
Afatinib |
Pancreatic adenocarcinoma |
0.049866718 |
Sensitive |
| ENSG00000229152.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.018019376 |
Sensitive |
| ENSG00000229660.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.020624413 |
Sensitive |
| ENSG00000229666.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.035487299 |
Sensitive |
| ENSG00000229801.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.016819959 |
Sensitive |
| ENSG00000230698.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.037778471 |
Sensitive |
| ENSG00000230732.3 |
Afatinib |
Pancreatic adenocarcinoma |
0.049502848 |
Sensitive |
| ENSG00000231187.2 |
Afatinib |
Pancreatic adenocarcinoma |
0.046862835 |
Sensitive |
| ENSG00000231551.2 |
Afatinib |
Pancreatic adenocarcinoma |
0.001476707 |
Sensitive |
| ENSG00000231734.4 |
Afatinib |
Pancreatic adenocarcinoma |
0.012305682 |
Sensitive |
| ENSG00000232082.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.041082696 |
Sensitive |
| ENSG00000232118.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.030897929 |
Sensitive |
| ENSG00000232151.5 |
Afatinib |
Pancreatic adenocarcinoma |
0.041090976 |
Sensitive |
| ENSG00000232354.3 |
Afatinib |
Pancreatic adenocarcinoma |
0.021166205 |
Sensitive |
| ENSG00000233799.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.031375491 |
Sensitive |
| ENSG00000233834.2 |
Afatinib |
Pancreatic adenocarcinoma |
0.00460158 |
Sensitive |
| ENSG00000234650.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.002020908 |
Sensitive |
| ENSG00000235236.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.036243295 |
Sensitive |
| ENSG00000235398.4 |
Afatinib |
Pancreatic adenocarcinoma |
0.030987486 |
Sensitive |
| ENSG00000235659.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.029586088 |
Sensitive |
| ENSG00000235908.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.020429733 |
Sensitive |
| ENSG00000235999.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.010781479 |
Sensitive |
| ENSG00000236199.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.020828878 |
Sensitive |
| ENSG00000236383.3 |
Afatinib |
Pancreatic adenocarcinoma |
0.030606789 |
Sensitive |
| ENSG00000236889.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.034780471 |
Sensitive |
| ENSG00000236943.2 |
Afatinib |
Pancreatic adenocarcinoma |
0.009730682 |
Sensitive |
| ENSG00000237819.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.033381628 |
Sensitive |
| ENSG00000239335.4 |
Afatinib |
Pancreatic adenocarcinoma |
0.043619798 |
Sensitive |
| ENSG00000239653.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.017555499 |
Sensitive |
| ENSG00000240006.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.049830668 |
Sensitive |
| ENSG00000240373.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.028764397 |
Sensitive |
| ENSG00000243350.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.031184886 |
Sensitive |
| ENSG00000244649.2 |
Afatinib |
Pancreatic adenocarcinoma |
0.042456124 |
Sensitive |
| ENSG00000246228.2 |
Afatinib |
Pancreatic adenocarcinoma |
0.027517028 |
Sensitive |
| ENSG00000247095.2 |
Afatinib |
Pancreatic adenocarcinoma |
0.029610397 |
Sensitive |
| ENSG00000248996.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.000317498 |
Sensitive |
| ENSG00000250608.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.027244529 |
Sensitive |
| ENSG00000250950.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.024494182 |
Sensitive |
| ENSG00000253522.2 |
Afatinib |
Pancreatic adenocarcinoma |
0.021675194 |
Sensitive |
| ENSG00000253972.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.017612571 |
Sensitive |
| ENSG00000254258.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.033821388 |
Sensitive |
| ENSG00000254414.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.008960649 |
Sensitive |
| ENSG00000254418.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.03812646 |
Sensitive |
| ENSG00000254632.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.01493775 |
Sensitive |
| ENSG00000254691.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.043197248 |
Sensitive |
| ENSG00000254694.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.044832053 |
Sensitive |
| ENSG00000254777.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.010187155 |
Sensitive |
| ENSG00000254929.2 |
Afatinib |
Pancreatic adenocarcinoma |
0.044976748 |
Sensitive |
| ENSG00000255148.2 |
Afatinib |
Pancreatic adenocarcinoma |
0.006249893 |
Sensitive |
| ENSG00000255355.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.011629685 |
Sensitive |
| ENSG00000257588.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.04499422 |
Sensitive |
| ENSG00000257894.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.021093071 |
Sensitive |
| ENSG00000258317.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.02965748 |
Sensitive |
| ENSG00000258412.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.044065483 |
Sensitive |
| ENSG00000258424.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.03795461 |
Sensitive |
| ENSG00000259039.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.025564967 |
Sensitive |
| ENSG00000259083.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.042150644 |
Sensitive |
| ENSG00000259354.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.017249273 |
Sensitive |
| ENSG00000259359.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.040909604 |
Sensitive |
| ENSG00000259380.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.036004515 |
Sensitive |
| ENSG00000259450.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.032118654 |
Sensitive |
| ENSG00000259595.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.027089891 |
Sensitive |
| ENSG00000259644.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.042247953 |
Sensitive |
| ENSG00000259659.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.002099709 |
Sensitive |
| ENSG00000259663.2 |
Afatinib |
Pancreatic adenocarcinoma |
0.03302951 |
Sensitive |
| ENSG00000259727.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.021784193 |
Sensitive |
| ENSG00000259767.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.026851152 |
Sensitive |
| ENSG00000260509.2 |
Afatinib |
Pancreatic adenocarcinoma |
0.020488293 |
Sensitive |
| ENSG00000260558.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.011024276 |
Sensitive |
| ENSG00000260586.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.039767386 |
Sensitive |
| ENSG00000260742.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.00069945 |
Sensitive |
| ENSG00000260877.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.030492492 |
Sensitive |
| ENSG00000263220.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.039510784 |
Sensitive |
| ENSG00000263680.2 |
Afatinib |
Pancreatic adenocarcinoma |
0.010115434 |
Sensitive |
| ENSG00000263718.2 |
Afatinib |
Pancreatic adenocarcinoma |
0.045464477 |
Sensitive |
| ENSG00000263847.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.027603927 |
Sensitive |
| ENSG00000263893.2 |
Afatinib |
Pancreatic adenocarcinoma |
0.040378256 |
Sensitive |
| ENSG00000264304.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.047711978 |
Sensitive |
| ENSG00000264672.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.044548488 |
Sensitive |
| ENSG00000264954.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.04164076 |
Sensitive |
| ENSG00000265490.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.025746033 |
Sensitive |
| ENSG00000265519.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.041428804 |
Sensitive |
| ENSG00000265845.2 |
Afatinib |
Pancreatic adenocarcinoma |
0.006177284 |
Sensitive |
| ENSG00000266718.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.012124848 |
Sensitive |
| ENSG00000267016.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.031862626 |
Sensitive |
| ENSG00000267117.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.002542694 |
Sensitive |
| ENSG00000267263.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.038895851 |
Sensitive |
| ENSG00000267288.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.033525376 |
Sensitive |
| ENSG00000267474.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.001270625 |
Sensitive |
| ENSG00000269172.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.005266868 |
Sensitive |
| ENSG00000269652.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.038309906 |
Sensitive |
| ENSG00000269680.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.037805634 |
Sensitive |
| ENSG00000269925.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.018565788 |
Sensitive |
| ENSG00000270190.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.02712103 |
Sensitive |
| ENSG00000271778.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.047115181 |
Sensitive |
| ENSG00000271948.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.040992235 |
Sensitive |
| ENSG00000272346.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.023634392 |
Sensitive |
| ENSG00000272650.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.006277879 |
Sensitive |
| ENSG00000272954.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.02342362 |
Sensitive |
| ENSG00000273193.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.048102767 |
Sensitive |
| ENSG00000273343.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.038776008 |
Sensitive |
| ENSG00000273447.1 |
Afatinib |
Pancreatic adenocarcinoma |
0.013980687 |
Sensitive |
| ENSG00000184274.3 |
Afatinib |
Sarcoma |
0.043451661 |
Sensitive |
| ENSG00000203288.3 |
Afatinib |
Sarcoma |
0.006056777 |
Sensitive |
| ENSG00000203356.2 |
Afatinib |
Sarcoma |
0.035855436 |
Sensitive |
| ENSG00000214432.5 |
Afatinib |
Sarcoma |
0.014692334 |
Sensitive |
| ENSG00000219665.4 |
Afatinib |
Sarcoma |
0.049322256 |
Sensitive |
| ENSG00000225173.1 |
Afatinib |
Sarcoma |
0.018418415 |
Sensitive |
| ENSG00000227617.4 |
Afatinib |
Sarcoma |
0.040585459 |
Sensitive |
| ENSG00000228084.1 |
Afatinib |
Sarcoma |
0.041145693 |
Sensitive |
| ENSG00000229228.1 |
Afatinib |
Sarcoma |
0.046209381 |
Sensitive |
| ENSG00000231690.2 |
Afatinib |
Sarcoma |
0.034580954 |
Sensitive |
| ENSG00000233627.2 |
Afatinib |
Sarcoma |
0.042878262 |
Sensitive |
| ENSG00000237646.1 |
Afatinib |
Sarcoma |
0.024491855 |
Sensitive |
| ENSG00000240990.5 |
Afatinib |
Sarcoma |
0.001017608 |
Sensitive |
| ENSG00000253347.1 |
Afatinib |
Sarcoma |
0.033530146 |
Sensitive |
| ENSG00000253408.1 |
Afatinib |
Sarcoma |
0.014790612 |
Sensitive |
| ENSG00000253476.1 |
Afatinib |
Sarcoma |
0.022990749 |
Sensitive |
| ENSG00000257256.1 |
Afatinib |
Sarcoma |
0.04211371 |
Sensitive |
| ENSG00000259417.2 |
Afatinib |
Sarcoma |
0.038495659 |
Sensitive |
| ENSG00000260368.1 |
Afatinib |
Sarcoma |
0.010086654 |
Sensitive |
| ENSG00000264729.1 |
Afatinib |
Sarcoma |
0.032484148 |
Sensitive |
| ENSG00000264829.1 |
Afatinib |
Sarcoma |
0.015798154 |
Sensitive |
| ENSG00000267042.1 |
Afatinib |
Sarcoma |
0.02101948 |
Sensitive |
| ENSG00000267383.2 |
Afatinib |
Sarcoma |
0.017753238 |
Sensitive |
| ENSG00000267394.1 |
Afatinib |
Sarcoma |
0.034481086 |
Sensitive |
| ENSG00000269235.1 |
Afatinib |
Sarcoma |
0.033683974 |
Sensitive |
| ENSG00000272109.1 |
Afatinib |
Sarcoma |
0.035076435 |
Sensitive |
| ENSG00000272158.1 |
Afatinib |
Sarcoma |
0.019868525 |
Sensitive |
| ENSG00000188660.3 |
Afatinib |
Skin cutaneous melanoma |
0.035408012 |
Sensitive |
| ENSG00000189196.4 |
Afatinib |
Skin cutaneous melanoma |
0.006939223 |
Sensitive |
| ENSG00000198106.7 |
Afatinib |
Skin cutaneous melanoma |
0.031452443 |
Sensitive |
| ENSG00000203325.3 |
Afatinib |
Skin cutaneous melanoma |
0.013332594 |
Sensitive |
| ENSG00000204666.3 |
Afatinib |
Skin cutaneous melanoma |
0.026017422 |
Sensitive |
| ENSG00000204706.10 |
Afatinib |
Skin cutaneous melanoma |
0.044058427 |
Sensitive |
| ENSG00000204815.4 |
Afatinib |
Skin cutaneous melanoma |
0.02758665 |
Sensitive |
| ENSG00000205056.8 |
Afatinib |
Skin cutaneous melanoma |
0.03176342 |
Sensitive |
| ENSG00000215068.3 |
Afatinib |
Skin cutaneous melanoma |
0.043184092 |
Sensitive |
| ENSG00000215159.3 |
Afatinib |
Skin cutaneous melanoma |
0.043178831 |
Sensitive |
| ENSG00000223711.1 |
Afatinib |
Skin cutaneous melanoma |
0.03920047 |
Sensitive |
| ENSG00000224017.1 |
Afatinib |
Skin cutaneous melanoma |
0.002569636 |
Sensitive |
| ENSG00000224699.4 |
Afatinib |
Skin cutaneous melanoma |
0.000103237 |
Sensitive |
| ENSG00000224729.4 |
Afatinib |
Skin cutaneous melanoma |
0.013211773 |
Sensitive |
| ENSG00000226017.2 |
Afatinib |
Skin cutaneous melanoma |
0.006172114 |
Sensitive |
| ENSG00000226386.1 |
Afatinib |
Skin cutaneous melanoma |
0.039953295 |
Sensitive |
| ENSG00000226754.1 |
Afatinib |
Skin cutaneous melanoma |
0.019130075 |
Sensitive |
| ENSG00000227527.2 |
Afatinib |
Skin cutaneous melanoma |
0.028500112 |
Sensitive |
| ENSG00000228775.3 |
Afatinib |
Skin cutaneous melanoma |
0.046051245 |
Sensitive |
| ENSG00000229373.4 |
Afatinib |
Skin cutaneous melanoma |
0.03755536 |
Sensitive |
| ENSG00000230613.1 |
Afatinib |
Skin cutaneous melanoma |
0.014277954 |
Sensitive |
| ENSG00000230825.1 |
Afatinib |
Skin cutaneous melanoma |
0.009286465 |
Sensitive |
| ENSG00000231028.4 |
Afatinib |
Skin cutaneous melanoma |
0.013507685 |
Sensitive |
| ENSG00000231329.3 |
Afatinib |
Skin cutaneous melanoma |
0.030537904 |
Sensitive |
| ENSG00000231881.1 |
Afatinib |
Skin cutaneous melanoma |
0.049807006 |
Sensitive |
| ENSG00000231969.1 |
Afatinib |
Skin cutaneous melanoma |
0.026601093 |
Sensitive |
| ENSG00000232151.5 |
Afatinib |
Skin cutaneous melanoma |
0.031084235 |
Sensitive |
| ENSG00000232453.1 |
Afatinib |
Skin cutaneous melanoma |
0.04018907 |
Sensitive |
| ENSG00000232977.2 |
Afatinib |
Skin cutaneous melanoma |
0.035919222 |
Sensitive |
| ENSG00000233058.1 |
Afatinib |
Skin cutaneous melanoma |
0.032288998 |
Sensitive |
| ENSG00000233143.1 |
Afatinib |
Skin cutaneous melanoma |
0.018471459 |
Sensitive |
| ENSG00000233862.1 |
Afatinib |
Skin cutaneous melanoma |
0.029116806 |
Sensitive |
| ENSG00000234091.1 |
Afatinib |
Skin cutaneous melanoma |
0.008685434 |
Sensitive |
| ENSG00000234199.2 |
Afatinib |
Skin cutaneous melanoma |
0.028281266 |
Sensitive |
| ENSG00000234350.1 |
Afatinib |
Skin cutaneous melanoma |
0.017605453 |
Sensitive |
| ENSG00000235652.3 |
Afatinib |
Skin cutaneous melanoma |
0.049052542 |
Sensitive |
| ENSG00000235902.1 |
Afatinib |
Skin cutaneous melanoma |
0.034056147 |
Sensitive |
| ENSG00000236094.1 |
Afatinib |
Skin cutaneous melanoma |
0.02528502 |
Sensitive |
| ENSG00000237234.2 |
Afatinib |
Skin cutaneous melanoma |
0.004180766 |
Sensitive |
| ENSG00000237502.2 |
Afatinib |
Skin cutaneous melanoma |
0.029008624 |
Sensitive |
| ENSG00000238107.1 |
Afatinib |
Skin cutaneous melanoma |
0.012439079 |
Sensitive |
| ENSG00000239920.1 |
Afatinib |
Skin cutaneous melanoma |
0.013339245 |
Sensitive |
| ENSG00000243533.2 |
Afatinib |
Skin cutaneous melanoma |
0.016948963 |
Sensitive |
| ENSG00000244252.1 |
Afatinib |
Skin cutaneous melanoma |
0.037169115 |
Sensitive |
| ENSG00000246548.3 |
Afatinib |
Skin cutaneous melanoma |
0.032086532 |
Sensitive |
| ENSG00000247809.3 |
Afatinib |
Skin cutaneous melanoma |
0.022686059 |
Sensitive |
| ENSG00000247853.2 |
Afatinib |
Skin cutaneous melanoma |
0.023918037 |
Sensitive |
| ENSG00000248079.2 |
Afatinib |
Skin cutaneous melanoma |
0.031776832 |
Sensitive |
| ENSG00000251615.3 |
Afatinib |
Skin cutaneous melanoma |
0.030509763 |
Sensitive |
| ENSG00000251687.1 |
Afatinib |
Skin cutaneous melanoma |
0.020440633 |
Sensitive |
| ENSG00000253632.1 |
Afatinib |
Skin cutaneous melanoma |
0.04821983 |
Sensitive |
| ENSG00000253837.1 |
Afatinib |
Skin cutaneous melanoma |
0.037827661 |
Sensitive |
| ENSG00000254607.2 |
Afatinib |
Skin cutaneous melanoma |
0.033606573 |
Sensitive |
| ENSG00000254932.2 |
Afatinib |
Skin cutaneous melanoma |
0.031971793 |
Sensitive |
| ENSG00000255090.1 |
Afatinib |
Skin cutaneous melanoma |
0.027509465 |
Sensitive |
| ENSG00000255248.2 |
Afatinib |
Skin cutaneous melanoma |
0.024376301 |
Sensitive |
| ENSG00000257859.1 |
Afatinib |
Skin cutaneous melanoma |
0.047534763 |
Sensitive |
| ENSG00000258302.1 |
Afatinib |
Skin cutaneous melanoma |
0.006573139 |
Sensitive |
| ENSG00000258323.1 |
Afatinib |
Skin cutaneous melanoma |
0.04128927 |
Sensitive |
| ENSG00000258454.1 |
Afatinib |
Skin cutaneous melanoma |
0.011197738 |
Sensitive |
| ENSG00000258479.1 |
Afatinib |
Skin cutaneous melanoma |
0.010971967 |
Sensitive |
| ENSG00000259065.1 |
Afatinib |
Skin cutaneous melanoma |
0.017079231 |
Sensitive |
| ENSG00000259146.2 |
Afatinib |
Skin cutaneous melanoma |
0.021141923 |
Sensitive |
| ENSG00000259225.2 |
Afatinib |
Skin cutaneous melanoma |
0.03971996 |
Sensitive |
| ENSG00000259523.1 |
Afatinib |
Skin cutaneous melanoma |
0.032914447 |
Sensitive |
| ENSG00000259635.1 |
Afatinib |
Skin cutaneous melanoma |
0.02312382 |
Sensitive |
| ENSG00000259644.1 |
Afatinib |
Skin cutaneous melanoma |
0.026442808 |
Sensitive |
| ENSG00000259763.1 |
Afatinib |
Skin cutaneous melanoma |
0.036165404 |
Sensitive |
| ENSG00000259775.1 |
Afatinib |
Skin cutaneous melanoma |
0.025157048 |
Sensitive |
| ENSG00000260063.1 |
Afatinib |
Skin cutaneous melanoma |
0.044993617 |
Sensitive |
| ENSG00000260186.1 |
Afatinib |
Skin cutaneous melanoma |
0.032137453 |
Sensitive |
| ENSG00000260194.1 |
Afatinib |
Skin cutaneous melanoma |
0.011688108 |
Sensitive |
| ENSG00000260910.1 |
Afatinib |
Skin cutaneous melanoma |
0.031850152 |
Sensitive |
| ENSG00000260953.1 |
Afatinib |
Skin cutaneous melanoma |
0.046561547 |
Sensitive |
| ENSG00000261286.1 |
Afatinib |
Skin cutaneous melanoma |
0.037841381 |
Sensitive |
| ENSG00000261295.1 |
Afatinib |
Skin cutaneous melanoma |
0.048594092 |
Sensitive |
| ENSG00000261597.1 |
Afatinib |
Skin cutaneous melanoma |
0.040091842 |
Sensitive |
| ENSG00000261654.1 |
Afatinib |
Skin cutaneous melanoma |
0.010311297 |
Sensitive |
| ENSG00000266469.1 |
Afatinib |
Skin cutaneous melanoma |
0.004122887 |
Sensitive |
| ENSG00000266957.1 |
Afatinib |
Skin cutaneous melanoma |
0.013516883 |
Sensitive |
| ENSG00000267313.2 |
Afatinib |
Skin cutaneous melanoma |
0.032352618 |
Sensitive |
| ENSG00000269574.1 |
Afatinib |
Skin cutaneous melanoma |
0.015504872 |
Sensitive |
| ENSG00000271334.1 |
Afatinib |
Skin cutaneous melanoma |
0.035928564 |
Sensitive |
| ENSG00000272128.1 |
Afatinib |
Skin cutaneous melanoma |
0.037295109 |
Sensitive |
| ENSG00000272144.1 |
Afatinib |
Skin cutaneous melanoma |
0.022698271 |
Sensitive |
| ENSG00000272156.1 |
Afatinib |
Skin cutaneous melanoma |
0.044745597 |
Sensitive |
| ENSG00000272416.1 |
Afatinib |
Skin cutaneous melanoma |
0.024003151 |
Sensitive |
| ENSG00000272949.1 |
Afatinib |
Skin cutaneous melanoma |
0.019999784 |
Sensitive |
| ENSG00000272970.1 |
Afatinib |
Skin cutaneous melanoma |
0.037980666 |
Sensitive |
| ENSG00000273257.1 |
Afatinib |
Skin cutaneous melanoma |
0.043327223 |
Sensitive |
| ENSG00000273464.1 |
Afatinib |
Skin cutaneous melanoma |
0.025360189 |
Sensitive |
| ENSG00000179523.4 |
Afatinib |
Stomach adenocarcinoma |
0.016845665 |
Sensitive |
| ENSG00000184068.2 |
Afatinib |
Stomach adenocarcinoma |
0.041683977 |
Sensitive |
| ENSG00000205559.3 |
Afatinib |
Stomach adenocarcinoma |
0.049718892 |
Sensitive |
| ENSG00000224959.1 |
Afatinib |
Stomach adenocarcinoma |
0.04142257 |
Sensitive |
| ENSG00000225039.1 |
Afatinib |
Stomach adenocarcinoma |
0.019038846 |
Sensitive |
| ENSG00000225335.2 |
Afatinib |
Stomach adenocarcinoma |
0.005449781 |
Sensitive |
| ENSG00000226328.2 |
Afatinib |
Stomach adenocarcinoma |
0.047751785 |
Sensitive |
| ENSG00000227210.1 |
Afatinib |
Stomach adenocarcinoma |
0.003932139 |
Sensitive |
| ENSG00000227598.1 |
Afatinib |
Stomach adenocarcinoma |
0.009346037 |
Sensitive |
| ENSG00000227619.1 |
Afatinib |
Stomach adenocarcinoma |
0.025847424 |
Sensitive |
| ENSG00000228251.1 |
Afatinib |
Stomach adenocarcinoma |
0.0386517 |
Sensitive |
| ENSG00000229127.1 |
Afatinib |
Stomach adenocarcinoma |
0.036404681 |
Sensitive |
| ENSG00000230074.1 |
Afatinib |
Stomach adenocarcinoma |
0.020316487 |
Sensitive |
| ENSG00000230423.1 |
Afatinib |
Stomach adenocarcinoma |
0.048722948 |
Sensitive |
| ENSG00000231770.1 |
Afatinib |
Stomach adenocarcinoma |
0.040929781 |
Sensitive |
| ENSG00000232311.1 |
Afatinib |
Stomach adenocarcinoma |
0.048463383 |
Sensitive |
| ENSG00000232442.1 |
Afatinib |
Stomach adenocarcinoma |
0.049650005 |
Sensitive |
| ENSG00000233368.2 |
Afatinib |
Stomach adenocarcinoma |
0.03778034 |
Sensitive |
| ENSG00000233654.1 |
Afatinib |
Stomach adenocarcinoma |
0.037288247 |
Sensitive |
| ENSG00000233895.1 |
Afatinib |
Stomach adenocarcinoma |
0.0316871 |
Sensitive |
| ENSG00000233903.2 |
Afatinib |
Stomach adenocarcinoma |
0.021394641 |
Sensitive |
| ENSG00000234684.2 |
Afatinib |
Stomach adenocarcinoma |
0.008951375 |
Sensitive |
| ENSG00000235381.1 |
Afatinib |
Stomach adenocarcinoma |
0.019856217 |
Sensitive |
| ENSG00000235387.1 |
Afatinib |
Stomach adenocarcinoma |
0.010743919 |
Sensitive |
| ENSG00000235453.3 |
Afatinib |
Stomach adenocarcinoma |
0.026780346 |
Sensitive |
| ENSG00000235527.2 |
Afatinib |
Stomach adenocarcinoma |
0.02354444 |
Sensitive |
| ENSG00000235823.1 |
Afatinib |
Stomach adenocarcinoma |
0.036524057 |
Sensitive |
| ENSG00000235954.2 |
Afatinib |
Stomach adenocarcinoma |
0.032950472 |
Sensitive |
| ENSG00000235958.1 |
Afatinib |
Stomach adenocarcinoma |
0.007407656 |
Sensitive |
| ENSG00000236432.3 |
Afatinib |
Stomach adenocarcinoma |
0.014787672 |
Sensitive |
| ENSG00000236914.3 |
Afatinib |
Stomach adenocarcinoma |
0.048703332 |
Sensitive |
| ENSG00000237489.2 |
Afatinib |
Stomach adenocarcinoma |
0.034846544 |
Sensitive |
| ENSG00000238113.2 |
Afatinib |
Stomach adenocarcinoma |
0.02134459 |
Sensitive |
| ENSG00000240350.1 |
Afatinib |
Stomach adenocarcinoma |
0.016868377 |
Sensitive |
| ENSG00000245685.2 |
Afatinib |
Stomach adenocarcinoma |
0.014808952 |
Sensitive |
| ENSG00000246898.1 |
Afatinib |
Stomach adenocarcinoma |
0.035290826 |
Sensitive |
| ENSG00000247809.3 |
Afatinib |
Stomach adenocarcinoma |
0.02358778 |
Sensitive |
| ENSG00000249395.2 |
Afatinib |
Stomach adenocarcinoma |
0.035574413 |
Sensitive |
| ENSG00000249476.1 |
Afatinib |
Stomach adenocarcinoma |
0.036016788 |
Sensitive |
| ENSG00000249637.1 |
Afatinib |
Stomach adenocarcinoma |
0.036217572 |
Sensitive |
| ENSG00000251003.3 |
Afatinib |
Stomach adenocarcinoma |
0.005170235 |
Sensitive |
| ENSG00000251350.1 |
Afatinib |
Stomach adenocarcinoma |
0.031916747 |
Sensitive |
| ENSG00000251396.2 |
Afatinib |
Stomach adenocarcinoma |
0.011338409 |
Sensitive |
| ENSG00000253716.1 |
Afatinib |
Stomach adenocarcinoma |
0.047473803 |
Sensitive |
| ENSG00000253948.1 |
Afatinib |
Stomach adenocarcinoma |
0.022364095 |
Sensitive |
| ENSG00000254258.1 |
Afatinib |
Stomach adenocarcinoma |
0.004568414 |
Sensitive |
| ENSG00000254718.2 |
Afatinib |
Stomach adenocarcinoma |
0.039833548 |
Sensitive |
| ENSG00000255031.1 |
Afatinib |
Stomach adenocarcinoma |
0.047744044 |
Sensitive |
| ENSG00000257543.1 |
Afatinib |
Stomach adenocarcinoma |
0.026797192 |
Sensitive |
| ENSG00000257681.1 |
Afatinib |
Stomach adenocarcinoma |
0.037525739 |
Sensitive |
| ENSG00000259523.1 |
Afatinib |
Stomach adenocarcinoma |
0.028703487 |
Sensitive |
| ENSG00000259883.1 |
Afatinib |
Stomach adenocarcinoma |
0.010917044 |
Sensitive |
| ENSG00000259891.1 |
Afatinib |
Stomach adenocarcinoma |
0.041485951 |
Sensitive |
| ENSG00000260000.2 |
Afatinib |
Stomach adenocarcinoma |
0.044910376 |
Sensitive |
| ENSG00000260081.1 |
Afatinib |
Stomach adenocarcinoma |
0.024586837 |
Sensitive |
| ENSG00000260095.1 |
Afatinib |
Stomach adenocarcinoma |
0.043633107 |
Sensitive |
| ENSG00000260368.1 |
Afatinib |
Stomach adenocarcinoma |
0.008472369 |
Sensitive |
| ENSG00000260418.1 |
Afatinib |
Stomach adenocarcinoma |
0.030200368 |
Sensitive |
| ENSG00000260436.1 |
Afatinib |
Stomach adenocarcinoma |
0.040300527 |
Sensitive |
| ENSG00000260517.1 |
Afatinib |
Stomach adenocarcinoma |
0.024361264 |
Sensitive |
| ENSG00000260708.1 |
Afatinib |
Stomach adenocarcinoma |
0.021389738 |
Sensitive |
| ENSG00000261019.1 |
Afatinib |
Stomach adenocarcinoma |
0.02872751 |
Sensitive |
| ENSG00000261286.1 |
Afatinib |
Stomach adenocarcinoma |
0.037804404 |
Sensitive |
| ENSG00000261485.1 |
Afatinib |
Stomach adenocarcinoma |
0.034658569 |
Sensitive |
| ENSG00000261533.1 |
Afatinib |
Stomach adenocarcinoma |
0.011141546 |
Sensitive |
| ENSG00000261534.1 |
Afatinib |
Stomach adenocarcinoma |
0.036589561 |
Sensitive |
| ENSG00000262155.1 |
Afatinib |
Stomach adenocarcinoma |
0.030086095 |
Sensitive |
| ENSG00000264107.1 |
Afatinib |
Stomach adenocarcinoma |
0.044188792 |
Sensitive |
| ENSG00000264569.1 |
Afatinib |
Stomach adenocarcinoma |
0.032148944 |
Sensitive |
| ENSG00000265204.1 |
Afatinib |
Stomach adenocarcinoma |
0.011373906 |
Sensitive |
| ENSG00000267150.1 |
Afatinib |
Stomach adenocarcinoma |
0.025150594 |
Sensitive |
| ENSG00000267383.2 |
Afatinib |
Stomach adenocarcinoma |
0.01723382 |
Sensitive |
| ENSG00000267560.1 |
Afatinib |
Stomach adenocarcinoma |
0.022994022 |
Sensitive |
| ENSG00000269439.1 |
Afatinib |
Stomach adenocarcinoma |
0.045132047 |
Sensitive |
| ENSG00000269463.1 |
Afatinib |
Stomach adenocarcinoma |
0.042749832 |
Sensitive |
| ENSG00000269483.1 |
Afatinib |
Stomach adenocarcinoma |
0.011374295 |
Sensitive |
| ENSG00000269980.1 |
Afatinib |
Stomach adenocarcinoma |
0.031767442 |
Sensitive |
| ENSG00000269996.1 |
Afatinib |
Stomach adenocarcinoma |
0.008243195 |
Sensitive |
| ENSG00000269997.1 |
Afatinib |
Stomach adenocarcinoma |
0.008132964 |
Sensitive |
| ENSG00000270048.1 |
Afatinib |
Stomach adenocarcinoma |
0.003466369 |
Sensitive |
| ENSG00000270084.1 |
Afatinib |
Stomach adenocarcinoma |
0.007152166 |
Sensitive |
| ENSG00000270104.1 |
Afatinib |
Stomach adenocarcinoma |
0.03493719 |
Sensitive |
| ENSG00000271427.1 |
Afatinib |
Stomach adenocarcinoma |
0.027275415 |
Sensitive |
| ENSG00000271913.1 |
Afatinib |
Stomach adenocarcinoma |
0.01477515 |
Sensitive |
| ENSG00000271930.1 |
Afatinib |
Stomach adenocarcinoma |
0.036488484 |
Sensitive |
| ENSG00000271978.1 |
Afatinib |
Stomach adenocarcinoma |
0.048273932 |
Sensitive |
| ENSG00000272102.1 |
Afatinib |
Stomach adenocarcinoma |
0.022408105 |
Sensitive |
| ENSG00000272373.1 |
Afatinib |
Stomach adenocarcinoma |
0.00369971 |
Sensitive |
| ENSG00000272993.1 |
Afatinib |
Stomach adenocarcinoma |
0.041861809 |
Sensitive |
| ENSG00000273026.1 |
Afatinib |
Stomach adenocarcinoma |
0.020668556 |
Sensitive |
| ENSG00000273033.1 |
Afatinib |
Stomach adenocarcinoma |
0.020911961 |
Sensitive |
| ENSG00000273091.1 |
Afatinib |
Stomach adenocarcinoma |
0.01334816 |
Sensitive |
| ENSG00000273240.1 |
Afatinib |
Stomach adenocarcinoma |
0.032844962 |
Sensitive |
| ENSG00000273247.1 |
Afatinib |
Stomach adenocarcinoma |
0.013252434 |
Sensitive |
| ENSG00000273350.1 |
Afatinib |
Stomach adenocarcinoma |
0.02549207 |
Sensitive |
| ENSG00000273366.1 |
Afatinib |
Stomach adenocarcinoma |
0.044720634 |
Sensitive |
